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OBJECTIVES

The purpose of this study is to determine whether the transfer of cellular proteins
from the cytosol into lysosomes is an obligatory step in their degrada.tion. To achieve the
objectives of this study:

1.

I will prepare large unilamellar phosphatidylserine (PS-LUV) liposomes as
possible vehicles for the injection of

radio]abeled

proteins into the

extralysosomal-cytoplasmic compartment of cultured cel11;.
2.

I will develop assays to monitor the extent of vesicle-cell fu5ion. If this technique
is successful, it will be possible to study the intracellular traffic llnd metabolism of
"newly" introduced cytosolic proteins against an unlabeled cell11Lar background.

3.

If PS-LUV prove unsuitable as vehicles for the microinjecti<>n of _proteins, I will
investigate the degradation of cellular proteins by labeling them with [3H]-leucine
and monitor the appearance of TCA-soluble and
medium.

-insolulJle products in the

In order to determine whether the lysos<>me is an intermediate

compartment in the degradation of cytosolic proteins,, protein tumover will be
studied under culture conditions which are believed io alte1 the extent of
sequestration of cellular proteins into lysosomes. The effeci5 cf pharmacological
agents known to alter intracellular vesicular trans.port,, intracellular protein
transport and lysosomal function will also be investigated.

xvn

xvm
4.

I will characterize the nature of any TCA-insoluble products released into the
culture medium to determine whether they arise from cell leakage, cell
detachment, vesicular shedding, or regurgitation of cell uLar proteins following
their prior sequestration in lysosomes.

5.

I will utilize the kinetic data to formulate a model to explain the appearance of
both TCA-soluble and TCA-insoluble products released jnto the culture medium,
the multiphasic nature of cellular protein turnover, and the effecis of temperature,
serum and amino acid deprivation, and added pharmaco logic agents.

Sarah Jones Olenick
Loyola University of Chicago
PATHWAYS OF INTRACELLULAR PROTEJN TURNOVER
IN CULTURED HUMAN FIBROBLASTS

Phosphatidylserine large unilamellar liposomes were investigated as a means of
injecting labeled proteins into fibroblasts to identify and quantiiaie pathways of cytosolic
protein turnover. Methods were developed to quantify liposome-ceJI fusion. The results
do not support liposome-plasma membrane fusion as the primary event in PS-LUVfibroblast interaction. Rather, PS-LUV tightly adhere to the

pla~ma membrane

of

fibroblasts and are difficult to remove by washing, giving the impression that liposomecell fusion has occurred.
The unsuitability of PS-LUV as a means of microinj ecting lalJ el ed proteins
prompted an investigation of the degradation of cellular proteiJ1s metalJolicaLly labeled
with [3H-4,5]-L-leucine. The turnover of cellular proteins resuli~ in tbe release into the
cultured medium of both TCA-soluble and -insoluble products iJ1 2 phases: a fast phase
(largely completed by 5 hours) and a slow phase (half life of aµpm1'imatel~ 4.8 days).
Electrophoretic analysis of TCA-insoluble radio labeled maierja] suggested that a
significant amount could have arisen from cell leakage or death. Protein
inhibitors had no effect on the appearance of TCA-insoluble produc:ts.

s~J1thesis

Protein turnover under serum-supplemented conditions was inhibited by
lysosomotropic amines, protein synthesis inhibitors, and serum and amino acid
deprivation. However, lysosomal proteinase inhibitors had no effect on cellular protein
degradation. This process was temperature-sensitive between 3 70 and 260 C with an Ea
=

7.8 kcal/mol. Under conditions of amino acid and protein deprivation, _:protein

degradation was diminished. This reduced turnover was no Longer inhibited by
lysosomotropic amines and was temperature-insensitive between 26° and37° C.
These results indicate that there are at least 2 pathways for cellular protein
turnover, one temperature-sensitive and the other temperature-insensitiYe. The
temperature-sensitive pathway is inhibited by lysosomotropic amines, serum and amino
acid deprivation, and protein synthesis inhibitors. It is presumed t<> be Lysosomal and is
responsive to rates of protein synthesis. The temperature-insensitive pathway is not
sensitive to lysosomotropic amines and is not inhibited by amino acid and protein
deprivation. It is presumed to be non-lysosomal and independentofraies of protein
synthesis.

CHAPTER I
INTRODUCTION
General Concepts of Protein Degradation in Cells
The concentration of a specific cellular protein depends on both its rate of
synthesis and its rate of degradation. Although the mechanisms for protein synthesis are
fairly well understood, those of degradation have not been well- c:harac:terized.

Both

processes may be modified experimentally in cell culture (Goldberg & St. John, 1976) by
manipulating the levels of serum, media constituents, hormones and growth factors, and
pharmacological agents (Doherty & Mayer, 1985; Gronostajski et al., 19 85; Thoene et al.,
1985; Okada & Dice, 1984; Ahlberg et al., 1985; Etlinger & GoJdber!\, 1977; Marshall &
Olefsky, 1983; Dice, 1982; Knowles & Ballard, 1981; Poo]e et al, 1978).

Protein

synthesis within growing cells is more sensitive to changes in high eoe1gy intermediates
(Gronostajski et al., 1985): a 90% reduction in ATP levels ca11ses only a 50% decrease in
proteolysis in growing fibroblasts, while a 15% reduction in ATP

Cllus~s

a 50% inhibition

of protein synthesis.
Cell growth occurs when protein synthesis exceeds proteolysis (Goldberg & St.
John, 1976). There is evidence that cellular protein levels are Jargely controlled by rates
of degradation rather than those of synthesis, which is more "economjcal" with respect to
energy expenditure. It has been noted that protein gain io Jiver dUJjng starved mice
refeeding is dominated by a marked decrease in degradation, -vvith

Jes~

drllmatic increases

2
in synthesis (Mortimore et al., 1983).

In addition, growing (non-confluent) 3T3-Ll

cultures degrade proteins more slowly than confluent cultures (Doherty & Mayer, 1985).
This coincides with the observation that cathepsin activity i_s higher in high-density and
quiescent cultures than in rapidly-proliferating and sparse cul1ures (Kenagy & Bierman,
1983).
Age may affect the rate of proteolysis within a cell. Microinjected 1251-labeled
RNAase A has a t112 of 90 h in young human lung fibroblast cultures, while half-life
(tl/2) is > 120 h in senescent cultures. Protein t112 is correlated with cell passage (r =
0.873) in this model. The same trends are generally observed with 3H-labeled RN Aase A
(reductive methylation) (Dice, 1982) and intracellular proteins (metaboli_cally-labeled
with 3H-Leucine) (Ballard et al., 1981; Okada & Dice, unpublished results, cited in Dice,
1982). Also, serum deprivation enhances proteolysis of microinjected RNAase A 1.6fold in the younger cultures, but has little effect in the senescent cultures (Dice, 1982).
However, the differences between young and old cultuJes on the proteolysis of
metabolically-labeled proteins are of less magnitude than those ofmicroinjected proteins.
This may indicate that cellular aging does not affect the catabolism of all proteins
identically (Dice, 1982). Recently, Dice and his associates haYe sh<>wn that RNAase A
possesses a recognition signal which directs its sequesimtio:n

b~

lysosomes under

conditions of serum deprivation (Dice et al., 1986).
Experimentally, it has been observed that cellular proteins fall within 2
generalized groups: long-lived proteins which have slow turnoYer rates,, and short-lived

3
proteins with comparatively high turnover rates (Hershko & CiechanoYer, 1982). Within
each group, there is substantial diversity with regard to degradai]on rates. It has been
postulated that proteins which are degraded rapidly are rate-l:im]ting enzymes for
metabolic pathways (Goldberg & Dice, 1974), or proteins which are synthesized for
secretion or routing to other cellular compartments which are degraded prematurely (Berg
& Neblock, 1985). It has been reported that large, acidic proteins are degraded more
rapidly than small, basic proteins (Neff et al., 1981 ). HoweYer, others have denied any
relationship between the half-lives of cellular proteins and subunit molecular weight,
isoelectric point, or secondary structure (Rechsteiner et al, 19 gq)_ Proteolysis of a
specific protein was not found to vary much between diffe1e11t cell bnes (Rechsteiner et
al., 1984; Zavortink et al., 1979).
Serum deprivation studies in rat fibroblasts show a strong jnve1se correlation
between proteolysis and thymidine incorporation (Poole et

al.~

J 97~). Degradation of

long-lived proteins (14c-labeled for 50 h) more than doubles jn t:h.e absence of serum,
while the breakdown of short-lived proteins (3H-labeled for 1 h) is affected very little.
These observations also occur in the presence of serum when amino adds, glucose, or
phosphate are omitted from the medium.

Addition of a mixture of insulin,

dexamethasone, and fibroblast growth factor in 0% :;erum :i11creases 3H-labeled
thymidine incorporation and decreases the release of TCA-soluble 14c-labeled amino
acids to about 75% of the level seen with 10% serum-suppleme11ted :fibt«>blasts (Poole et
al., 1978).

Recently, Dice et al. (1986; 1987) have sho-vm that pt«>teins which are

4
degraded more rapidly on serum deprivation contain the pentapepbde sequences related
to Lys-Phe-Glu-Arg-Gln, and that such proteins are degraded in the lysosome.

Cytosolic

De~radative

Systems

The nature and locations of the proleolytic efi2Ymes responsible for the
degradation of cellular proteins is a matter of great controversy.

Earlier studies have

produced a general consensus that short-lived proteins are degraded to a Larger extent by
an ATP-dependent

enzyme system within the cytosol (Etling er & Goldberg, 1977;

Knowles & Ballard, 1981; Rechsteiner et al., 1984; Bigelow ei al, 198 L). Proteolysis in
the 1o5 x g supernatant of reticulocytes is stimulated by 0.1-1 mM ATP, while ADP and
a,p-methylene-ATP cause slight increases. AMP, cAMP and f),r-methylene-ATP have
no significant effects on proteolysis (Etlinger, 1977). Cytosolic proteolysis is inhibited
by chloromethyl ketones (TPCK and TLCK) 1 and sul:fhydryl blocking agents (Nethylmaleimide and iodoacetamide), which suggests the partjcjpation of (a) sulfhydryl
protease(s). Metalloenzyme activity is also suggested, since ihe hea.i,ry metal chelator ophenathroline also inhibits cytosolic proteolysis (Etlinger & Goldl>erg,, 1977).
Recently, several high molecular weight nonlysos.omal proieinases have been
discovered in reticulocytes and other animal cells.

These prote:iu s are composed of

multiple subunits of Mr 21,000 to 34,000 (Bond & Butler,

19~7;

McGuire et al., 1988)

and appear to contain multiple catabolic sites (Bond & Butler, 19gJ). These enzymes

1TPCK =

TLCK =

L-1-tosylamido-2-phenylethyl-chloromethyl keiooe
N-a-p-tosyl-L-lysine-chloromethyl ketone (Thoene et al., 1985).

5

have been termed multicatalytic proteinases. One group of multicatalytic proteinases, Mr
700,000, appears to be identical to a 20 S cylindrical or ring-like particle called a
prosome (proteosome) which has been found in many types of eukaryotic cells (Rivett,
1989). These enzymes appear to be cysteine proteinases because of their sensitivity to
inhibition by thiol reagents, but there is evidence that some of these subunits may be
serine endopeptidases (Rivett, 1989; Tanaka et al., 1988). Based on the sensitivity of this
enzyme system to thiol reagents, it has also been called macropain (McGuire et al., 1989).
The activity of the proteosome is latent, and it can be activated by treatment with
polylysine (Tanaka et al., 1988) and detergents (Tanaka et al., 1989; McGuire et al.,
1989).

The requirement of proteosome proteolysis for ATP is a matter of some

controversy. Driscoll and Goldberg (1989) have reported that the hydrolysis of peptide
substrates by proteosomes is stimulated 12-fold by ATP, other nucleotide triphosphates,
and by nonhydrolyzable ATP analogs. ATP also stimulated the hydrolysis of protein
substrates such as casein. However, the caseinolytic activity of the proteosome is not
stimulated

by

nonhydrolyzable

ATP

analogs,

indicating

that

high

energy

phosphoanhydride bond hydrolysis is required for peptide bond cleavage with a protein
substrate.

In contrast, others have reported that ATP hydrolysis is not required for

peptide bond cleavage (reviewed in Bond & Butler, 1987).
Reticulocytes contain a 26 S ATP/ubiquitin-dependent proteolytic system which
is believed to function in the degradation of globin (Bond & Butler, 1987). A similar
system has been shown to participate in the degradation of short-lived proteins in yeast

6

(Bachmair et al., 1986). These systems act by first conjugating a 9000-dalton peptide,
ubiquitin, to protein substrates in an ATP-dependent fashion. Substrates which are multiubiquitinylated are then degraded by cysteine-like proteinases. Recently, McGuire et al.
(1988) have reported that the proteosome aggregate (macropain) or an immunologically
related protein can degrade ubiquitinylated protein substrates. Eytan et al. (1989) have
demonstrated that the 26 S ATP/ubiquitin-dependent protease complex contains the 20 S
"multicatalytic" protease as its catalytic core.

The incoIJ>oraiion of the 20 S

multicatalytic protease into the 26 S ubiquitin-dependent proiease complex is an ATP
requiring process (Eytan et al., 1989).
Bachmair et al. (1986), using recombinant DNA techniques, have demonstrated
that the identity of the amino terminal residue in proteins is a major determinant of
protein half-life in yeast. The amino-terminal amino acid residues Arg, Asn, Trp, Phe,
Leu, Asp, and Lys destabilize cytosolic proteins by directing iheir rapid ubiquitinylation
and degradation by the 26 S ubiquitin-dependent proteolytic system. Such proteins have
half-lives of 2-3 minutes in yeast. In contrast, the presence of an amino terminal Ala,
Cys, Gly, Met, Ser, Thr, or Val confers a marked stabilizing affect, and such proteins are
typically long-lived in yeast. Bachmair et al. have termed this phenomenon the N-end
rule for selective protein breakdown.
The role of the amino terminus in determining the rate of turnover of a protein has
suggested additional mechanisms by which protein half-lives might by regulated. New
amino termini might be exposed by limited endo- or exopeptidolytic cleavage of a
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protein.

Alternatively, the amino terminus of a protein may be altered in reactions

catalyzed by aminoacyl-tRNA-protein transferases, which are known to exist in cells
(Bachmair et al., 1986; Dice, 1987).

Recently, it has been shown that ornithine

decarboxylase, a protein which turns over rapidly in vivo, can undergo selective Nterminal arginylation (destabilizing) in vitro. Furthermore, an inhibitor of arginyl-tRNA:
protein arginine transferase can strongly inhibit the turnover of ornithine decarboxylase in
cultured hepatocytes in vivo (Kopitz et al., 1990).
The calpains represent another group of cytosolic proteinases.

These are

sulfhydryl-dependent proteases which are characterized by a requirement for millimolar
to micromolar concentrations of calcium, depending on their type (Band & Butler, 1987).
The calpains appear to cleave specific categories of protein substrates and to initiate or
regulate specific physiological responses.

Calpains appear to be involved in the

degradation of membrane and structural proteins in muscle and nerve cells (Wang &
Beermann, 1988; Siman & Noszek, 1988; Inomata et al., 198 9), ihe reorganization of the
cytoskeleton in response to calcium (Nix, 1989), and the degntdaiion of cellular proteins
following injury-induced calcium influx (Kuwaki et al., 1989; Siman et al., 1989).
Calpains also participate in myoblast fusion (Bond & Butler, 1987) and platelet activation
(Tsujinaka et al., 1990). It has been suggested that proteins susceptible to proteolytic
cleavage by calpains contain sequences rich in proline and in acidic and hydroxylated
amino acids known as PEST sequences (Siman & Christoph, 198<); R()gers et al., 1986).
There is some question as to the identity of the rate-Jimiting siep in the putative
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cytosolic proteolytic enzyme systems.

Activation energies (Ea) (determined by

Arrhenius plots oflog kn vs. 1/T) for the turnover of a small number of proteins tested in
vivo are 27

±5

kcal/mol.

This rules out local protein unfolding and peptide bond

hydrolysis for being the rate-limiting steps in cytosolic proteolysis, since these processes
have Ea's <15 kcal/mol. Ubiquitin-conjugated lysozyme was degraded 10-fold faster
than non-conjugatd lysozyme, but Ea's were in the range 2 7

±5

kcalfmol, for both

processes which eliminates ubiquitin conjugation as the rate-limiting reaction.

It is

postulated that the rate-limiting event(s) is (are) related to ihe recycling or assembly of
the complicated ATP-dependent proteolytic system, loosely analogous to assembly of the
components of the complement system (Rechsteiner et al., 1984).

Lysosomal Degradative Systems
Long-lived proteins (t112 > 1 day) are degraded--at least in part--within lysosomes
(Doherty & Mayer, 1985; Ahlberg et al., 1985; Rechsteiner ei

al.~

1984; Dean, 1975).

Particulate proteins and proteins having low solubiliiy in Triton X-100 are also
principally degraded in lysosomes (Doherty & Mayer, 1985; Re<:hsteiner et al., 1984).
The mechanism of entry of intracellular proteins into the lysos<>mes is ill-defined, but it
appears that sequestration of the substrate into autophagic va<: uoJes (AV) or lysosomes
may be the rate-limiting step in this pathway (Katunuma & Kominarni, 1983; Bond &
Aronson, 1983), since lysosomal proteases are present in ie"ce f.!; (Katunuma &
Kominami, 1983). AV are not by themselves sufficiently ac:idic for oµtimal proteolysis.
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Hydrolytic enzymes are acquired by fusion with lysosomes or endoplasmic reticulum
(ER) membranes which apparently form the limiting membranes of the AV. Incubation
of these structures in an acidic (pH 5) environment markedly increases proteolytic
activity of AV above that seen at neutral pH (Ahlberg et al., 1982).
Lysosomes appear to be acidified by an ATP-dependent proton pump;
acidification appears to occur by electroneutral rather than electrogenic mechanisms.
Acidification is optimal when cytosolic (external) pH is slightly alkaline (pH 7.5).
Lysosomal hydrolases are not required, as lysosome "ghosts" (disrupted lysosomes
containing <10% enzyme activity) are still capable of acidific:ation (Schneider, 1981).
The acidic environment dramatically reduces the binding beiween ligands and plasma
membrane receptors, which facilitates receptor recycling

(Gonzalez-Noriega et al.,

1980).
Lysosomal enzymes are a subset of

glycoproteins~

and are synthesized,

transported and processed in a directional manner. Transla1ion and glyeosylation occur in
the rough endoplasmic reticulum (RER), the oligosaccharide side chains are modified in
the Golgi apparatus, and the enzymes are packaged into lysosome-direc1ed transport
vesicles in the trans Golgi network (Goldberg & Kornfeld, 19 83; Kornfeld, 1987). Most
lysosomal enzymes contain the sugars

N-acetylglucosamine~

mannose, galac1ose and

sialic acid (Hasilik, 1980). At least one of the mannose units is pbosphorylated and serves
as a lysosomal recognition marker (Neufeld, 1981; Pohlmann et al., ] 982; Hasilik, 1980;
Goldberg & Kornfeld, 1983; Kornfeld, 1987). Without the marker, lysosomal enzymes
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are secreted in precursor form into the medium. This has been effectively demonstrated
using I (inclusion)-cell disease fibroblasts (Neufeld, 1981 ).

This cell line secretes

enzymes which are not phosphorylated but are active, and this results in a deficiency of
hydrolases within the lysosomes (Lightbody et al., 1971;

Wiesmann et al., 1971;

Wiesmann & Herschowitz, 1974). These secreted enzymes cannot be endocytosed by
normal cell lines (Hickman & Neufeld, 1972).

However, normal phosphorylated

lysosomal enzymes added to culture medium can be endocytosed by the I-cell fibroblasts
and are subsequently delivered to lysosomes (Neufeld, 1981).
Several thiol proteases have been isolated from the lysosomes.

Cathepsin B

[EC.3.4.22.1] is the best characterized and has a Mr between 24-28,000 (Katunuma &
Kominami, 1983). Studies using peptide [Katunuma et al., 1981 (l); Katunuma et al.,
1981 (2); Towatari & Katunuma, 1983] and protein substrates (Nakai et al., 1978;
Hannappel et al., 1982; Katunuma et al., 1982) indicate that cathepsin B acts primarily as
a dipeptidyl carboxypeptidase which sequentially releases dipeptides from the C-terminus
of the protein substrate. However, there is evidence that cathepsin B can also function as
an endopeptidase (Bond & Butler, 1987), depending on pH (Folgar & Csoma, 1987).
Cathepsin H [EC.3.4.22.16] (Mr 21-24,000) appears to be both an endopeptidase and an
aminopeptidase, although this enzyme has not been as well-studied.

Cathepsin L

[EC.3.4.22.15] (Mr 21-24,000) appears to be an endopeptidase that cleaves peptide bonds
which have neutral amino acids--Phe, Val, Leu, Trp, Tyr--in the P2 position (Kargel et
al., 1980; Katunuma et al., 1982; Katunuma et al., 1981). All three are unstable at pH's
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greater than 6.0-7.0. Other thiol proteases include cathepsins S, T and N. Cathepsin S
has a molecular weight of 25,000 and a substrate specificity similar to those of cathepsins
L and N, but prefers small neutral residues in the P2 and P3 positicms (Bromme et al.,
1989). Cathepsin T (Mr 33,500-35,000) was discovered on the basis of its ability to
catalyze the limited proteolytic modification of tyrosine aminotransferase, converting it
from the Type I form to the Type III form (Gohda & Pitot, 1980; Gohda & Pitot, 1981).
Cathepsin N, isolated from human placenta (Mr 34,600) and bovine spleen (Mr 1820,000), appears to have a specificity for collagen (Katunuma & Kominami, 1983).
Cathepsin D [EC.3 .4.23 .5] is the only known aspartate protease located within the
lysosomes (Faust et al., 1985). It is an endopeptidase which primaril:Y cleaves bonds at
the carboxyl ends of aromatic amino acids (Barrett,

1977~

Whitaker & Seyer, ] 984). It

shows homology with other aspartyl proteases, which suggests similar tbJee-dimensional
structures (Tang, 1979).
The cDNAs for cathepsins B, D, H, Land Shave been cloned and sequenced (San
Segundo et al., 1985; Faust et al., 1985; Qian et al., 1990; Ishida et al., 1987; Chan,
unpublished results). In all cases, the enzymes are synthesized as single polypeptide
chains which undergo successive cleavages to remove an ami_oo terminal prepeptide
signal sequence and a propeptide.

Removal of the propepti de resulis in enzyme

activation. Further maturation can involve C-terminal cleavages (Erickson & Blobel,
1983), and intra-polypeptide cleavages--possibly occurring within the lysosomes--to give
light and heavy chains. For cathepsin D, there is a simple enJoproteolytic cleavage
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between amino acids 97 and 98 (Faust et al., 1985); an internal dipeptide between amino
acids 47 and 48 (final product) is removed in cathepsin B (San Segundo et al., 1985). An
internal di peptide, Ser-177 Asn-178, is removed in cathepsin L (Ishidoh et al., 1987), and
an endoproteolytic cleavage between Asn-177 and Gly-178 in cathepsin H (Ritonja et al.,
1988). Both single- and double-chain forms of cathepsin D and cathepsin B are active
(Huang et al., 1979; Takahashi et al., 1986).

Compartmentalization and Re~ulation of Cellular Proteolysis
There are many estimates of the contribution of lysosomal proteolysis m
endogenous protein breakdown. These range from a low of 10 to 30% (Bigelow et al.,
1981) to a high of 85 to 100% (Ahlberg et al., 1985); Hutson & Mortimore, 1982).
Apparently, the tissue type and culture conditions largely determine the extent of
lysosomal proteolysis. Fibroblasts (Gronostajski et al., 1985), macrophages (Poole et al.,
1978) and rat yolk sacs (Knowles & Ballard, 1981) do not appear to utilize lysosomal
proteolysis as extensively for endogenous proteins as the liver (Hutson & Mortimore,
1982; Ahlberg et al., 1985; Dean, 1975) and HeLa cells (Rechsteiner et al., 1984).
However, many conclusions of these studies are hampered by short radioactive labeling
and chase periods (<4 hours) (Poole et al., 1978; Knowles & Ballard, 1981). Thus, only a
small fraction of the cellular protein pool is labeled and only a small amount of the
labeled proteins are degraded during the period of observation. The amines and cathepsin
inhibitors, which are used to "abolish" lysosomal protease activity, inhibit proteolysis
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only partly, even when used in combination, possibly because of the presence of many
different (redundant) proteases in lysosomes (Ahlberg et al., 1985).

In addition,

intracellular thiol protease inhibitors present in the cytosol (Kominami et al., 1982)
inhibit lysosomal cathepsins when lysosomes are ruptured during tissue homogenization
(Katunuma & Kominami, 1983). This may result in an overestimation of the degree of
inhibition of lysosomal enzymes by added inhibitors and underestimation of the
contribution of lysosomal proteolysis to intracellular protein turnover.
Proteolysis can be enhanced by serum deprivation. The preferred substrates have
been reported to be long-lived (small, basic) proteins (Poole et al., 1978; Neff et al., 1981;
Backer et al., 1983). Seventy percent of the deprivation-induced proteolytic activity is
associated with the lysosomes in liver, while only 5% is associated with the cytosol
(Mortimore & Ward, 1981). The selectivity for substrate is considerable; serum-deprived
fibroblasts break down microinjected RNAase A in preference to microinjected RNAase
S protein (Backer et al., 1983). Thus enhanced degradation of RNAase A in serum
deprived conditions occurs largely in the lysosomal compartment (Backer et al., 1986). A
pentapeptide sequence KFERQ (or in opposite orientation QREFK) has been shown to be
responsible for the increased transfer of serum deprivation-responsive proteins to
lysosomes on serum withdrawal (Backer et al., 1986; Dice, 1987; Dice, 1990). The
covalent attachment of this peptide to heterologous proteins also causes their degradation
rates to increase in response to serum withdrawal.

Using antibodies to this peptide

sequence, 30% of cytosolic proteins were shown to be immunoreactive in fibroblasts.
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The degradation of these immunoreactive proteins was serum responsive, whereas the
nonimmunoreactive proteins were degraded at the same rate in the absence of serum
(Chiang & Dice, 1988). A member of the heat shock protein (hsp 70) family was found
to bind to the KFERQ peptide region in RNAase A and to facilitate the direct transfer of
the protein into lysosomes in vitro, possibly by a process related to the direct transfer of
protein from the cytosol into mitochondria (Chiang et al., 1989). This protein, which has
a molecular mass of 73 kDa, has been referred to as prp 73. Prp 73 increases in response
to serum deprivation (Chiang et al., 1989) and has been shown to bind to proteins which
undergo enhanced degradation on serum withdrawal (Dice, 1990).
Other mechanisms for targeting cytosolic proteins to lysosomes may also exist. A
recent report suggests that the ubiquitin-dependent pathway and the lysosomal
degradative pathway for protein turnover may converge.

Thus, ubiquitin-protein

conjugates are found to be specifically enriched in the lysosomal compartment of 3T3-Ll
fibroblasts. Treatment with the lysosomal cysteine proteinase inhibitor E-64 causes an
increase in the lysosomal compartment and an increase in the cellular content of
ubiquitin-protein conjugates (Laszlo et al., 1990). In addition, Ciechanover (1990) has
reported that the heat shock induced increases in cellular protein degradation which
occurs in lysosomes is blocked in mutant Chinese hamster cells, which have a defect in
ubiquitin conjugation to cellular proteins. This result suggests that the stress-induced
lysosomal degradation of intracellular proteins is also mediated by the ubiquitin system.
Interestingly, these cells are normal with respect to the basal turnover of long-lived
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proteins indicating that the majority of long-lived proteins in Chinese hamster cells are
degraded by a ubiquitin-independent system (Ciechanover, 1990).
In rat liver, the size of the lysosomal substrate pool is directly proportional to the
measured rate of protein degradation. The largest accumulation of cellular substrates
within lysosmes occurs in liver during glucagon-induced starvation, while the lysosomal
compartment is smallest in liver from well-fed rats (basal conditions) (Mortimore &
Ward, 1981). Furthermore, partial hepatectomy, which largely abolishes basal turnover
in liver, causes a further reduction in the size of the lysosomal substrate pool (Scomik &
Botbol, 1976; Swick & Ip, 1974). In rat liver homogenates, 80% of the short-lived (15
min label) and 90% of the long-lived (16 h label) proteins were degraded in isolated
lysosomes under basal conditions (Ahlberg et al., 1985).

These results have been

interpreted to indicate that the lysosomes are the major site of protein degradation in rat
liver (Mortimore & Ward, 1981).

De~radation

ofMicroinjected and Endocytosed Proteins

For each specific protein tested in human diploid fibroblasts, loss of endogenous
or microinjected label from cells exhibits first-order kinetics (Dice, 1982; Neff et al.,
1981; Rechsteiner et al., 1984). Also, loss of label from cells is independent of the form
of label (i.e. 125I, 3H) (Backer et al., 1983). Loss of microinjected label from the
neoplastic HeLa cell line also followed a first-order time course

for bovine serum

albumin (Zavortink et al., 1979). However, these conclusions may be biased by the
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manner m which the microinjection studies were conducted.

In addition, not all

microinjected proteins exhibit first-order degradation kinetics after injection into HeLa
cells (Rechsteiner et al., 1984).
In contrast, it has been shown that release of endogenous label from isolated rat
liver lysosomes occurs as the result of a multiphasic process (Mortimore & Ward, 1981 ).
Specifically, there is an initial rapid phase (0-30 minutes) followed by a slower,
somewhat linear phase (30-90 min); after 90 minutes, the release slows considerably, and
an almost constant rate is observed after 120-150 minutes.

In addition, it has been

observed that the degradation of endocytosed proteins, which occurs in the lysosomes, is
a multiphasic process, where the progress curves are described as the sum of individual
first-order decay curves (Thyagarajan & Frankfater, 1985).
The relative proportions of endocytosed proteins and microinjected proteins
which are degraded vary for individual proteins; 20% to >50% of the label is released as
trichloroacetic acid (TCA)-insoluble products (Zavortink et al., 1979; Thyagarajan &
Frankfater, 1985; Buktenica et al., 1987). The remainder of the label (50-80%) appears in
a TCA-soluble form, primarily labeled amino acids (Dice, 1982; Zavortink et al., 1979;
Thyagarajan & Frankfater, 1985; Buktenica et al., 1987).
Endocytosed and microinjected proteins are regurgitated in parallel with
degradation (Rechsteiner et al., 1984; Buktenica et al., 1987; Thyagarajan & Frankfater,
1985; Isenman & Dice, 1989). With endocytosed proteins, the observed rate constants
(kobs) for the multiphasic appearance of TCA/PTA precipitable products are identical
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with those of TCA-/PTA soluble products, which implies either a common ratedetermining step for the release of both products or a common compartment as the
source of both products (Buktenica et al., 1987; Thyagarajan & Frankfater, 1985). The
regurgitated material appears in the medium as the intact protein and peptide fragments
(Buktenica et al., 1987). Both degradative and regurgitative processes are inhibited by
inhibitors of degradation, thus preserving the similarity in rate constants observed for the
appearance of TCA/PTA-soluble and -insoluble products Buktenica et al., 1987). This
indicates that the TCAIPTA-soluble products and regurgitated proteins are derived from a
common intracellular degradative compartment, presumably the lysosomes (Buktenica et
al., 1987; Thyagarajan & Frankfater, 1985).

Vehicles for Cellular Microinjection
The study of proteolysis for endogenous (metabolically-labeled) proteins is
difficult, as all cellular proteins are labeled. Therefore, it is not always possible to
observe the fate of individual proteins.

Consequently, several techniques have been

developed to attempt the delivery of labeled proteins into the cytosol of unlabeled cells.
Microinjection via loaded erythrocytes (RBC ghosts) results in a random distribution of
injected proteins within the cytoplasm as shown by autoradiography (Neff et al., 1981;
Zavortink et al., 1979). Fluorescent-labeled proteins injected through erythrocytes or by
scrape-loading tend to have a perinuclear distribution similar to that of lysosomes
(Zavortink et al., 1979; Stacey & Allfrey, 1977; McNeil et al., 1984). However, it has
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been shown that injected proteins may not have the same initial distribution within the
cytosol as endogenous cytosolic proteins, with the former associated with sedimentable
structures (Doherty & Mayer, 1985). Proteins microinjected through capillaries show a
uniform cytoplasmic distribution immediately upon injection. Subsequently, many of
these proteins appear to become localized within "vacuoles", although it has not been
proven that these structures are truly membrane-bound. Eventually, the injected proteins
assume a perinuclear distribution (Stacey & Allfrey, 1977).

The time-course for

vacuolization is dependent upon the protein injected (3 hours to 3 days), and there is a
tendency for larger, more acidic proteins to be "vacuolized" more rapidly. While some
believe microinjected proteins are broken down chiefly through lysosomal processes
(Doherty & Mayer, 1985), others maintain that cytoplasmic systems provide a significant
contribution to their degradation (Bigelow et al., 1981 ).

Results from capillary

microinjection have shown that vacuolized proteins eventually have the same distribution
as lysosome-specific acid phosphatase; however, not all proteins are vacuolized. This
suggests that not all proteins are processed identically and that there is more than one
degradation process (Stacey & Allfrey, 1977).
In this present study, I have explored the feasibility of using liposomes for
microinjecting proteins into cells. The potential advantages of this method are the ease of
preparation of liposomes, the low cost of raw materials, no disruption of the cell
monolayer, and the higher probability of a random distribution of injected material.
The principle theory behind cell microinjection through a liposome vehicle is
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vesicular phospholipid fusion with cellular membranes. Although liposome-cell fusion
has never been absolutely proven to occur, numerous studies have provided
circumstantial evidence to indicate that fusion does take place.

Bivalent Cations and Membrane Phospholipid Interactions
Bivalent cations are reported to modulate membrane fusion with acidic,
unilamellar liposomes.

At physiological monovalent salt concentrations, only acidic

phospholipids (PS, PA) bind strongly to bivalent metal ions (Papahadjopoulos, 1968). PS
appears to be the principle phospholipid involved in ca++ -mediated permeability
changes within biological membranes. PS is usually 10-20% of the total cell membrane
phospholipid.

Membranes lacking PS (prokaryotes, mitochondria and chloroplasts)

usually contain PG or other glycerol-containing phospholipids (Papahadjopoulos, 1971).
Membranes are generally stable structures. For membrane fusion to take place,
there must be destabilization at some point (Papahadjopoulos et al., 1977).

The

parameters of fusion have been stated (Papahadjopoulos et al., 1976):
1.

Lipids must be in the fluid phase.

2.

There is a threshold concentration of ca++ or Mg++ required for fusion, and this
concentration varies for each phospholipid.

3.

Induction of fusion by cations is not due to electrostatic charge neutralization.

4.

ca++_induced fusion results in the crystallization of acyl chains and an increase in
the phase transition temperature.
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The ability of ca++ to increase liposome membrane permeability (decrease
membrane stability) appears to be related to differences in the Ca++ concentration
between the inside and outside of the liposome. Thus, addition of the calcium ionophore
A23187 reduces Ca++ concentration differences across the liposome membrane and also
reduces the effect of ca++ on membrane permeability and fusion. When ca++ is added
to a phospholipid vesicle suspension, ions bind only to the outer monolayer.
charge neutralization occurs, and the vesicles begin to aggregate.

Some

As the ca++

concentration is increased above > 1 mM, more condensation of the phospholipids occurs
to the point of crystallization of the outer monolayer. However, the inner layer remains
fluid. Structural defects may occur, exposing the hydrocarbon chains to water. This
creates a very unstable state, which is suggested to cause increased permeability and
susceptibility toward fusion. As the bilayer crystallizes, phospholipid molecules cannot
accomodate the high curvature of the original vesicular structure. Ruptures occur, and
flattened bilayer disks are formed in which hydrocarbon (HC) edges are exposed to water.
These hydrocarbon-water interactions are unfavorable, so the HC structures tend to fuse,
producing large membranous sheets (Papahadjopoulos et al., 1977).

Liposome Visualization
Nearly all visualization studies of liposomes have been performed using electron
microscopy, which is necessarily a static process. Therefore, these studies are limited to
structural characteristics rather than dynamic properties. One group (Rand et al., 1985;
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Kachar et al., 1986) recently observed the structural changes in giant complex
phospholipid

vesicles

(GCV)--prepared

from

either

pure

PS,

dioleyl

phosphatidylethanolamine (DOPE)/PS or PC/PS lipid mixtures--in a ca++_containing
buffer using video-enhanced differential interference light microscopy and rapid mixing
freeze fracture electron microscopy. Addition of 60 mM CaCl2 to the phospholipid
suspensions caused adhesion of the vesicles. The zone of adhesion between PS-LUV and
between DOPE/PS GCV vesicles appeared as a flat diaphragm made up of two tightly
apposed bilayers. The vesicles often deformed as the contact area enlarged, with the
interior angles between the diaphragm and the vesicle bilayer at the margins of the
contact zone becoming progressively smaller.

This produced such a high level of

membrane curvature and stress in the membrane adjacent to the contact region that the
vesicles either remained adherent but lost volume as a consequence of membrane rupture
or leakage, or the interface between the vesicles ruptured, resulting in vesicle fusion.
Fusion was often observed to occur when at least one of the vesicles was multilamellar or
when there was a high proportion of smaller vesicles present. Fusion and rupture were
equally likely events with PS-LUV aggregates. Eventually, an end-state was reached,
which consisted of multilamellar bilayer stacks, as revealed by freeze fracture electron
microscopy.

The formation of chocleate cylinders as discribed by Papahadjopoulos

(1970) was not reported in this study (Rand et al., 1985).
Somewhat different results were obtained with lipid vesicles of differing
composition. With DOPE/PS-GCV, vesicle adhesion and diaphragm formation occured
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and was then apparently followed by either vesicle fusion or vesicle deflation. Although
adherant vesicles frequently collapsed, there was no evidence of vesicle rupture. It was
suggested that vesicle collapse could result from leakage of vesicle contents across highly
stressed membrane regions at the margins of the contact zones (diaphragms). Eventually,
the system decayed with the extrusion of the vesicle contents. The individual lipids then
separate to form bulk lipid phases with appearances similar to that of pure DOPE
(hexagonal phase lipid) and pure PS-Ca (lamellar phase lipid). In contrast, when Ca++
was added to PC/PS vesicles, large aggregates were formed.

These PC/PS vesicle

aggregates were stable (no fusion, no loss of volume) for at least several hours. X-ray
diffraction of these aggregates revealed an amorphous structure with no evidence for a
regular multilamellar phase as seen with pure PS-Ca.
It has been proposed (Kachar et al., 1986) that mechanical bilayer tension is

required--in addition to enhanced contact--for bilayer fusion or rupture. Bilayer tensions
greater than 3 dynes/cm caused by high surface curvature and surface area increases
greater than 3% caused by osmotic stress lead to bilayer rupture (Evans & Parsegian,
1983; Evans & Kwok, 1982). In contrast, stable aggregation (as observed for PC/PS
vesicles) may be attained if low-adhesion energies result in tensions below the critical
level. When bilayer tension is high, stress may be relieved by rupture of the contact area
(fusion, by rupture of the bilayer adjacent to the contact zone seen with PS-LUV), or by
volume loss without rupture (seen with DOPE/PS-GCV) (Kachar et al., 1986). PS-LUV
have been observed to rupture rapidly prior to formation of very large aggregates (Rand
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et al., 1985). DOPE/PS vesicles form large, stable aggregates before rupture tensions are
attained (Kachar et al., 1986). Calcium, which has a high affinity for pure PS vesicles,
produces adhesions with high surface tensions (Parsegian & Rand, 1983). Ca2+_PS-Ca
complexes appear to form very early (Rand et al., 1985). This results in dehydration of
PS bilayers, permitting their close apposition (Rand et al., 1985). In addition, calcium
might increase bilayer-bilayer adhesion by forming a bridge (PS-Ca2+ _ps) between the
polar head groups of adjacent PS-containing bilayers.
In summary, model studies employing PS-liposomes indicate that ca++ mediates
a tight aggregation of vesicles with resulting stress to the bilayer. This stress is relieved
by either vesicle fusion or vesicle rupture, with both being equally likely. Incorporation
of PC into PS liposomes reduces the interaction evergy between adherent bilayers and
causes vesicle fusion and/or rupture to become less likely.

Liposome-Cell Membrane Interactions
After reviewing the theoretical concepts of lipid-lipid interactions and fusion, the
practical experimental aspects of lipid-cell membrane interactions must be examined. It
must again be stressed that liposome-cell fusion has not been conclusively proven to
occur in any experiment, although there is considerable indirect evidence that it does. It
is known that mammalian cells can incorporate large numbers of lipid vesicles without
cytotoxicity.

Fusion with plasma membranes, endocytosis, surface adsorption and

molecular exchange may all be methods of transport between vesicles and cells
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(Papahadjopoulos et al., 1974).

Charge neutralization by ca++ (and to some extent

Mg++) of acidic phospholipids allows vesicle aggregation and fusion (Papahadjopoulos
et al., 1977 & 1976). Presumably, the same principles apply to vesicle-cell membrane
fusion.
The route of vesicular incorporation is highly dependent on both the electrical
charge and the phase of the phospholipids within the vesicles. 14c-sucrose uptake by
3T3 cells was studied using 3 types of vesicles:
1. Solid-charged (PS/DSPC/DPPC)
2. Fluid-neutral (PC)
3. Charged-fluid (PS/PC).
Treatment of cells with the endocytosis inhibitor cytochalasin B (Cyto B) resulted in an
80 to 90% inhibition of sucrose uptake compared to controls for solid-charged and fluidneutral vesicles.

In contrast, the uptake of sucrose from charged-fluid vesicles was

inhibited only 35% by Cyto B. Much more 14c-sucrose was incorporated into Cyto Btreated cells from charged fluid than from charged solid vesicles (Poste &
Papahadjopoulos, 1976).
Inhibitors of glycolysis and respiration, when used in combination, effectively
inhibit endocytosis but not fusion. Uptake of 14c-sucrose from fluid-neutral and solidcharged vesicles was completely inhibited in cells treated with these inhibitors, while
charged-fluid vesicle uptake was decreased only 30-40%. The temperature dependence
of uptake of fluid-charged vesicles shows a marked change in slope at 16-18° C, while
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fluid-neutral and solid-charged vesicles do not demonstrate such a slope change.
Membrane fusion processes have distinct transition temperatures at 180 C, but
endocytosis has a simple linear dependence (Poste & Papahadjopoulos, 1976).
These results suggest that fluid-neutral and solid-charged vesicles are
incorporated into 3T3 cells primarily by endocytosis, while charged-fluid vesicles may be
incorporated at least 60% by fusion with the plasma membrane. They also suggest that
vesicles may be targeted; different lipids can be used to introduce substances into
different cellular regions. Solid-charged and fluid-neutral vesicles which enter by
endocytosis would deliver materials to the lysosomes, while charged-fluid fused vesicles
would release their contents into the cytoplasm. Fusion of charged-fluid vesicles may also
change the composition of the plasma membrane.
Other studies have also suggested that fusion, rather than molecular exchange,
occurs between charged-fluid lipid vesicles and cells (Papahadjopoulos et al., 1974).
L929 and 3T3 cells after incubation with PS/PC/cholesterol liposomes containing 14ccholesterol and 3H-dipalmitoylphosphatidyl choline (DPPC) show nearly identical ratios
of 3H: 14c (1: 1.8) as that of the original liposomes (1: 1.9). If molecular exchange was
the mode of transfer of label from liposomes to cells, cholesterol uptake was expected to
have been much greater than PC uptake. Electron micrographs of RBC ghosts incubated
with multi-lamellar vesicles (PS/PC) revealed "patches" devoid of intramembrane
particles (integral membrane proteins) not seen in untreated controls. The dimensions of
the patches were similar to those of the vesicles. In addition, the surface density of
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intramembranous particles on vesicle-treated cells not showing patches was lower than in
untreated cells, which suggests an increase in cell surface area (Papahadjopoulos et al.,
1974).
An enzyme repletion study was conducted with invertase-deficient macrophages

and fibroblasts (Gregoriadis & Buckland, 1973). [Invertase converts sucrose to glucose+
fructose.] These cells were incubated with sucrose, which resulted in the appearance of
phase-lucent vacuoles in the perinuclear region. The vacuoles had not disappeared by 5
hours (macrophages) or 24 hours (fibroblasts) after the cells were exposed to a sucrosefree medium.
Incubation of the sucrose-loaded cells with liposomes (egg lecithin, cholesterol,
phosphatidic acid, 7: 2: 1) containing invertase for 3 hours (macrophages) or 24 hours
(fibroblasts) resulted in the disappearance of the vacuoles in most of the cells. These
observations were supported by radioimmunoasays in which the cells were incubated
with U-14c-sucrose. After incubation with invertase-containing liposomes, much more
radioactivity was released from the cells into the medium (glucose and fructose diffused
out) than from cells incubated with denatured invertase-containing liposomes or controls
(no invertase).
The authors (Gregoriadis & Buckland, 1973) suggest that invertase entrapped in
liposomes is taken up by "liposome uptake", and finds its way to a sucrose-containing
secondary lysosome. The liposomal membrane is then disrupted, perhaps by lysosomal
lipases, and the enzyme is released. These results are consistant with those of Poste, et al.
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(1976) which suggest that PC enriched liposomes are targeted to lysosomes.
Several studies involving viral infectivity have been done with PS liposomes,
which indicate that the viral particles are entrapped within the vesicle interior and are
introduced into the cell by a non-endocytotic mechanism. PS vesicles capture naked
nucleotides at 5-10% efficiency (Wilson et al., 1979; Mayhew et al., 1977). It appears
that a minimal nucleotide concentration of 1 ng/nmol lipid is required for maximal
capture (Wilson et al., 1979). The maximum efficiency of poliovirus RNA infection is 1
RNA molecule/vesicle. This implies that the RNA is highly infectious once it enters the
cell, and that the rate-limiting step is the vesicle-cell interaction. It also implies that the
encapsulated RNA is not significantly degraded by lysosomal nucleases.

Therefore,

endocytosis is probably not the mode of uptake of the encapsulated RNA (Wilson et al.,
1979). The encapsulated RNA is also resistant to added ribonuclease (Taber et al., 1978).
In fact, RNAase treatment of the vesicles increases infectivity 10-15 fold (Wilson et al.,
1979). However, this effect may be due to the high positive charge of RNAase, because
the denatured enzyme had a similar effect.

The positively-charged RNAase may

neutralize the negative charge on the vesicles, which may enhance vesicle-cell
interactions (Wilson et al., 1979).
The synthetic interferon inducer polyribosyl inosine phosphate/polyribosyl
cytosine phosphate (rln.rCn) has been encapsulated by liposomes. Uptake of rln.rCn by
cells was 2.5-9 fold higher when the polynucleotides were in vesicles than when free in
solution. In free solution, the rCn strand was taken up more slowly than rln, even though
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they were from the same double helix. However, rln.rCn uptake from vesicles showed
that both strands entered the cell unaltered. Furthermore, only vesicle-entrapped rln.rCn
produced significant increases in antiviral activity in human fibroblasts compared with
Vesicle-entrapped single-stranded rln and rCn and mixtures of
nonencapsulated rln.rCn +pre-formed vesicles had no effect (Mayhew et al., 1977).
Poliovirus has been encapsulated in PS liposomes. The encapsulated viruses were
antibody resistant; antibody decreased free virus infectivity 1o5 fold (Taber et al., 1978),
while the "vesicular" virus infectivity was reduced less than 10 fold (Taber et al., 1978;
Wilson et al., 1977). Chinese hamster ovary (CHO) cells, which do not have the primatespecific membrane receptor for poliovirus, can be infected by the encapsulated viruses.
Free virus, free virus +vesicles and vesicles alone have no effect (Taber et al., 1978).
These studies give, at best, indirect proof for the validity of the fusion mechanism.
Furthermore, they involve potent molecules which produce strong responses (e.g.
cytotoxicity, infections, resistance) when only a relatively small number are delivered.
Thus, such studies do not provide quantitative information about the efficiency of
liposome-cell fusion as a means for injecting substances into cells in bulk. One purpose
of this study was to evaluate liposomes as a vehicle for the bulk injection of proteins into
the cytosol of cultured cells. This required the development of an assay to quantify
liposome-cell fusion.

CHAPTER II
MATERIALS AND METHODS

PART I. LIPOSOME-MEDIATED MICROINJECTION OF
PROTEINS INTO FIBROBLASTS
Cell Culture
Normal adult human diploid fibroblasts, GM3440, were obtained from N.I.G.M.S.
Human Genetic Mutant Cell Repository located in the Institute for Medical Research
(Camden, NJ).

Fibroblasts were grown in medium consisting of 85% Dulbecco's

Modified Eagle's Medium (DMEM, Flow Laboratories), 13% heat-inactivated (56-65° C,
30 min) fetal bovine serum (Gibco), and 2% of a penicillin-streptomycin solution (200
units penicillin, 200 µg streptomycin per 1 ml complete medium) (Gibco). Cells were
grown either in 10 ml complete medium on 75 cm2 tissue culture flasks (Falcon or Lux)
or in 5 ml medium on 60 x 15 mm tissue culture dishes (Falcon or Coming) at 37° Cina
95% air/5% C02 atmosphere (McGarrity, 1979).
When cells reached confluency, they were detached with 0.5% Trypsin (ICN) in
phosphate buffered saline (Flow) and passed 1:3 (75 cm2) or 1:6 (60 x 15 mm). Time to
confluency generally ranged between 5-14 days, depending on cell passage.

Unless

otherwise stated, all experiments were done with confluent monolayers of cells having
passage numbers between 7 and 17.
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Preparation of Large Unilamellar Liposomes
Large unilamellar liposomes (LUV) were prepared by formation of ca++_
cochleate structures (Papahadjopoulos, 1970) or multibilayer stacks (1985) from small
unilamellar vesicles (SUV), followed by chelating the ca++ with EDTA (or EGTA)
(Wilson et al., 1977; Mayhew et al., 1977; Papahadjopoulos et al., 1975). Ten µmol of
bovine brain phosphatidylserine (Sigma, P-L Biochemicals) was transferred to a screwcap test tube which had been flushed with N2, and the CHCl3 solvent was evaporated
under N2. One ml of buffered saline (100 mM NaCl, 2 mM histidine, 0.1 mM EDTA, 2
mM TES, pH 7.4) was added under N2. The test tube was capped, vortexed 10 minutes
to suspend the lipid, then sonicated 30 min with a Branson bath-type sonicator with a
cooling coil. The resulting suspension, which contained small unilamellar liposomes,
was left at room temperature in a nitrogen atmosphere for 1 h before further processing.
Seventy µl of 0.1 M CaCl2 was added to the liposome suspension and the
resulting material incubated for 1 h at 370 C. [At this point, the ca++ cochleate of
phosphatidylserine could be stored overnight at 40 C]. The suspension was centrifuged at
10,000 x g for 10 min at 200 C and the supernatant discarded. [At this point, the pellet
may be stored at -20° C under a N2 atmosphere for several months]. The pellet was
mixed with 0.1 ml of saline buffer containing the material to be entrapped, and 3 glass
beads were added. The suspension was vortexed 10 seconds, then sonicated 10 sec to
maximize dispersion. Eighty µl 0.1 M EDTA and 50 µl 0.1 M NaOH were added (or 150
µl 0.1 M EGTA, pH 7.4), and the mixture was shaken for 10 min at 370 C. After
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equilibration for 30 min at 37°, 0.5 ml buffer was added. This suspension was either
dialyzed against 1 of buffer for 30 h.

Alternatively liposomes were collected by

centrifugation at 40,000 xg for 25 minutes at 20° and the pellet resuspended in lml buffer
three times to remove nonencapsulated materials.

2

Phosphorus Determination
Phospholipid concentration was measured by determining phospholipid
phosphorus (Bartlett, 1959; Bottcher et al., 1961 ). Five µl aliquots of the final liposome
suspension were pipetted into acid-washed screw-cap test tubes, to which were added 0.2
ml 70% perchloric acid (HCl04) (Mallinckrodt). The tubes were then placed in a heating
block (Tecam Dri-Block) at 1680 C for 40 min. The tubes were cooled to about 500 and
0.2 ml 5% ammonium molybdate (Fisher) and 0.2 ml Fiske-Subbarow reagent were
added. The tubes were vortexed, loosely capped, and then incubated in a boiling water
bath for 7 min. The tubes were cooled and distilled water was added to the 5.0 ml mark.
Absorbance was measured at 830 nm. A series of dilutions of a standard phosphate
solution were made from a 10-4 M stock NaH2P04 (Sigma) solution to obtain
phosphorus contents ranging from 0-0.20µmoles.
The Fiske-Subbarow reagent was made by adding 0.5 g of purified 1-amino-2naphthol-4-sulfonic acid to 200 ml of a freshly prepared 15% NaHS03 (Mallinckrodt)

2

All glassware for liposome preparation was soaked in HN03:H2S04(1:10) for 1 h
and rinsed thoroughly with deionized water. Stirring bars were soaked in a solution of
EDTA/EGTA and rinsed with deionized water. All aqueous solutions were degassed
before use.
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solution, followed by 1.0 g Na2S03 (anhydrous) (Allied Chemical). The suspension was
heated to dissolve the solutes, and the solution was stored in a dark bottle at 40.
To purify 1-amino-2-naphthol-4-sulfonic acid, 1.5 g of the crude material
(Eastman Chemicals) was added to 100 ml water containing 15 g NaHS03 and 1 g
Na2S03 and heated to 900. The mixture was stirred until all but an amorphous impurity
was dissolved. The hot solution was suction filtered, and the filtrate cooled thoroughly.
One ml of 12 N HCl was added to precipitate the product, and the mixture was suction
filtered. The precipitate was washed with 30 ml cold water followed by cold ethanol until
the washings were colorless (Fiske & Subbarow, 1925).

Electron Microscopy
Liposomes were characterized by electron microscopy using a pH-neutral
negative stain. The liposomes were prepared as before, except that the saline buffer
contained 1% phosphotungstate (Baker) (Egerdie & Singer, 1982). Samples were placed
on prepared copper mesh grids. After 1 min, the grids were drained, then allowed to air
dry. Photographs were taken with Kodak electron microscope film-4489.
The negatives were developed in the following manner:
D-19 developer

4min

H20

1.5 min

Kodak fixer

8min

H20

1 min
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Kodak hyperclear

2min

H20

5 min
The prints were made the following way:

Dektol

1 min

Stop bath (Kodak indicator) 15-30 sec
2-4 min
5 min

Measurement of Entrapped Aqueous Space
14c-labeled sucrose was added to the saline buffer during the entrapment step in
order to determine the efficiency of the trapping step and the average size of liposomes
(calculated from surface area to volume ratios). Two µCi [U-14q sucrose (10 µl
sterilized aqueous solution containing 3% ethanol, 200 µCi/ml) (Amersham) was added
with 0.1 ml of saline buffer prior to the addition of EDTA. The untrapped sucrose was
removed by dialysis before the liposomes were isolated in the final pellet. The liposome
mixture was placed in dialysis tubing which had been pretreated with EDTA/EGTA and
rinsed thoroughly with deionized water. The bag was dialyzed against 1000 ml of NaCl
buffer (pH 7.4) overnight. The retentate was again dialyzed against 1000 ml fresh buffer
for 5 h.

Samples taken from the dialysates and retentates were dissolved in 10 ml

Aquasol and radioactivity was determined by liquid scintillation (Beckman LG 7500).

34
Calculation of Avera~e Liposome Size
Average liposome size was determined by 3 methods: (1) Direct measurement by
electron microscopy; (2) molecular sieve chromatography; and (3) calculation of the
average liposome diameter, D, from the entrapped volume. The relationship between
diameter, volume and surface area is given by the following equation:
D = 6 x Vol/Area
6 x (µl trapped) x 1018 nm3/µl
D-~~~~~~~~~~~~

(µmol PS) x 1.89 x 1017 nm2/µmol
Volume is the µl of entrapped aqueous space per µmole of phospholipid recovered, and is
calculated from the amount of [14q sucrose and phospholipid recovered from the
liposomes. Area is the surface area of a bilayer which can be formed from 1 µmole of
phospholipid, assuming a packing density found in hydrated bilayers formed from egg
lecithin (62.7 A/polar head group) (Levine & Wilkens, 1971).
Further experiments for characterizing liposome size were completed by others in
this laboratory (Thyagarajan, 1985). PS-LUV liposomes were prepared as previously
described in the presence of either [14qsucrose (2-4 µCi/ml), FD (40 mg/ml) or [ 1251]labeled phosphorylase b 100 µCi/ml) in the NaCl buffer. These were separated from
unentrapped solutes by gel filtration on a 1.5 x 50 cm column of Sepharose CL4B
presaturated with PS and eluted with the same buffer.
calibrated using microspheres of defined sizes as standards.

This column was previously
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Preparation of [14C]-Cholesterol-Labeled Liposomes
Liposomes were sometimes prepared with 14c-cholesterol. The procedure was
identical to that described above, except that 5 µCi [4-14q cholesterol (5 µl toluene
solution, 100 µCi/ml, specific activity= 58.4 mCi/mmol) (Amersham) was added to the
phosphatidyl serine solution before solvent evaporation. The liposomes were dialyzed as
for the sucrose-labeled liposomes.

Entrappment of Fluorescent Probes in Liposomes
Fluorescein isothiocyanate-dextran (average MW = 10,500) (Sigma) was
entrapped into LUV to be used as a pH-sensitive fluorescent probe in order to detect
liposome-cell fusion (Okuma & Poole, 1978).

Liposomes were prepared as before,

except that 10.4 mg fluorescein isothiocyanate-dextran (FD) was added with 0.1 ml
buffer prior to the addition of EDTA.

The liposomes were washed 3 times by

centrifugation.
In some experiments, 6-carboxyfluorescein (Sigma) (6-CF) was entrapped within
LUV. To purify the compound, 750 mg 6-CF was stirred in 50 ml H20 and solubilized
with a few drops of NaOH. The solution was filtered and adjusted to pH 7.4 with acid.
Molarity was determined to be 0.388 M by absorbance measurements. Liposomes were
prepared as before, except that 80 µl of a purified 0.388 M 6-CF stock aqueous solution
and 20 µl of 5 x saline buffer, were added prior to the addition of EGTA. The liposomes
were washed 3 times by centrifugation.
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Fluorescence was detected with a Perkin-Elmer MPF-44B fluorescence
spectrophotometer operated in the Ratio mode, and corrected fluorescence spectra were
obtained. Instrument settings were as follows:
Emission slit width = 20 nm
Excitation slit width = 10 nm
Emission = 519 nm
Excitation = 400-500 nm in the scanning mode, or 450 & 495 nm in the fixed
wavelength mode
Neutral density plate 4
A standard curve of A495/A450 (excitation wavelengths) vs. pH was made by adding 100
µl of a 300 µg/ml FD solution to 3 ml of buffers ranging in pH from 4.0-8.5.

To

determine the pH dependency of liposome-entrapped FD, 100 µl of the final liposome
preparation was added to 3 ml of buffer at pH 4.75, 6.8, and 8.5.

Fluorescence of

liposome-entrapped 6-CF was determined by adding 10 µl LUV (or 20 µl
phosphatidylcholine SUV) to 3 .0 ml NaCl-Tris buffer in the presence and absence of 0.1
ml of 10% Triton X-100 [Excitation= 492 nm; Emission= 520 nm].

Liposome-Cell Fusion
Confluent monolayers of GM 3440 fibroblasts grown in 75 cm2 flasks were used
for all experiments. The growth media was removed from the cell cultures, and the cells
were washed with 5 ml of phosphate buffered saline (PBS) (Flow). Two ml fresh PBS +
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1 ml liposomes were added to the "experimental" flask. "Control" flasks contained 3 ml
PBS and either 1 µl 14c-sucrose or 1 µl 14C-cholesterol for the radioactive experiments.
Controls for the fluorescent experiments consisted of cells which had been incubated with
empty liposomes. The cells were incubated 2.5 hat 37°, then washed 3 times with 5 ml
PBS. The cells were either detached with 2 ml 0.5% trypsin or disrupted by adding 1 ml
of 0.1% Triton X-100 and sonicating 10 min in a Bendix bath-type sonicator. One ml of
cell suspension was dissolved in 10 ml Aquasol to count radioactivity.

Preparation ofFluorescein-Labeled Bovine Serum Albumin
Forty mg bovine serum albumin (BSA) (Sigma) was dissolved in 4 ml 0.05 M
Tris, 0.1 M NaCl (pH 9.2) buffer. Eight mg fluorescein isothiocyanate (FITC) (Sigma)
was dissolved in 10 ml dimethyl formamide to give a 2 mM solution. Forty µl of the
FITC solution was added to the BSA solution and allowed to react for 45 min.
The reaction mixture was loaded onto a 1.5 x 25 cm Sephadex G-25 column
equilibrated with ca++_free/Mg++_free PBS (pH 7.4) and eluted with the same buffer
(flow rate= 33.0 ml/h). One ml fractions were collected and analyzed for fluorescence:
2.9 ml PBS + 0.1 ml fraction
Excitation = 492 nm
Emission = 520 nm
Signal gain = 3
Fluorescent fractions which eluted with the void volume of the column were pooled and
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stored at -200 C.

Preparation of Small Unilamellar Vesicles (SUV)
All

lipids were purchased from

Sigma.

Five mg

egg

yolk L-a-

phosphatidylcholine (PC) + 1.05 mg lysolecithin + 0.27 mg stearylamine (molar ration of
lipids 70: 20: 10, respectively) were placed in a 50 ml round-bottom flask and dissolved
in 9 ml CHCl3 and 1 ml methanol. The solvents were evaporated to dryness on a rotary
evaporator (2 h). The entrapment buffer was added: 1 ml ca++_free/Mg++_free PBS +
10 mg FD or 0.7 ml FITC-BSA stock solution+ 0.8 ml PBS. The flask was flushed with
N1 for 3 min, then sonicated 45 min with a Branson bath-type sonicator. The suspension

was allowed to equilibrate 1 h at room temperature. The liposomes were washed by
centrifuging 3 times at 40,000 x g (18,000 rpm) at 20° C for 25 min. The final pellet
was suspended in 1 ml PBS (Ca++-free/Mg++-free).
Percent entrapment was determined by fluorescence measurements.

The

fluorescence of a blank solution containing 2.9 ml (2.9) ml PBS + 0.1 ml 0.1 % Triton X100 was set to 0. The stock FITC-BSA solution was analyzed by adding 5 µl to 2.9 ml
PBS+ 0.1ml0.1% Triton X-100. Liposome fluorescence was measured by adding 50 µl
of the suspension to 2.8 ml PBS+ 0.1ml0.1% Triton X-100.
Excitation
Emission

=
=

492 nm
520 nm
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Preparation of Cells for Microscopic Examination
Cells were prepared for microscopic examination by (1) suspension of trypsinized
cells in PBS and (2) formaldehyde fixation of cells grown on coverslips. For the first
method, 5 ml PBS was added to trypsinized cells (as previously described). The cells
were pelleted by centrifugation and resuspended in 1 ml PBS.

One drop of the

suspension was placed on a microscope slide and observed under a fluorescence
microscope.
For the second method, glass coverslips were coated with 1 ml 10% FCS in PBS
and incubated at least 1 h at room temperature in a tissue culture hood. The FCS solution
was removed and the coverslips were air-dried and sterilized under a U.V. light for 24 h.
Medium was removed from the fibroblasts, and the cells were washed with 5 ml
PBS. Five ml medium were added, and the cells were detached by scraping. The cells
were pelleted by centrifugation and resuspended in complete medium. One ml of the
suspension and 1 ml of medium were added to each treated coverslip. The fibroblasts
were allowed to incubate at 37° at least 1 day to permit attachment and spreading.
After incubation, the medium was removed, and the coverslips were washed with
2 ml sterile PBS.

The cells were then incubated with SUV prepared from PC,

lysolecithin and stearylamine containing either FD or FITC-BSA.

Two methods of

incubation were used:
I.

The coverslips were incubated 1 hat 370 C with 1.0 ml PBS (containing no ca++
or Mg++), 0.9 ml of the liposome preparation, and 0.1 ml ca++ (final ca++
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concentration= 40 mM). [The control coverslips were incubated in 2.0 ml PBS
which was made 40 mM in ca++.] The coverslips were washed 3 times with 2 ml
PBS (Whittaker) and fixed with 2 ml Immunofix II for 4 min at room temperature.
The coverslips were washed at least 3 times with PBS, then glued to alcoholwashed slides with UVInert.
2.

The coverslips were incubated 2 hat 37° with 0.5 ml liposome suspension and
1 ml PBS (Whittaker). After rinsing with PBS, one coverslip was immediately
fixed with Immunofix II (as described in 1). The second coverslip was incubated
for 2 h at 37° in complete growth medium, rinsed with PBS, and fixed with
Immunofix II.
An endocytosis experiment was also performed with the cells seeded on

coverslips.

The coverslips were incubated with 2 ml complete growth medium

containing 1 mg FD/ml medium for 18 h at 370. The medium was removed, and the cells
were washed several times to remove the fluorescent compound. The cells were then
fixed with Immunofix II.
Immunofix II was prepared by heating 0.25 g paraformaldehyde (Sigma) in 2.5 ml
H20 until it began to steam (about 60° C). Care was taken to avoid boiling. Two to four
drops of 0.1 N NaOH was added to clarify the solution. Cacodylate buffer (12.5 ml of
0.2 M, pH 7.4) and 10 ml H20 were then added (final volume 25 ml).
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Photography
Photographs of the trypsinized cells were made as observed under U.V. lighting:
ASA=400
Recip. = 3
Exposure time = automatic
Photographs were made of the cells as observed under phase-contrast and U.V. lighting.
Black and white Tri-X and Ektachrome 400 color films were used.
ASA=800
Timing = Automatic mode
The slides and prints were made professionally (Loyola Photography Department).
Measurement of Intracellular pH
Confluent monolayers of fibroblasts were pretreated with empty PS-LUV for 2 h
in PBS containing ca++ and Mg++. The monolayer was then washed 4 times and the
cells harvested by trypsin treatment. Washed cells were then resuspended in ice cold 50
mM

MES

buffer,

pH

6.2,

containing

the

non-fluorescent

derivative

(5)6-

carboxyfluorescein (CF) diacetate (35 µM). After a 15 minute incubation at 4° C, the
cells were washed, resuspended in ice cold PBS, and aliquots removed for fluorescence
measurements in buffers of various pH. The aliquots of the medium were also analyzed
for fluorescence in the various buffers (Thyagarajan et al., 1985).
Excitation = 450 nm, 495 nm
Emission = 519 nm
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PART II. DEGRADATION OF ENDOGENOUS CELLULAR PROTEINS
Measurements of Cell Leak.age by the Lactate Dehydrogenase Method
Media was removed from confluent monolayers of fibroblasts grown on 60 x 15
mm dishes. The cells were washed 3 times with 2 ml of complete growth medium
warmed to 37oc. Media samples were collected in two ways:
1.

Five ml fresh medium at 37°C was added, and cells were incubated at 37oc. At
various time points, 1 ml of the medium was withdrawn for assay and replaced
with 1 ml fresh medium. The samples were then assayed immediately for lactate
dehydrogenase activity with a Perkin-Elmer 320 spectrophotometer.

2.

One ml fresh medium at 37oc was added, and cells were incubated at 37oc. At
intervals of 1 h, the entire medium (1 ml) was removed and replaced with 1 ml of
fresh medium (37°C). All samples were assayed immediately as before.

After the last time point, the cells were washed 3 times with 2 ml warmed media, and 2
ml of fresh media were added. The cells were scraped into the media, and 20 µl 20%
Triton X-100 were added. The cells were disrupted in ice by a Cole-Parmer ultrasonic
probe-type homogenizer (4710 series) and 0.1 ml was removed for measurement of
lactate dehydrogenase.
Lactate dehydrogenase activity was measured by the method outlined by
Kornberg (Kornberg, 1955). The assay mixture contained 2.7 ml 0.03 M phosphate
buffer (pH 7.4), 0.1 ml 0.002 M NADH (pH 8) (Sigma), 0.1 ml 0.01 M sodium pyruvate
(pH 7) (Eastman) and 0.1 ml of the sample. Change in absorbance was measured at

43
340 run for at least 2 min. Activity was recorded as µmol lactate formed/ml of medium
or cell lysate/min.

SDS-Polyacrylamide Gel Electrophoresis
Acrylamide and N,N'-methylene bisacrylamide were purchased from Eastman.
Trizma base, glycine, Coomassie Brilliant Blue, bromphenol blue, and sodium lauryl
sulfate (SDS) were purchased from Sigma.

Mercaptoethanol and TEMED were

purchased from Bio-Rad. Acetic acid and methanol were purchased from American
Scientific Products.
A stock acrylamide solution consisted of 30% acrylamide + 0.8% bisacrylamide.
This solution was stored for no longer than 1 month at 4°. The lower gel buffer consisted
of 1.5 M Tris (pH 8.8) and 0.4% SDS. The upper gel buffer consisted of 0.5 M Tris (pH
6.3) and 0.4% SDS. Running buffer was made from a 1: 10 dilution of 0.25 M Tris,
1.92 M glycine and 1% SDS (pH 8.3). The reducing sample buffer (2 x) was prepared
with 10 ml glycerol, 23 ml of a 10% SDS solution, 5 ml of

~-mercaptoethanol,

2 ml of a

0.1 % bromphenol blue solution, 8.3 ml of the upper gel buffer and 1. 7 ml of deionized
water.
The 9% lower running gel was prepared with 9 ml of the lower gel buffer, 10.8 ml
of the acrylamide solution and 16.2 ml of deionized H10. After degassing, 75 µl of a
10% freshly prepared ammonium peroxydisulfate solution and 10 µ of TEMED were
added to initiate polymerization. The gel was poured immediately into a Bio-Rad gel
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apparatus, covered with distilled H20, and allowed to polymerize overnight.
The 4.5% stacking gel was made by combining 2.5 ml of the upper gel buffer,
1.5 ml acrylamide solution, and 6.0 ml of deionized H20. After degassing, 300 µl of
10% ammonium peroxydisulfate and 10 µl of TEMED were added to initiate polymerization. The gel was poured around an insert comb and allowed to polymerize. The comb
was then removed in the presence of the running buffer.
The gel was placed in the upper tank of a Bio-Rad Protean 16CM electrophoresis
apparatus and the upper gel buffer was added. Either 50 µl of the prepared samples or
20 µl of the molecular weight standards were added to the sample wells. The lower tank
was filled with running buffer, the upper tank was placed within the lower tank, and
buffer was added to cover the cathode. The gel was run overnight (20 h) at 8 mamps
(constant current) (Laemmli, 1970).
When the dye front reached the bottom of the gel, the power source was
disconnected, and the gel was removed from the plates and placed immediately into a
staining solution containing 46% methanol, 8% acetic acid, and 0.1 % Coomassie Blue.
After staining overnight, the gel was placed in a destaining solution containing 20%
methanol and 8% acetic acid. The gel was destained until the bands were clearly visible
(2-3 days). The gel was then photographed on a light box with Polaroid type 667 film [Fstop =16, shutter speed= 60, U.V. filter in place] (Laemmli, 1970).
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Fluoro~raphy

Fluorography of the gels was performed according to Chamberlain's procedure
(Chamberlain, 1979). The destained gel was soaked 30 min in 1 M salicylate (pH 7.0)
(Sigma), then rinsed with 30% methanol. The gel was then placed on filter paper and
covered with plastic wrap.

The gel was dried overnight on a Hoefer Scientific

Instruments Slab Gel Dryer (Model SE 540), then placed in a Wolf X-ray Corporation
cassette equipped with Du Pont intensifier screens. Du Pont X-ray film was placed on the
gel in total darkness and exposed 1 month at -700. The film was developed in total
darkness with Kodak GBX developer for 5 min and Kodak GBX fixer for 5 min. The
developed film was washed with tap water.

Protein Metabolism in Cultured Fibroblasts
L-Leucine and trichloroacetic acid (TCA) were purchased from Sigma. [3H-4,5]
L-leucine was purchased from ICN and Amersham. Leucine-free/glutamine-free medium
was purchased from Hazelton. Phosphotungstic acid (PTA) was purchased from Baker.
Media was removed from confluent fibroblasts grown on 60 x 15 mm dishes, and
the cells were washed with 2 ml PBS. The cells were then labeled by incubating them in
2 ml complete growth medium containing 1 µCi [3H-4,5] L-leucine (0.5 µCi/ml) for
approximatedly 40 h. After the labeling period, the media was discarded, and the cells
were washed 3 times with 2 ml PBS. The cells were then incubated 5 min at 37° with
5 ml of experimental media containing 2 mM Leu (non radioactive, "cold") to remove
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free 3H-Leu. This media was removed and discarded. To measure intracellular protein
degradation, 1 ml of fresh medium was added, and the cells were incubated at 370
(Gronostajski et al., 1985; Neff et al., 1977).

Periodically, the entire medium was

removed, and 1 ml of fresh medium was added. Each medium sample so obtained was
treated with an equal volume of ice cold 20% TCA-1 % PTA solution (Buktenica, 1983).
This suspension was centrifuged at 5000 rpm for 10 min at 4°. The supernatant was
removed and dissolved in 10 ml Ecoscint. The pellet was dissolved in 1 ml 1 N NaOH
and added to 10 ml Ecoscint (Bond & Aronson, 1983).

At the conclusion of the

experiment, the cells were disrupted with 2 ml of 0.6% SDS-0.01 M EDTA (Hirt, 1967)
and dissolved in 10 ml Ecoscint. Radioactivity was measured with a Beckman LS7500
liquid scintillation spectrometer.
These experiments were conducted in the presence of a variety of agents known to
affect cellular protein metabolism. The essential amino acid leucine was added to the
complete growth medium at concentrations of 0, 2 and 10 mM; the control level was set
at 2 mM Leu.

The protein synthesis inhibitor cycloheximide (Sigma) was used at

concentrations of 10 and 50 µM (Thoene et al., 1985). The lysosomotrophic agents
ammonium chloride and chloroquine (Sigma) were added in 10 mM and 25 µM concentrations, respectively (Doherty & Mayer, 1985; Hasilik & Neufeld, 1980; GonzalezNoriega et al., 1980).

The effects of two thiol proteinase inhibitors--leupeptin and

antipain (Protein Research Foundation)--were also examined. Leupeptin was used at
concentrations of 20 µM and 200 µM, while the concentration of antipain was 40 µg/ml
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(Okada & Dice, 1984; Mego, 1984; Umezawa & Aoyagi, 1977). Vinblastine (Sigma), a
microtubule inhibitor, was used at 55 µM (Ahlberg, 1982). Cytochalasin B (Sigma), an
actin inhibitor, was used at 6.6 µg/ml

(Stacey & Allfrey, 1977). Experiments with

control medium were also performed at 260 C (Dunn et al., 1980).
Experiments were also performed in the absence of serum with leucinefree/glutamine-free medium (Poole et al., 1978). At least 1 compound from each class of
agents listed above was tested. Under these conditions, the concentrations were changed
to enhance the effects or to prevent cell death. The concentration of antipain was raised
to 100 µg/ml. The carboxyl protease inhibitor pepstatin A (Protein Research Foundation)
was added as a saturated solution (Mego, 1984; Umezawa & Aoygi, 1977).
chloroquine concentration was reduced to 5 µM.

The

The vinblastine concentration was

reduced to 12 µM. The concentration of cytochalasin B was changed to 7.5 µg/ml.
For electrophoresis, cells were labeled as before, except that 55.6 µCi [35s]methionine (27.8 µCi/ml) (Amersham) was used in place of 3H-Leu. Two incubation
periods were used: 30 min and 42 h. The experimental medium consisted of complete
growth medium containing 2 mM Met (Sigma).

Samples were treated with equal

volumes of 2 x electrophoresis sample buffer and heated in boiling water for at least
2 min. Samples were stored at -20° prior to electrophoresis (Hasilik & Neufeld, 1980;
Sahagian & Gottesman, 1982).
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Measurements of Cell Detachment and Vesicle

Sheddin~

The cells were metabolically labeled and washed as before. Cells were incubated
in either complete growth medium or in serum-free, Leu-free, Gln-free medium for 3 hat
37°. All l ml of the medium was then removed to Beckman 343778 centrifuge tubes and
balanced to the nearest 0.01 g. The media was centrifuged at 18,000 rpm (14,116 x g) on
a Beckman TL-100 ultracentrifuge for 15 min at 40. The supernatant was removed to
new tubes; the pellet was dissolved in 0.5 ml of the 0.6% SDS-0.01 M EDTA solution
and added to 10 ml Ecoscint.
The supernatants were balanced as before, then centrifuged at 50,000 rpm
(108,920 x g) for 1 hat 40. The supernatant was removed and precipitated with 1 ml ice
cold TCA-PTA. This suspension was centrifuged at 5000 rpm for 10 min at 40, and the
supernatant was dissolved in 10 ml Ecoscint. The pellet was dissolved in 1 ml 1 N NaOH
and added to 10 ml Ecoscint. The high-speed pellet was dissolved in 0.5 ml SDS-EDTA
and added to 10 ml Ecoscint.
Two ml fresh media were added to the cells, which were then incubated overnight
at 370. In the afternoon of the second day, the medium was removed, and the cells were
washed 3 times with 2 ml PBS. The cells were next incubated overnight with 1 ml fresh
medium.

All 1 ml samples of medium were transferred to centrifuge tubes and

centrifuged at 18,000 rpm and 50,000 rpm as before. The monolayer was disrupted with
2 ml SDS-EDTA and the extract was dissolved in 10 ml Ecoscint. Radioactivity was
determined by liquid scintillation spectrometry.
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Cathepsin B Activity in Cultured Fibroblasts
CBZ-L-Arg-L-Arg-4-methoxy-p-naphthylamide, ethy lenediamine tetraacetic acid
(EDTA) and L-dithiothreitol (DTT) were purchased from Sigma.
Media was removed from confluent fibroblasts grown on 60 x 15 mm dishes, and
the cells were washed with 2 ml PBS. The cells were incubated for 66 h in 4 ml of each
of the following media:
1. Complete growth medium containing 2 mM Leu.

2. Leu-free/Gin-free medium containing penicillin-streptomycin.
3. Complete growth medium containing 2 mM Leu and 100 µg/ml antipain.
The cells were washed 3 times with 2 ml PBS, then incubated at room
temperature in 2 ml ofhypotonic 50 mM acetate/I mM EDTA buffer (pH 5.2) for 2 hon
a shaking water bath. Samples (100 µl) of the resulting cellular extract were incubated
with 100 µ activator (30 M DTT, 15 mM EDTA, pH 5.2) for 30 min at 370.

The

reactions were initiated by the addition of 200 µl 0.2 M citrate/phosphate buffer (pH 6.2)
and 100 µl of the substrate (0.68 mM CBZ-L-Arg-L-Arg-4-methoxy-p-naphthylamide).
At intervals of 5, 15, and 25 min, the reactions were terminated with 2 ml ice cold 1 N
HCL A product standard was prepared with of 100 µl of the acetate buffer, 100 µl of the
activator, 200 µl of the citrate/phosphate buffer, 100 µl of 4-methoxy-p-naphthylamide
(final concentration 100 µM), and 2 ml 1 N HCL
Fluorescence was measured with a Perkin-Elmer MPF-44B fluorescence
spectrometer at the following settings:
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Excitation = 300 nm
Emmission

= 420 nm

Excitation slit width = 10
Emission slit width = 10
Signal gain = 1
The 100 nM standard was set to read 120 fluorescence units.

Analysis of the Data from Studies of Protein Catabolism in Fibroblasts
A complete copy of the program used in processing the data obtained from the
release of radioactivity from fibroblasts appears in Appendix 2. This section contains a
brief explanation of the programs and a summary of the calculations used.
1.

Program 1--Data
The amounts of TCA-soluble and TCA-insoluble radioactivity released at each

time point are entered into the computer along with the total radioactivity remaining in
the monolayer by the end of the experiment, [CPM]monolayer·

With this data, the

program calculates the cumulative radioactivities released at each time for the two
products, [CPMsollt and [CPMinslt- The program next calculates the rates of release of
TCA-soluble and -insoluble radioactivity at late times by linear regression analysis of
[CPMsollt vs. t and [CPMinslt vs. tat late times. These rates are then used to calculate
the ratio of TCA-soluble to total radioactivity released at late times, R2, from the relationship R2 =rate [CPMsol]/rate [CPMtotall at late times. The program next partitions
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the radioactivity remammg m the monolayer between the two expected products
according to the relationships
[CPMmonolayerlsol = R2 x [CPMmonolayerl and
[CPMmonolayerlins = (l-R2) x [CPMmonolayerl•
The total TCA-soluble and -insoluble radioactivity released by the monolayer were the
reaction to proceed to completion, [CPMsolJoo and [CPMinsloo, should then be
[CPMsolJoo = [CPMsolltotal released by+ R2 x [CPMmonolayerl
last time point
[CPMinsJoo = [CPMinsJtotal released by+ (l-R2) x (CPMmonolayerl
last time point
The fractions of TCA-soluble and TCA-insoluble remaining in the cells at each time
point are then given by
Fsol = {[CPMsolJoo - [CPMsolJt}![CPMsolloo and
Fins= {[CPMinsJoo - [CPMinsJt}l[CPMinsloo
The program next calculates the natural logs (ln) of Fsol and Fins· The program also
calculates RT, the ratio of total TCA-soluble to total soluble and insoluble label released
were the reaction to go to completion. RT is given by
RT= [TCAs0 1] 00 /{[TCAsolloo + [TCAinsloo}
Lastly, a data file is created which stores the number of data points (N), R2, RT,
(CPM]monolayer, time, [(CPM)sol]t, [(CPM)inslt, ln(FsoOt and ln(Finsk
2.

Program 2--Enzfitter
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This is a non-linear regression, data analysis program for IBM PC and compatible
computers (Elsevier-Biosoft, Cambridge, UK). The best fit curve is calculated using the
algorithm of Marquart (Bevington, 1969). The equations to be fitted to the data can be
selected from a menu of available equations, and new equations can be added to the
program using the integral equation editor.

The operator can enable or disable an

algorithm for eliminating "outliers" (data points which fall well outside the error range of
the majority of the observations ( Mostellei & Tukey, 1977; Duggilby, 1981).

The

operator can also choose from among different methods of data weighting, depending on
how the error is distributed about the measured values. In order to help the operator
select from among the weighting schemes available (simple weighting when the error is
due to instrumental uncertainties and pipetting errors, proportional weighting, or
statistical weighting), the program will also plot residual error versus the observed value
(L1y vs. y) and relative residual error versus the observed value (L1y/y vs. y). It was
observed that progress curves for the appearance of TCA/PTA-soluble and -insoluble
radioactivity in the culture medium could be described as a sum of two exponential
equations.

Therefore, plots of [(CPM) 00

-

(CPM)tl vs. time were fitted to an equation

for Double Exponential Decay selected from the equation menu. Furthermore, as the
residual error, L1y, was found to be independent of the observed value, y, simple
weighting was used in fitting the data to this equation (Leatherbarrow, 1987).

The

program then calculated the extent of each of the two phases of the decay curve, the
corresponding first order rate constants, and their standard errors. The standard errors
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were generally less than 10%, indicating "good" experimental data sets (Leatherbarrow,
1987).

CHAPTER III
RESULTS

PART I. LIPOSOME-MEDIATED MICROINJECTION OF
PROTEINS INTO FIBROBLASTS
Characterization of Large Unilamellar Vesicles
The recovery of phospholipid in the liposome preparations was determined by
measuring their phosphorus content as described in Methods. Table 1 lists Ag30 and
phosphorus (P) concentrations for three liposome preparations. With the exception of the
first preparation, 1 ml of the final liposome suspension contained approximately 6 µmol
P, which represented a recovery of approximately 60% of total lipid used for each of the
preparations.
Samples were taken at the different stages in the preparation of the PS-LUV--the
initial SUV, the Ca2+_cochleate intermediate, and the final LUV--and analyzed by
electronmicroscopy (see Figures 1, 2, 3). Scales were made for the photographs, so that
liposome sizes could be measured directly from the prints with a metric ruler.
SUV (Figure 1) were actually a heterogeneous collection of structures.

The

vesicles were often multilamellar and displayed a wide range of sizes, with the average
diameter being about 65 nm.

Very little could be seen in the electronmicrographs

obtained from the ca++_cochleates (Figure 2). They appeared as irregular, lattice-like
structures, possibly formed by the aggregation of smaller spherical components. Freeze-
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Table 1.
Preparation

Phosphorus assay of liposomes.

Ag3ol

[P]2
(mM)

µmolP
recovered

Recovery

%

1

0.199

1.00

1.0

10

2

0.263

6.40

6.4

64

3

0.237

6.10

6.1

61

1Average of 3 determinations.
2Determined from phosphorus standard curve obtained at the time of the analysis.
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Figure 1.

Electronmicrograph of PS-SUV,
phosphotungstate negative staining,
magnification 92,000 X. Ten µmol of bovine brain phosphatidylserine was
sonicated for 30 minutes in buffered saline containing 1% phosphotungstate
as described in MATERIALS AND METHODS. The vesicles show
heterogeneity in size, shape and lamination. Average diameter was 65 nm.
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Figure 2.

Electron.micrograph of "Ca++_chocleates" prepared by the precipitation of
PS-SUV with ca++, magnification 80,000 X. PS-SUV were precipatated by
the addition of CaCl2, final concentration 6.5mM, in the presence of 1%
phosphotungstate. See MATERIALS AND METHODS for details. These
"chocleates" appear as tightly aggregated complexes arranged in a lattice-like
structure.
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fracture electronmicroscopic studies (Papahadjopoulos et al., 1975) showed that the
calcium cochleate resembles a bilayer wound around a central axis to form a "jellyroll"like structure. Such structures were not evident in any of our photographs.
LUV (Figure 3) had sizes ranging from 200-300 nm in diameter, with an average
diameter of about 250 nm. Their appearance was somewhat translucent and spherical
with electron opaque centers. The dark centers were assumed to be the entrapped phosphotungstate stain.
Molecular sieve chromatography was also used in this laboratory to determine
LUV size (Thyagarajan, 1985). Figure 4 shows a calibration curve obtained following
chromatography of monodispersed polystyrene latex beads of known diameter on a 1.5 x
50 cm column of Sephacryl S-1000. The arrows correspond to the elution volume of two
liposome preparations. Liposome diameter was determined to be 0.26-0.28 µm, which
falls within the range obtained by electron microscopy.

The Trappin~ Efficiency of Phosphatidylserine LUV
[14c]-Labeled sucrose was used to determine the percent of aqueous space
entrapment within LUV, and to estimate liposome size, while [14C]-labeled cholesterol
was used as a marker for lipid incorporation into liposomes. Table 2 lists the results for 3
separate liposome samples prepared in the presence of 2 µCi [14C]-sucrose. Five µl of
each preparation was removed for measuring radioactivity. The total volume of each
sample was 830 µI. Trapping efficency for these preparations ranged from 0.28-2.77%.

61

Figure 3.

Electronmicrograph of PS-LUV,
phosphotungstate negative staining,
magnification 23,000 X. PS-LUV were prepared by adding EDTA, final
concentration 7.9 mM, to a suspension of ca++ -chocleates in buffered saline
containing 1% phosphotungstate. The vesicles are aggregate in small groups:
Vesicle diameters ranged from 200-300 nm with an average of250 nm.
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Figure 4.

Molecular sieve chromatomatography of LUV on Sephacryl S-1000. Open
circle are the sieve coefficients of monodispersed polystyrene latex beads of
known diameters eluted with 0.15 M NaCl, 0.02 M NaHC03, and 3 mM
SDS, pH 8.
Arrows correspond to the sieve coefficients of two
preparations of LUV chromatographed in the absence of SDS.
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Percent incorporation of 14c-sucrose 1 into liposomes.

Table 2.

Preparation

Total activity
recovered (cpm)

Aqueous space
entrapment (%)

Total internal
yo)ume (µI)

1

122,840

2.77

23.0

2

16,770

0.38

3.15

3

12,450

0.28

2.32

1The initial concentration [ 14c]-sucrose used in each preparation of PS-LUV
was 2µCi/ml.
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The volume of the internal space per mole of liposome phospholipid is also presented.
Other LUV preparations were made in this laboratory to entrap [ 14c]-sucrose,
fluorescyl-dextran and [125r]-phosphorylase b (Thyagarajan, 19gs). LUV preparations
typically entrapped 3-4% of the aqueous medium and had an internal volume ranging
from 6.5-10 µIIµ mol PS (Table 3). Assuming that LUV are spheres, and I µmol PS can
form a bilayer with a surface area of 1.89 x 1017 nm2, (Levine & Wilkens, 1971) it is
possible to calculate the average radius of the LUV from the entrapped volume as
described in Materials and Methods according to the equation:
6 x ( µl trapped) x 1018 nm3/µl
D =-------------

(µmol PS) x 1.89 x 1017 nm2/µmol
The internal volume can be determined from the entrapped radioactivity and the
phosphorus content of the liposomes. The calculated

diameter~

Listed in Table 3 fall

within the range obtained by electron microscopy.

Incorporation of 14c-Cholesterol into Phosphatidyl~erine LUV
[14q-Cholesterol was incorporated into LUV more effidently (33o/1>) than [14c]sucrose (Table 4). This was expected since cholesterol would be incorporated directly in
the PS bilayer of the liposomes. Typical recoveries of PS in LUV were 60 to 70%. The
33% incorporation of labeled cholesterol was thus half of

expe~ted.

Bowever, some

spillage of the liposome preparation had occurred during the dialysi1;
decreasing the amount of [14q label recovered.

~iep,

thereby
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Table 3.

Characterization ofLUV from internal volume.

% Entrapment

Internal volume
(µl/µmol PS)

Av. diameter
(mn)

Fluorescyl-dextran

3.3

8.7

276

[14q sucrose

2.9

7.4

234

[125r] phos-

3.1

8.5

270

Aqueous space
marker

phorylase b
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Table 4.

Percent incorporation of 14c-cholesterol into liposomes.

14c-cholesterol
added (µCi)

Sample size
(µl)

14c activity
(cpm)

Total
activity

0.5

1

7100

534,000

Entrapment
(%)

Isome loss of material occured during recovery from the dialys:is tubing.
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The Transfer of Aqueous Space and Membrane Markers from
LUV to Cultured Human Fibroblasts
Cultured fibroblasts (GM 3440) were grown as a confluent monolayer as
described in Methods. Prior to the experiment, the cells were washed with PBS and then
incubated for 2.5 hours at 37° C with 3.0 ml of PBS containing phosphatidylserine LUV
(6 µmoles P) in which [14C]-sucrose had been entrapped.

In order to make

comparisons, control cells were incubated in the same way with 3.0 ml of PBS containing
free surcose (0.2 µCi). Both experimental and control cells were then washed 3 times
with 5.0 ml PBS, the cells detached from the culture flask (Methods), and the cellular
radioactivity measured. The results are shown in Table 5. It can be seen that fibroblasts
incorporated 16 to 17.5 times more sucrose as the percent of the total label in the
medium, when the sucrose was presented entrapped in liposomes than when it was
presented in free form and internalized by pinocytosis.
The incorporation of [14C]-cholesterol into cells which had been exposed to
liposomes containing labeled cholesterol was also examined. From Table 6, it can be
seen that the percent incorporation of labeled liposome membrane markers into cells was
very similar to the percent incorporation of the fluid phase marker [14q sucrose. This
supports the conclusion that the liposome-mediated delivery of sucrose to cells involves a
physical contact between liposomes and the cells. Not unexpectedly, when cells were
incubated with an insoluble dispersion of free cholesterol, a larger percentage of the
cholesterol was delivered to cells than by liposomes alone (Table 6).
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Table 5.

Comparison of liposomes with pinocytosis in the deli very of 14c-sucrose to
human fibroblasts.
Free 14c_
Lipsome 14c _

Preparation

sucrosel(cpm)

1

sucrose2
activity (cpm)

Cellular
radioactivity
activity (cpm)

Incorporation
(%)

440,000

3984
1218

4.9
0.3

291

2.2
0.1

82,000

2

12,450

600

440,000

1Total 14c-sucrose entrapped in PS-LUV. Approximately 6 moles phospholipid
were added per culture dish.
2Total 14c-sucrose added directly to the media.

Table 6.

Percent incorporation of 14c-cholesterol into cells from liposomes.

Liposome 14c cholestrol (cpm)

Free 14c-cholesterol
(cpm)

470,1601
220,0002

Cellular radioaciivify
(cpm)

Incorporation
(%)

11,554

2.5

25,442

11.6

1Total14c-cholesterol associated with PS-LUV. Approximately 6 µmoles of
phospholipid added.
2Total cholesterol added as an insoluble dispersion.

71

Quantification of Phosphatidylserine LUV-Cell Fusion
The previous results suggest that the transfer of an aqueous space marker from PS
liposomes to cells involves a direct interaction between them. However, the results do
not prove that liposomes fuse with the plasma membrane of cells and inject their contents
directly into the cytosol.
The pH-sensitive fluorescent probe fluorescein was utilized as a marker
forliposome-cell fusion.

This probe was theoretically

convenient~

since it could be

quantified by fluorometry and visualized by fluorescence microscopy. Thiee fluoresceinlabeled compounds were used: fluorescein-dextran (FD), 5(6)-carboxyfluorescein [5(6)CF], and fluorescein-labeled bovine serum albumin (FITC-BSA).
The fluorescence of 5(6)-CF is quenched at high concentrations of this
fluorophor; dilution causes large increases in the fluorescence of 5(6)-CF.

This is

illustrated in Part II. Table 7, where phosphatidylcholine (PC)-SUV prepared by
sonicating PC in the presence of 0.388 M 5(6)-CF exhibited little flumescence above the
buffer blank. However, when 0.1 ml 10% Triton X-100 was added to the cuvette to
disrupt the liposomes, fluorescence increased more than 20-fold. Consequently, if one
was to observe a large increase in cellular fluorescence on incubating PS-LUV containing
5(6)-CF with fibroblasts, this could be evidence for liposome-mediated injection of 5(6)CF into the cytosol with concommitant dilution of the fluoropbore. Unfortunately, as
shown in Part I. of Table 7, the preparation of PS-LUV had a muc:h higher initial
fluorescence (10 compared with 1), while the addition of Triton X-100 caused only a 2-
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Table 7.

Fluorescence of liposomes containing 5(6)-carboxy fluorescein.
Sample

I.

IL

Fluorescence 1

PS-LUV
1. Tris/NaCl buffer, pH 7.42
2. Buffer+ PS-LUV3
3. Buffer+ PS-LUV +Triton X-1004

0.1±0.2
9.8 ± 0.5
22.6 ± .5

PC-SUV
1. Tris/NaCl buffer, pH 7.4
2. Buffer + PC-SUV
3. Buffer+ PC-SUV+ Triton X-1004

0.0± 0.0
1.0 ± 0.1
21.7 ± 0.2

1Each value represents the average of 3 different samples.
2The buffer contained 100 mM NaCl, 20 mM Tris, 2 mM Hi_s, pH 7.4.
310 µl of a preparation of PS-LUV (6 µmol/ml, assuming a 6()% recovery of PS)
was added.
4The final concentration of Triton X-100 was 0.33%.
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fold increase in fluorescence. It was also observed that on overnight storage, 5(6)-CF
leached into the buffer from the liposomes. Therefore, it was postulated tha1 the PS-LUV
were permeable to 5(6)-CF, and that 5(6)-CF was not efficiently incorporated into PSLUV.
Further experimentation proved that the fibroblasts were also permeable to 5(6)CF. This was determined in the following way. Cells are freely permeable 10 the nonfluorescent derivative 5(6)-CF diacetate. On incubation with 5(6)-CF diacetate, the cells
became fluorescent as a consequence of its hydrolysis to 5(6)-CF by nonspecific
cy1oplasmic esterases. When fluorescent cells were suspended in buffers of varying pH,
it was found that the fluorescence of such suspensions was due to 2 components:
extracellular 5(6)-CF which had leaked from the cells and intracelluar 5(6)-CF. The two
could be independently quantified by measuring the fluorescence of cell suspensions
before and after the cells were pelleted by centrifugation. The results are shown in Figure
5. From the squares in Figure 5, it can be seen that the cellular fluorescence was largely
independent of the external pH, indicating that the cells were either impermeable to
protons or else were able to maintain their cytosolic pH over a range of external pH's. In
contrast, the fluorescence associated with the extracellular medium was markedly pH
dependent (circles). From the point at which the 2 curves crossed, it was possible to
estimate that the intracellular pH was about 6.6 and that i1 was largely unaffected by the
external pH between 5.5 and 7.5.
Cell permeability to 5(6)-CF was also seen microscopically. Cells incubated with
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Figure 5.

Effect of pH on the fluorescence of intra- and extracellular 5(6)carboxyfluorescein [5(6)-CF]. Fluorescence was observed at 519 nm
following excitation at 495 and 450 nm. Circles, extracellular 5(6)-CF
fluorescence; squares, intracellular 5(6)-CF fluorescence. See MATERIALS
AND METHODS for details.
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5(6)-CF (free in solution) and 5(6)-CF-containing liposomes were more fluorescent than
control cells. However, since the lipsomes were found to leak 5(6)-CF and cells were
permeable to free 5(6)-CF, it was not certain whether cellular fluorescence was due to
liposome-cell fusion or from free 5(6)-CF which diffused into the cells.
Fluorescein isothiocyanate-dextran (FD) was used as a non-permeant, pHsensitive fluorescent probe to quantify liposome-cell fusion.

The ratio of FD

fluorescence at two different excitation wavelengths (F495fF450) is obseJYed to change
with pH (Okuma & Poole, 1978). The results of fluorescence measurements at different
pH's are given in Table 8 and the resulting standard curve in Figlll"e 6. The curve is
sigmoid with the lowest absorbance ratios at pH 4.0 and the highest at pH ll .5. Results of
replicate measurements

between pH 5.5 and 8.0 are also presented i_n Figure 7

(Thyagarajan, 1985) at somewhat different instrument settings.
In order to determine whether PS-LUV are permeable to protons, liposomes
containing entrapped FD were suspended in buffers of varying pH alld the:ir fluorescence
measured at the two different excitation wavelengths as described aboYe. The ratio
F495/F 450 as a function of pH is presented in Table 9. From Table 9, :it is evident that
the buffer alone and a suspension of empty liposomes had almost no fluorescence at the
wavelengths tested. Thus, almost all the fluorescence seen in FD-conia:inillg liposomes is
due to entrapped FD. The results also show that, PS-LUV were permeal:de to protons,
since the fluorescence ratio of the PS-LUY-entrapped FD was extremely sensitive to the
pH of the external buffer. Thus, the fluorescence ratios obtained at e,;.temal buffer pH's
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pH vs fluorescence standard curve for fluorescyl dexiran.

Table 8.
pH

F450 1

F495 2

F495!F450

4.0

3.2

1.6

0.50

4.5

6.3

4.4

0.70

4.75

6.7

5.3

0.79

5.0

7.3

7.5

LOJ

5.5

8.8

16.4

1.86

6.0

11.6

32.5

2.80

6.3

15.2

57.7

3.80

6.5

15.2

53.6

3.53

6.8

17.2

65.l

3.78

7.0

17.8

71.5

4.02

7.4

18.6

80.6

4.33

8.0

18.8

82.1

4.37

8.5

19.8

90.1

4.55

1Fluorescence at 520 nm when excited at 450 nm.
2Fiuorescence at 520 nm when excited at 495 nm.
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Figure 6.

Effect of pH on the fluorescence of fluorescyle destran (FD) (standard curve).
Ex wavelengths = 495 and 450 run; Em wavelength = 519 nm. Fluorescyle
destran (300 µg/ml) was added to various buffers at the indicated pH values.
Fluorescence was then measured at excitation wavelengths of 495 and 450
run, and the emission wavelength of 519 run.
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Figure 7.

Effect of pH on the fluorescence of fluorescyl dextran (FD). The excitation
wavelengths were 495 run and 450 run, and the emission waYelength was 519
run. Open circles, free FD; closed circles, FD trapped in PS-LUV at pH 7.4
and transferred to buffers at the indicated pH's.
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Table 9.
LUV.

pH dependency of the fluorescence of Fluorescyl dexiran entrapped in PS-

Sample

External
pH

F450 1

F495 2

Raiio
(corrected)

Buffer
Liposomes
Liposomes c/FD

4.75
4.75
4.75

1.3
1.4
4.3

LI
L2
3.3

Cl.72

Buffer
Liposomes
Liposomes c/FD

6.8
6.8
6.8

1.2
L.5

2.3

8.0

30.5

Buffer
Liposomes
Lipsomes c/FD

8.5
8.5
8.5

1.2
1.3
8.6

] .'.2
] .4

lfluorescence at 520 nm when excited at 450 nm.
2Fluorescence at 520 nm when excited at 495 nm.

1.1

~4.0

4.33

4.47
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of 4.75 and 8.5 are similar to values with free FD alone (compare Tables 8 and 9). At pH
6.8, the absorbance ratio indicated an internal pH of 7.4 (that of 1he entrapmen1 buffer).
Figure 7 shows fluorescence titration curve for PS-LUY-entrapped FD. It is evident that
the PS-LUV were leaky to protons, such that a comple1e equiljbration between the
internal and external pH was obtained (Thyagarajan, 1985).
As shown above, FD-containing PS-LUV were permeable 1Cl protons, whereas the
pH of the cell cytosol was relatively independent of the pH of the medium.

These

observations were used to develop a method to distinguish be1ween the passive
adsorption of PS-LUV to the plasma membrane and membrane-vesicle fusion.

The

fluorescence of FD in plasma membrane-bound PS vesicles should show a similar
dependency on external pH as does FD in PS-LUV. In C()ntrast, fl11orescence of FD
injected into the cytosol following membrane-vesicle fusion should be independent of the
pH of the medium as was seen for 5(6)-CF.

It shouJd, therefore, be possible to

distinguish between liposome binding to the membrane and vesicle-memb1ane fusion.
Figure 8 shows theoretical curves calcula1ed for various degrees ()f fusjCln of bound
vesicles with the cell membrane according to the equation:
(FR)calc=f x (FR)pH6.6+(1-f) x (FR)pHofmedium
In this equation, FR is the ratio of fluorescence at the excitation waveleog1hs. of 495 and
450, and f is the fraction of membrane-bound vesicles. -w:b.ich fuse, injecting the
fluorophor into the cytosol. (FR)pH 6.6 is 1he fluorescence ratio at pH

6.6~

the apparant

pH of the cytosol as determined from the intersec1ion of the curres inFigme j.
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Figure 8.

Theoretical effect of vesicle-membrane fusion on the pH dependency of cellassociated FD. Curve 1, calculated for no fusion of membrane-bound LUV;
curve 2, calculated for 25% fusion; curve 3, 50% fusion; curve 4~ 75% fusion;
curve 5, 100% fusion. See text for the details of these calc.ulati om;.
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Figure 9 shows the experimental data obtained with FD-containing PS-L UV. The
open circles represent the experimental values of FR, the dashed line was calculated
assuming 25% fusion of membrane-bound vesicles, and the solid line was calculated for
0% fusion. The results indicate that much less than 25% and probably closer to 0% of the
cell associated vesicles have actually fused with the plasma membrane (Thyagarajan,
1985).
Figures 10 and 11 show the appearance of fluorescence intracellularly after
endocytosis of FD dissolved in the media.

Figure 10 was µhotograµhed with phase-

contrast lighting, while 11 was photographed with U.V. light to show the Buorescence.
Although not apparent from the black and white photograph, the1e was a marked contrast
between cellular autofluorescence (gold) and FD fluorescence (green). The fluorescein
fluorescence appeared to be confined within discrete vesicle-like structures in the cytosol,
presumably lysosomes, giving the cell a stippled appearance. These results show that
intracellular FD could have been visualized by PS-LUV.

Preparation ofLiposomes

Containin~

Lysolecithin and Stem!.amine

The failure of PS-LUV to fuse with cells as judged by the ftuorescence assay
prompted the examination of other liposome preparations as p«>teoti<tl -vehicles for the
microinjection of proteins into cultured cells. The rlltionale fm incorporating lysolecithin
and stearylamine into liposomes is as follows. L yso lecithin is reported to d establilize a
lipid bilayer and to promote liposome membrane fusion (Martin & MacD<>nald, 1976a;
1976b).

Stearylamine is a positively-charged detergent which i11te1c'11ates into the
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Figure 9.

Interaction between human fibroblasts and flumes.c:y] dex:tran-containing PSLUV. Circles are the observed fluorescence ratios (exciiaiirn1 at 495 nm and
450 nm emission at 519 run) at the given pH. Solid li.oe~ ca1culitted for 0%
fusion of membrane-bound LUV; dllSbed line, calculated for 2 5% fu~don.
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Figure 10. Uptake of free fluorescyl dextran (FD) by cultured :fib1oblasts. Fibroblasts
were grown in medium containing tluorescyl dextran (I mg(ml), fixed on
glass coverslips; photographed with phase-contrast lighting (Tri-:X film).

90
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Figure 11. Fibroblasts grown in medium containing fluore:;cyl de"tran (FD), fixed on
glass coverslips; photographed w:ith U.V. light (Tr:i-X film). See Figure 10
for further details.
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membrane of liposomes, causing them to acquire a pos:itive charge.

ru

the plasma

membrane of cultured cells is negatively charged, steary1amine-containing liposomes
should have a high affinity for the cell surface.
Small unilamellar vesicles (SUV) were prepared from

PC~

lysoleci1hin and

stearylamine. FITC-bovine serum albumin (BSA) was used as ithe fluorescent probe for
these liposomes. The pH dependency of FlTC-BSA is given in Table I 0.

From the

fluorescence ratios, it is apparent that FITC-BSA :is not useful as a JJH-sensitive probe,
although it could be used as a fluorescent marker for fusion.

Percent entrapment of

FITC-BSA was determined by fluorescence and was found to be 1.03%.
The cells were incubated with the l:iJJosomes containing FlTC-B SA a.s described
in the Methods section. After the cells were fixed, they were examined microsc opically.
1

None of the cells showed any fluorescence other than the gold-colored ai1tof1luorescence
characteristic of the cell line. It was,

therrefore~

containing liposomes did not fuse withceUs.

concluded tba1 l?C.ILyso-PC!stearylamine-
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Effect of pH on the fluorescence of fluorescein isotbjocyanate-Labeled
Table 10.
bovine serum albumin (FITC-BSA).
pH

F450 1

F492 2

F492JF450

5.4

2.8

17.8

6.36

6.0

4.0

25.5

6.38

6.2

4.0

26.6

6.65

6.4

4.2

28.0

6.67

6.8

4.8

31.0

6.46

7.0

4.4

31.2

7.09

7.2

3.9

25.8

6.62

7.4

5.2

35.2

6.77

8.3

5.8

36.8

6.34

1Fluorescence at 520 nm when excited. at 4 SO nm.
2Fluorescence at 520 nm when excited.at 492 nm.
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PART II. RELEASE OF RADIOLABELED PRODUCTS FROM
METABOLICALLY-LABELED FIBROBLASTS
Models for the Release ofRadiolabeled Products from

Metabo1ica11~-Labeled

Fibroblasts

Cultured human fibroblasts, labeled in the presence of [3H-4,5] L-Leucine for 48
hours, were be observed to release boih TCAfPTA-soluble and TC.NPTA-jnsoluble
radioactivity into the culture medium. The TCA!PTA-insoluble radioactlvity rep1esented
about 30% of the total labeled products released in serum- and amino a.ci.d-supplemented
medium (Table 11.) Figure 12 reveals that semilog plots of the appearance of both
products with time were biphasic. The rapid phase generally rep1esented less than 15%
of the initial cellular radioactivity when rate constants and extents. of reacti_on were
determined by a non-linear least squares analysis of the data.
standard deviation (N
6.85

=

3), were found to be 1 .20

Th.ese mte constants, ±

± 0.37 x 1 o-3 min-1

(iJJ2 = 9.6 h) and

± 1.59 x 10-3 min-I (t112 = 1.1 h) for the rapid phase of Jelease of TCAJPTA-

soluble label and TCA/PTA-insoluble label, respectively. The non-i.dentify of these rate
constants indicates that the substrate pools which contrih11ted "to each of these products
were not identical (Buktenica et al., 198 7; Bllkteni ca & F1ankfater, 1 ~87). The half-life
for the rapid phase of release of TCAIPTA-soh1ble products fell -wjtbjn the range of
values previously reported for the degradation of a small

fra~b()!1

() f cellular proteins

which are observed to turn over rapidly (Pao le & Wibo, 1973). Ii bas. been ~mggested that
the degradation of such proteins does not jn_voJve the partid(latioo ofl:s's-osomes (Seglen
et al., 1979). This material was designated Po()) J.
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Table 11.

Rate constants and relative pool sizes for ceJlular protein turnover in the
presence of 13% fetal bovine ~erum.

Part A. Fast phase.
Addition

Ckl)sol
103 min-1

(k1Jins.
103 min-1

P1JP0

P2IP0

2 mM Leu (control 1)

0.88±0.23

4.99±0.70

0.076

0.044

OmMLeu

1.60±0.50

8.29±1.58

0.046

0.054

lOmMLeu

1.12±0.36

7.28± 1. 50

0.06'1

0.047

10 µM Cycloheximide

2.78±0.35

7.81±2.02

0.036

0.050

50 µM Cycloheximide

2.46±0.09

3.08±0.36

0.072

0.068

10 mMNH4Cl

0.77±0.17

4.21±0.33

0.071

0.071

25 µM Chloroquine

1.06±0.15

2.95±0.46

0.06L

0.058

20 µM Leupeptin

1.71±0.30

4.74±0.48

0.039

0.059

200 µM Leupeptin

1.81±0.38

5.27±0. gs

0.04L

0.056

40 µg/ml Antipain

1. 74±0.36

5.79±0.76

Q_QjQ

0.083

2 mM Leu (control 2)

0.63±0.16

4.47±.0.. !f5

0.165

0.041

6.67 µg/ml Cytochalasin B

0.56±0.05

6.73± 1. go

Q_Jj6

0.028

55 µM Vinblastine

2.17±0.05

11.43±0 .3"

0.04'1

0.037

260C

0.58±0.24

7 .30±0. '19

0.096

0.077
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Table 11.

Rate constants and relative pool sizes for celh1lar protein turnover in the
presence of 13% fetal bovine serum.

Part B. Slow phase.
(PJ)sol

(~)sol

(~)ins

10 min-1

lO min-1

P3fPo

(P3)total

2 mM Leu (control I)

7.87±0.67

8.49±0.3~

0.8~

0.71

OmMLeu

8.57±0.43

10.01±0.50

0.90

0.70

lOmMLeu

8.27±0.66

L0.16±0.57

0.89

0.72

10 µM Cycloheximide

5.99±0.23

4.29±0.34

0.9]

0.38

50 µM Cycloheximide

4.96±0.19

4.38±0 55

0.86

0.65

10 mMNH4Cl

5.58±0.64

6.26±0.23

0.86

0.56

25 µM Chloroquine

6.04±0.46

6.91±0.32

D.88

0.43

20 µM Leupeptin

9.37±0. 19

10.00±0 .3 9

D. 90

0.10

200 µM Leupeptin

8.74±0.37

10.26±0.55

(), 90

0.71

40 µg/ml Antipain

10.25±0.31

12.08±0.69

(), 87

0.71

2 mM Leu (control 2)

8.71±1.63

14.13±0.53

(), ?9

0.74

6.67 µg/ml Cytochalasin B

9.07±0.53

14.65±0.42

<l 82

0.71

55 µM Vinblastine

13.58±0.66

12.03±0.4 L

~.

<)2

0.58

260C

5.32±0.21

5 .32±0.57

~.~3

0.75

Addition
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Figure 12. Release of Protein Products from Human Fibroblasts Cultured in Serum and
Leucine Supplemented Medium. Near confluent monolayers of GM3440
human fibroblasts were preinc11ba1ed for 48 hrs with ['.>H-4,,5]-L-leucine.
After washing the monolayer the cells were incubated in medium
supplemented with 13% fetal calf serum and 2 mM unlabeled L-leucine. At
intervals the amount of TCAJPTA-soluble and -insol ub]e radioactivity
released into the medium was measured (see METHODS). The qmmtity (IF) is the fraction of TCAJPTA-soluble (closed circles) and -insoluble (open
circles) radioactivity remaining in the monolayer ateacb time point. The data
was analyzed by nonlinear least squares regression analysjs using the
program Enzfitter. The lines are 1he cakulated best :fit u5:ing the parameters
in Table 11. (k1)sol = 0.88±0 .23 x 10-3min-I,, (k J )ins = 4. ~9±0.]0 x 10-3
min-1, (k2)sol = 7.87±0.67 x 10-5 min-1, (k2)ins = ~.49±0.38 x 10-Sm1n-l.
Each data point is the average of three determina1ions.
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The half-life for the rapid appearance of TCAJPTA-ins.oluble radioactivity is
similar to the transit times reported for some proteins from the endoplasmic reticulum
through the Golgi apparatus to the cell surface (Dong et al., l 989; Mainfeme et al, 1985).
Consequently, the rapid phase of appearance of TCA/PTA-insoluble radioactivity could
represent the secretion of proteins synthesized during the period immediately preceeding
the chase. This material was designated as Pao 12.
In some experiments, the composition of the culture medium us.ed in laheling the
cells differed from that of the subsequent chase medium. As the respons.e of tbe cells to
such changes are not expected to be instantaneous, any ass.oc:iated lag phase would be
superimposed on the initial rapid phases of release of TCAJPTA-solub]e and -insoluble
products, complicating their interpretation.
The slow phase of products released corresponded to greater than 85% of the
initial cellular radioactivity and was characterized by apparently i deniica] rate constants,
8.24

± 0.35

x 10-5 min-I and 9.55 ± 0.92 x 10-5 min· 1 (lJ)J ::: 5 and

TCA/PTA-soluble and TCA/PTA-ins.oluble products.

j

.~ days) for

Tbes.e feJI -within the range of

values previously reported for the turnover of ihe majorify of cellular proieins. in human
tissues (Bradley, 1977). Identical rate c:ons.tants for the two products imply thai both
were derived from the same pool of cellular substrate (Buktenica et al.,, 19 ~j'; Bulctenica
& Frankfater, 1987), and/or that the processes which contributed to the appearance of

both products shared a common rate limiting siep.
Any explanation of the slow phases. of release of TCAf PTA-!;oluble and -insoluble
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products must account for their near identical rate constants. Models which assume that
tritiated leucine arising from the degradation of cellular proteins is reutili.zed in the
synthesis of secreted proteins can be eliminated as explanations of the near identity of the
rate constants for the slow release of both products. Thus, when the chase medium
contained increasing concentrations of unlabeled leucine---0 mM, 2 mM, and 10 mM--in
order to dilute the intracellular amino acid pool of free tritiated leucine, n<> significant
reduction was observed in the amount of TCAfPTA-insoluble label released during the
slow phase [(P3)s0 1/(P3)total is unchanged in Table 11; Figures 13, 14)]. In addition, 10
µMand 50 µM cycloheximide, concentrations which inhibited p1otein synihesis 34% and
greater than 90% (Table 12), failed to inhibit

01

abolish the slow phase of release of the

TCA/PTA-insoluble label [(P3)s 0 1/(P3)total is not increased in Table lJ)]. However,
consistent with prior observations of inhibition of protein degrndation by cyc:loheximide
(Goldberg & St. John, 1976), both concentrations of cycloheximide reduced Kobs for the
slow phases ofrelease of TCA/PTA-soluble and TCA/PTA-insoluble label by about 40%
(Table 11).
Three models can be proposed to explain identical 1aie (; onsian.ts for ih e rel ease of
TCA/PTA-soluble and -insoluble radioactivity from labeled fibrnblasis. The deriYations
of equations which permit calculation of rate constants aJJ.d pool si;zes for all 3 models
appear in complete form in Appendix 1 . Only bJief summmies ()f each model and the
final rate equations will be discussed in this section.
Model 1 is depicted in Figure 15. It po sits that tJie slow µhas e of loss of label
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Figure 13. Release of products vs. time for cells incubaied in serum-supplemented
medium containing 0 added Leu. F is the fraction of total TCAIPTA-soluble
(closed circles) or TCA/PTA-insoluble (open circles) radioactivity remaining
by each time. The solid lines were calculated 11sing ihe parameters in Table
11. (k1)sol = l.60±0.50x 10·3min-1, (kt)im; · 8.29±],jg,.; LQ-3 min-1,
(k2)sol = 8.57 x 10-5 min-I~ and (k2)ins = J0.01±0.5() x 10-jmin-l. See
Figure 12 for further details.
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Figure 14. Release of products vs. time for cells incubaied in serum-supplemented
medium containing 10 mM added Leu. Fis the fraction of total TCAJPTAsoluble (closed circles) or TCAJPTA-insoluble (open circles) 1adioactivity
remaining by each time. The solid Lines were calcu]a1ed 11sing the parameters
in Table 11. (k1)sol = 1.12±0.36 x to-3min-1, (kLXns = 7.2~±1.:50 x Lo-3
min-1, (k2)sol = 8.27±0.66 x 10-S min-1, (k2)ins = 10.16±0.57 x 10-Smin-l.
See Figure 12 for further details.
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Incorporation of 3H-Leu :into fibroblasts in the presence of
Table 12.
cycloheximide.
Medium I
(cpm)

Cell 1
(cpm)

Total
(cpm)

% [ncor-

Sample
Control-I
10 µM cycloheximide

854,1122
908,368

220,5042
145,833

1,074,6] 6
1,054,201

20.5
] 3.8

Control-2
50 µM cycloheximide

604,155
697,548

85,309
8,014

725,464
705,562

11.76

1Each value represents the average of 3.
2Each value represents the average of 2, rather than l

poration

1.14
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Figure 15. Illustration of Model 1 for the release of label from fLbro blasts. P 1 represents
a protein pool destined for rapid turnover (rate constant= ko). P1 represents
newly synthesized proteins destined for secretion (ra1e constant = ks). P3
represents a group of proteins which may either "leak" fr<>m the cell (rate
constant= kL) or are transferred 10 lys.osomes (rate con!;taot = kT) where they
are degraded (rate constant= ko').
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from the cell is due to a third pool of cellular proteins, pool P3, which can either "leak"
from the cell (TCA-insoluble) or be transferred to the lysosomes. Within the lysosome
(pool P3'), degradation to TCA/PTA-so1uble products ensuei:>.

The rate constants are

explained as follows:
1. kn = degradation rate constant for ihe unstable proieins fo Pt.
2. ks = exocytosis (secretion) rate constant for proteins in P2.
3. kT

=

rate constant for the transfer of proteins in P3 from ihe cyiosol to the
lysosomes.

4. kn' = rate constant for the degradation of proteins (P3 1) within the lysosomes.
5. kL = rate constant for leakage of proteins (P3) from the cells.
kn and ks are "fast-phase" rate

constants~

while kT, kL, and ko' me rate constants

relevant to the "slow phase".
The integrated rate equations for TCA-soluble and TCA-insoluble products,
assuming a steady-state between P3 andP3 1 , me as follows:
kT(P3)0
[(TCA)solh = (P1)0 [1 - e -knt] +

[1 - e -(k1 + kT)l]
kL +kT

[(TCA)insh = (P2) 0 [1 - e -kst] +

kL(P3) 0
[J - e -(kL + kT)t]
kL +kT

Note that identical rate constants are predicted for the slow phase of release of
TCA-soluable and TCA-insoluble products, lobs - kL and lJ. Fra.ctiona] p()o] sizes are
calculated from the extents of each phase and a knowledge of the total amount of protein
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which was labeled with tritiated leucine during the preinc11baiion period.

Thus

P0 = [(TCA)soll + [(TCA)insl
(P1)0 and (P2)0 are determined experimentally by fitting the alJOve equations to the
experimental data for TCA/PTA-soluble and -insoluble radioactivify (P3 )0 in tum is
given by the sum
kT(P3)0

kL(P3)0

+ ---

(P3)0=
kT+kL

kT+kL

Pool sizes are also collected in Table 11 .
Since kobs = kL + kT, and

=

kT and kL can be calculated. It is importani to note that under sieady state conditions, the
rate constant for degradation within the lysosome, ko', cannoi be determined.
In Model 2 (Figure 16), cellular leakage is thought io be insignificant; (TCA)ins
radioactivity arises solely from exocytosis from vacuolar compartments in steps ks and
kR P 1 and P2 are unchanged from Mode] 1 . The proteins in P3 are transferred to the
lysosomes (P3'), where they may be degraded (ko') or regurgitated(kR) (Buktenica et al.,
1987).

Assuming a steady-state between P3 and P3', the jntegrated rate eqootions for
Model 2 are as follows:

111

Figure 16. Illustration of Model 2 for the release of label from fibroblasts. P1, P2, ko,
and ks are explained in Figure 15. Proteins in P3 are transferred (kT) to the
lysosomes (P3 '), where they are either degraded (kn') or exocytosed {kR).
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kn'(P3)0
[(TCA)solh = (P1)0 [1 - e-knt] +
[1 - e-kTt]
kn'+kR
kR(P3)0
[(TCA)insh = (P2) 0 [1 - e-kst] +
[l - e-krt]
kn' +kR
(P1)0
Po

(P2)0
(P3)0
, _ _ ' and _ _ are determined as described in Model ] .
Po
Po

Now, however, _ __
(P3)total

kn' + kR

It is important to note that the absolute values of the intrinsic degradation and exocytosis

rate constants, kn' and kR respectively, cannot be determined, since k:obs for the slow
phase is equal to kT rather than (kn' + kR).
According to Model 3 (Figure 17), there is no signi£cant pmtejn degradation in
the lysosomes.

Instead, protein degradation occurs wholly -wjthin 1he cytosol.

Furthermore, there are two cytosolic degradative systems, suc.:.h that one :protein pool (P1)
is degraded rapidly, while the other (P3) is degraded s]()w!y.

The differenc.:.es in

degradation rates for these two populations may depend on tbe presence

01

absence of

signals which are recognized by cytosolic degradative sys1ems to de si,gnate proteins for
rapid destruction. The slow phase of release of TCA!PTA-insolnble radio.a..ctiYi ty is due
to leakage.
The

integrated

rate

equations

for

Model

l

are

a~

fo!Jows:
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Figure 17. Illustration of Model 3 for the release of label from fibroblasts. Ph P2, kn,
and ks are explained in Figure 15. Proteins in P3 may be either degraded by
a non-lysosomal degradative sys1em (kn') or "leak'' from the cell (kL)·
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kn'(P3)0
[(TCA)sollt = (P1)0 [1 - e-knt] +

(1 - e-(kD' + kL)t]
kn'+k1
k1(P3)0

[(TCA)inslt = (P2) 0 [1 - e-kst] +
[1 - e·(ko' + k1)1]
kn'+k1
The procedures described for Model 1 may be used 1o determine (Pt)0 , (P2) 0 , and (P3) 0 .
As kobs = kn' + k1, and

--(P3)total

=

--kn' + k1

kn' and k1 can now be calculated. The rate equations for Model 3 are

:~dmilar

to Model

1,except that the intrinsic rate constant calculated for the appearance of (TCA)s0 1
radioactivity in the slow phase is ko', rather than kT. Moreover, kD' in Model 3 would
depend on the activities of cy1osolic degradation systems and would be expected to be
insensitive to inhibition by inhibitors of lysosomal proteinases.

]IL

11ddi1io1L, jf peptide

bond cleavage steps are not rate determining for cytosolic p1oteiJ1 degrada1ive systems,
then kn' may also be insensitive to other pro1ease inhibitors.
These derivations yield an interesiing Jesuit which is noi usual1y stressed in
protein turnover studies. Peptide bond cleaYage steps are JlOt rate de1ermini11g in steady
state models of lysosomal proteolysis (Models 1 and 2), and consequently kD' cannot be
determined from measurements of the slow phase of release of TCAJPTA-soluble
products. What can be measured is kT, the rate constant for the trmsfer of proteins from
other compartments into the lysosome (Models l and 2), and kL, the r11te constant for
leakage of proteins from the cell (Model 1). The rate consirults ko' and kR c11n only be
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determined as a ratio, and then only in the case where the source ofTCA!PTA-insoluble
radioactivity is regurgitation of lysosomal contents (Model 2). Although ko' appears to
be determinable for nonlysosomal degradative models (Model 3), even in this case kn'
may not correspond to a proteolytic step.

[nstead, protein unfolding or covalent

modification is likely to be rate-limiting forcytosolic proteolysis.
Table 13 summarizes the identities of the observed rate constants for the fast and
slow phases of products released for each model.

For Model 1, kD' cannot be

determined; kL and kT can be calculated from kobs and [(P3)s0 J!(PJ)totall · [n Model 2,
kT

=

kobs; kn' and kR cannot be independently calculated. However, the ratio of

kn'/(kn' + kR) is equal to [(P3)s0 1/(P3)totad· Jn Model 3, ko' and k1 can be calculated.
However, kn' is due to a cytoplasmic degradative system and is insensitive to lysosomal
proteinase inhibitors and lysosomotropic agents. Moreover,, peptide bond deavage may
not be rate limiting, and kn' could correspond to a nonproteo lytic step.
Tables 11, 14, and 15 present the results for the turnover of celJular proteins
under a variety of experimental conditions.

These tables show the e:xperimentally

observed rate constants for the biphasic release of TCAJJ>TA-soluble ancl -insoluble
radioactivity, the fractional sizes of the three substrate pools,, and Die rati () of TCA/PTAsoluble to total products released from pooJ 3 [(P3)s0 1/(P3)totall

Lack of Re-utilization of [3H-4.5] L-Leucine in MetabolicaJl)'-Labeled Fjfnoblasts
The possible re-utilization oftritiated leucine in labeled:fib1oblasts dmjng a chase
in unlabeled medium may be expected to result in the underestimation of the rates of
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Table 13.

Model

Summary of rate constants for 3 models of celh1larprotein degradation.

Phase 1
kobs(sol)
kobs(ins)

Phase 2
kobs(sol)
kobs(imi)

(P3)totaL

1

ks

ks
lc:o'

ks

aModel 2 and Model 3 also differ in that kn' in the forme1 is clue to the
contribution of lysosomal proteinases, while kD' in the latte1 is due 10 contri bu1ions of
extralysosomal degradative systems.
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Rate constants and pool sizes calculated from experimental progress
curves obtained in the absence of serum.

Table 14.

Part A. Fast Phase
(k1)sol
103 min-I

(k1)ins
103min-1

P1!Po

P2IP0

None

1.26±0.06

1.92±0.30

0.136

0.088

2 mM Leu+ 13% FCS
(control 2)

0.63±0.16

4.74±0.72

0.165

0.041

1% FCS, 1.23 mM Leu

0.86±0.13

3.57±0.47

0.174

0.056

100 µg/ml Antipain

10.15±1.46

2.70±0.64

0.010

0.038

5 µM Chloroquine

5.56±0.64

3.38±0.39

0.032

0.060

Sat. Pepstatin

3.77±0.41

0.75±0.10

0.0:54

0.149

26°C

0.75±0.33

3 .52±0.33

0.01 s

0.027

Addition

Part B. Slow Phase
(P3)sol
Addition

(k2)sol
105 min·l

(k3)ins
10 min· I

P3JP0

(P3)total

None

2.07±0.06

5.16±0.38

().77

0.23

2 mM Leu+ 13% FCS
(control 2)

8.71±1.63

14.13±0.53

().79

0.74

1% FCS, 1.23 mM Leu

8.20±1.00

1 L.37±0.63

().77

0.71

100 µg/ml Anti pain

5.49±0.16

5.74±0.21

0.94

0.17

5 µM Chloroquine

10.23±0.38

9.03±0.22

0.91

0.20

Sat. Pepstatin

9.67±0.63

5.00±0.59

o.go

0.21

260C

2.99±0.97

3.52±0.33

0.96

0.51
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Table 15.

A veragea rate constant and % change for the slow phase of cellular protein
turnover under various experimental conditions.

Part A. In the presence of serum and amino acids.

Additions

kobsb
(105min·1)

% Change

P value

2 mM Leu (control 1)

8.05±0.59 (LS)

None

9.00±0.45 (14)

+11.8

n.s.c

lOmMLeu

8.80±0.63 (14)

+9.3

n.s.c

10 µM Cycloheximide

4.94±0.30 ( 15)

-38.6

<0.()D5

50 µM Cycloheximide

4.76±0.32 (14)

-40.9

<0.0()5

lOmMNH4Cl

5.88±0.4S (1 S)

-27.0

<0.0()5

2S µM Chloroquine

6.54±0.38 (15)

-18.8

<0.010

20 µM Leupeptin

9.56±0.2S (14)

+L8.8

n.s:.c

200 µM Leupeptin

9.18±0.42 (15)

+ 14.()

JI.~.~

40 µg/ml Antipain

10.78±0.42 (LS)

+33.9

<O.OJ ()

2mMLe
u (control 2)

10.12±1.34 (15)

6.67 µg/ml Cytochalasin B

10.68±0.50 ( 15)

+Sj

n_,:; ,c

55 µM Vinblastine

12.93±0.56 ( 12)

+27.8

<0.05

6.27±0.30 (6)

-38.()

<0.01

26°C
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Table 15.

Averagea rate constant and% change for the slow phase of cellular protein
turnover under various experimental conditions.

Part B. In the absence of leucine, glutamine and serum.

Additions

kobsb
(to5 min-1)

%Change

P value

None

4.45±0.43 (15)

1%FCS

3.89±0.46 (15)

-12.6

n.s.c

1 mM Leu, 1% FCS

9.12±0.89 (15)

+104.9

<O .0()5

2.8 mM Leu, 13% FCS

10.12±1.34 (1 S)

+127.4

<(),()05

5 µM Chloroquine

9.28±0.25 (14)

+108.5

<(),()Qj

100 µg/l Antipain

5.70±0.20 (15)

+28.1

<().Ol

Sat. Pepstatin

5.98±0.60 (15)

+34.4

<0.025

7.5 µg/ml Cytochalasin B

3.29±4.79 (5)

-26.J

D.S. C

12 µM Vinblastine

4.92±4.05 (8)

+10.6

o.s.c

260C

3.25±0.25 (15)

-26.9

<0.025

aThe average rate constant is a weighted average of kobs for the rel ease of
TCA/PTA-soluble and TCA/PTA-insoluble radioactivity from 1abeled :fibroblasts.
kobs is calculated as being equal to
(P3)sol
(P3)ins
(k2)sol x - - - + (k2)ins x - - (P3)total
(PJhotal
bvalues are the mean± the standard error. The numbers. jn pMeothe~es are the
number of data points on which the calculations of kobs are based.
cn.s. is not statistically significant (p > 0.05).
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turnover of cellular proteins based on measurements of release of radioactivi1y from 1he
cellular monolayer. Re-utilization of tritiated leucine might also be expected to result in
the continued release of labeled secre1ory proteins during the chase.

Therefore, we

examined the efficacy of adding increasing concentrations of cold leucine--0, 2 and 10
mM--in preventing the re-utilization of the 3H-Leu label when added to the complete
growth medium during the chase period. From Table 11, it is evident 1hat 1he complete
growth medium (0 added leucine) contained a sufficient concentration of endogenous
leucine (0.8 mM) and added serum proteins (13%) to prevent re-u1ili.zation of1he label,
since the rate constants, extents of

reaction~

and the ratio of soluble to to1a.J activity

released remained essentially unchanged when additional cold 1eucme wa~ added. This is
further illustrated in Figures 12-14, where the progress curves obtained at all three
concentrations of added unlabeled leucine are relatively superimposab1e (within
experimental error). The mean value of [(PJ)s0 Jl(P3)totaLl was

(),?I

with a standard

deviation of 0.010.
To further demonstrate that tritiated Je11cine reutilization is unjrnportant under the
conditions of these experiments, 10 µM and SO µM cycloheximide were added to the
chase medium (Figures 18 and 19).

These concentrations were shown to reduce the

incorporation of tritiated leucine into celJular proteins by 3 o~ and greaier than 90%,
respectively (Table 12). No increase in the ra1io of TCAIPTA-soluble io TCAJPTAinsoluble label released was noted at either concentra1ion [(P3)soJJ(P3)total in Table 11].
Instead, [(P3)s0 1/(P3)totall actually

decreased~

indicating that TCA!J>TA·insoluble
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Figure 18. Release of products vs. time for cells incubated in :;erum-supplemented
medium containing 2 mM Leu and 10 µM cyclohexjmjde. P is the fraction of
total TCA/PTA-soluble (closed circles) or TCA/PTA-in:;()luble (open circles)
radioactivity remaining by each time. The solid lines were c:alculated using
the parameters in Table 11. (kt)sol = 2.78±0.35 x J()-3min-1, (kJ)ins =
7.81±2.02 x 10-3 min-1, (k2)sol = 5.99±0.23 x 1()·5 min-L, (k2)ins
4.29±0.34 x 1o-Smin-1. See Figlll"e 12 for details.
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Figure 19. Release of products vs. time for cells incubated in serum-supplemented
medium containing 2 mM added Leu. F is the fraction of total TCA/PTAsoluble (closed circles) or TCA!PTA-insoluble (open circles) radioactivity
remaining by each time. Arrow indicates the time point (147() min) at which
50 µM cycloheximide was added to the medium. The 5olid line5 were
calculated using the parameters in Table 11. (kt)sol = 2.46±0.09 x: rn-3min1, (k1)ins = 3.08±0.36 x 1o-3 min-1, (k2)sol = 4.96±0. L9 x 1o-5 min-1,
(k2)ins = 4.38±0.55 x 10-5min-1. See Figure 12 for details.
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radioactivity did not arise from secretory proteins synthesized during the chase. Instead,
the source of TCA/PTA-insoluble radioactivity was proteins synthesized during the
labeling period.

In addition, the rate constant

for the loss of label from the

cellular monolayer was not increased as one might expect were reutilization of tritiated
leucine important. Instead, there was a nearly 50% inhibition of the rate of turnover of
cellular proteins, suggesting that protein synthesis and degradation are coordinately
regulated.

Table 16 shows that were Model 1 correct, the effect of both

concentrations of cycloheximide was to decrease by about 60% the rate of transport of
cellular substrates into lysosomes. Were Model 3 correct, th.en the cycloheximide effect
was to decrease the activity of (a) cytoplasmic: degradative system(s). Accmding to both
models, cycloheximide has no effect on the rates of celJ leakage andJm cell death.

(l) Ji decreases the rate of

According to model 2, cycloheximide has two effects:
transport of cellular proteins into lysosomes by about

40%~

and (2) it decreases protein

degradation within the lysosome, or increases protein regurgitation fiom the lysosome, or
both, thereby resulting in a 25 to 75% decrease in the ratio kn'JkR.

Effects ofLysosomotropic Amines and Lysosomal Proteinaselnhibitors
on Intracellular Protein Turnover
Ammonium chloride and chloroquine are lysosomotropi c: amines whi_cb disrupt
the intravacuolar pH in lysosomes (Maxfield, 1982),

thereb~

lysosomal hydrolases which have acidic pH optima. These

inhibiti_og many of the

agent~

a.ls(} interfere with the

transport of newly synthesized enzymes to lysosomes (Nishimura et al.,

19~ g).

Ten mM
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Table 16.

Effects of addition of cold leucine and cycloheximide on the raie constants
for the slow phase of release of TCA/PTA-soluble and -insoluble
radioactivity.

I. Model 1. Lysosomal degradation plus leakage.

Additions

kTa

kLa

kD'a

kRa

kT/kL

None

6.30±0.71

2.70±0.31

N.o.b

N.A.c

2.33

2mMLeu

5.72±0.71d

2.33±0.31 d

N.D.

N.A.

2.45

lOmMLeu

6.33±0.76d

2.41±0.3od

N.D.

N.A.

2.57

10 µM Cycloheximide

l.88±0.28e

3.06±0.46d

N.D.

N.A.

0.61

50 µM Cycloheximide

3.09±0.46e

l.67±0.35d

N.D.

N.A.

l.!~5

II. Model 2. Lysosomal degradation plus regurgitation.
Additions

kT

kL

kn'

kR

kD'(kR

None

9.00±0.45

N.A.

N.D.

N.D.

2.l3

2mMLeu

8.05±0.59d

N.A.

N.D.

N.D.

2.45

lOmMLeu

8.80±0.63d

N.A.

N.D.

N.D.

2Sl

10 µM Cycloheximide

4.94±0.3oe

N.A.

N.D.

N.D.

0.61

50 µM Cycloheximide

4.76±0.32e

N.A.

N.D.

N.D.

l .~5
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Table 16.

Continued.

III. Model 3. Cytosolic degradation plus leakage.
Additions

kT

ko'

kL

kR

ko'JkL

None

N.A.

2.70±0.31

6.30±0.71

N.A.

2.33

2mMLeu

N.A.

2.33±0.31 d

5.72±0.7 I a

N.A.

2.45

lOmMLeu

N.A.

2.47±0.3od

6.33±0.76d

N.A.

2.57

10 µM Cycloheximide

N.A.

3.06±0.46d

1.88±0.23e

N.A.

0.61

50 µM Cycloheximide

N.A.

l.67±0.35d

3.09±0.46e

N.A.

l.85

alo5 x min-1
bN.D.--not determinable
CN.A.--not applicable
dNot significantly different from conirol
eoiffers from control at a level of p < 0.005.
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NH4Cl caused small but significant decreases (31 %) in the rate constant:; for the slow
phases of release of TCA/PTA-soluble and -insoluble radioactivify
Figure 20).

[(P3)s0 1/(P3)totall was also decreased to

(Tables 11, 15;

0.56, which was more than 3

standard deviations below the mean value for the control.

Twenty-five f.LM chloroquine

(Figure 21) produced similar decreases in the rate constants for the slowpba:;e (Tables 11
and 15).

The value of [(P3)s0 1/(P3)total] with 25

µM chloroguine (0 .4 3) was also

significantly reduced with respect to the control (Table 11).
Table 17 contains the rate constants calculated from the data i11 Tables 11 and 15
for each of the three models for the slow phase of protein turnover. Jf Mode] I is correct,
then the respective effects of chloroquine aJld ammonium chloride was to reduce by 53%
and 45% the rate of transfer of cellular proteins into lysosomes. Accordjng to Model 1, it
is not possible to predict the effects of chloroquine and ammonium chloride 011 the rate of
proteolysis within the lysosome. If Model 3 is correct, then chloroquine and ammonium
chloride inhibited the activity of (a) cytoplasmic degradabve pathway(5) by 53% and
45%, respectively. According to both models, ammonium chforide ha:; no effect on cell
death and/or cell leakage.

Chloroquine, however, may inc1ease the

fra~tional

rate

constant for cellular leakage from 2.46 x J()-5 min-1 to 3.73 x J()-5 min-J (p < 0.05). If
Model 2 is correct, then chloroquine and ammonium chloride p[()iluced small decreases
(23% and 31 %, respectively) in the rates of transfer of cellular proie in1; into ly5osomes
while resulting in more substantial (69% and48%) decrease:; in the ratio of kn'rkR. Such
a result would be expected if chloroq11ine and ammonfom chloride were to inhibit
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Figure 20. Release of products vs. time for cells incubaied jn serum-supplemented
medium containing 2 mM Leu and 10 mM NH4Cl. F is the fraction of total
TCA/PTA-soluble (closed circles) or TCA!PTA-insoluble (open circles)
radioactivity remaining by each time. The soHd lines were calculated using
the parameters in Table 11. (k1)sol = 0.77±0.17,; to·3mi_n-1, (kt)ins =
4.21±0.33 x 10-3 min-1, (k2)sol = 5.58±0.64 x 10-:S min-1, (k2)ins =
6.26±0.23 x 10-Smin-l. See Figure 12 for details.
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Figure 21. Release of products vs. time for cells incubated in serum-:n1pplemented
medium containing 2 mM Leu and 25 µM chlomguine. F i~ the fraction of
total TCA/PTA-soluble (closed circles) or TCAJPTA-insoluble (open circles)
radioactivity remaining by each time. The solid line:; -were calcuJaied using
the parameters in Table IL (k1)sol = 1.06±0.15 x 10-3min-L~ (k t)ins =
2.95±0.46 x 10-3 min-1, (k2)so1 = 6.04±0.46 x 1 o-5 mio-1, (k.:2)ins =
6.91±0.32 x 10-Smin-l. See Figure l 2 for detaiJs.

-·
3
'---"'

-·
:J

3

~

Cl>

--i

I

0
•
'-.!
O>

I

0
•

I

0
•
01

+:a

•

I

0

1

0
•
VI

I

0
•
t'.J
•-.a.

l

0

0
•
0

0
0

o-+----------------......,----,-~..-----.~--1"'

OJ

0
0
0

~

0
0
0

(...J

N
0
0
0

0
0
0

0

I

0
•
CX>

In (1-F)
134

135

Table 17.

Effects of lysosomotropic agents of the rate constants for ihe slow phases
ofrelease ofTCA/PTA-soluble and TCA/PTA-inso1uble radioachvity.

I. Model 1. Lysosomal degradation plus leakage.
Additions

kTg

k:Lg

ko'g

kRg

krJkL

None

5.72±0.71

2.33±0.31

N.n.a

N.A_b

2.45

25 µM Chloroquine

2.81±0.30C

3.73±0.4Qd

N.D.

N.A.

0.75

lOmMNH4Cl

3.29±0.42C

2.59±0.33e

N.D.

N.A.

1.27

kL

ko'

kR

kD'rkR

II. Model 2. Lysosomal degradation plus regurgitation.
Additions

kT

None

8.05±0.59

N.A.

N.D-

N.D.

1.45

25 µM Chloroquine

6.54±0.38[

N.A.

N.D.

N.D.

().75

lOmMNH4Cl

5.88±0.45C

N.A.

N.D.

N.D_

] .17

lc:R

Ico'lk1

III. Model 3. Cytosolic degradation plus leakage.
Additions

kT

kL

kD'

None

N.A.

2.33±() .J L

5.72±0.71

N.A.

2.45

25 µM Chloroquine

N.A.

3.73±0.4Qd

2.81±0.JQC

N.A.

0. 75

lOmMNH4Cl

N.A.

2.59±0.33e

3.29±0.42C

N.A.

1.27
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Table 17. (Continued)

aN.D.--not determinable
bN.A.--not applicable
CDiffers from control at a level of p < 0.005
dniffers from control at a level of p < 0 .0 5
eNot significantly different from control
fDiffers from control at a level ofp < 0.010
g(x 105 min-1)
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lysosomal proteolysis without significantly altering the raie of s11bstrate regurgiiation
from the lysosome. While it is not possible to eliminate any of the three models, Model 3
is least consistent with the data, since there is no reason to suspect that chloroqujne and
ammonium chloride should inhibit cytoplasmic degradative systems which function at
pH's near neutrality.

From the inhibitions observed with 25 µM chloroquine (53%

according to Model 1 and 69% according io Model 2), we migh1 conclude that
extralysosomal (chloroquine-insensitive) degradative pathways could contribute no more
than 30 to 50% to the turnover of long-lived cellular proteins jn human :fibroblasts.

Effects of Lysosomal Proteinase Inhibitors on Cellular Protein IurnoYer
Leupeptin and antipain are specific cysteine protease inhibii<>rs. Both inhibit
cathepsins B, H, and L, known to be preseni in lysosomes. In addition, le11peytin inhibits
cytoplasmic calcium-dependent cysteine proteinases, calpajns J and I I in vjtro,, bui may be
unable to penetrate to the cytosol of cultured cells (Mehdi. 1991). Leupeptin, a110 µM
and 200 µM, had no effect on the rate constants for both fast and slow phases or on
[(P3)s0 1/(P3)totall (Tables 11 and 15; Figures 22 and 23). Aniipain, at 4() J.lg)ml. had no
effect on the rate constants for the fast phase of pro1ein turnove1,, bu1 djd produce a small
(27%) but significant (p < 0.010) increase in the rate of the s]ow phase of turnover
(Tables 11and15; Figure 24). [(P3)soJl(PJ)totall was also un<lffected by .anti pain.
Table 18 contains the rate consirutts calculated from the data ill I.ables 11 and 15
for each of the three models. It can be seen that leupeptin and m1tipain bad no effect on
any of the kinetic parameters calculated f01 Models 1 and 3. Aniipain did seem to
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Figure 22. Release of products vs. time for cells incubated i_n serum-supp]emented
medium containing 2 mM Leu and 20 µM leupeptin. Fi::; the fraciio11 of total
TCA/PTA-soluble (closed circle::;) or TCAJPTA-in1;olub le (()pen circles)
radioactivity remaining by each time. The solid Lines were ~lllculated using
the parameters in Table 11. (k1)sol = 1.71±().JO ~ 10-3mjn·l, (kJ)ins =
4.74±0.48 x 10-3 min·L, (k2)sol = 9.37±0. 19 x 10-S mi11-l,, (k2)ins =
10.00±0.39 x 10-Smin-l. See Figure 12 for detllils.
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Figure 23. Release of products vs. time for cel1s incubated in serum-supplemented
medium containing 2 mM Leu and 200 µM leupeptin. P is the fraction of
total TCA/PTA-soluble (closed circles) or TCAJPTA-insoluble <open circles)
radioactivity remaining by each time. The solid lines were calculated using
the parameters in Table 11. (k1)sol = 1.81±D.38 x 10-3min·l, (kJ)ins =
5.27±0.85 x 10-3 min-1, (k2)so] = 8.74±0.37 x Jo-5 mi11-l~ (k2)ins =
10.26±0.55 x 10-5min-1. See Figure 12 for details

'--"

-·
::l

3

~

CD

3

-·

-f

co

I

0
•
'1

m

•

I

0
CJ1

•

l

0
~

•

I

0

.VJ

I

0
f')

•

I

0

l
•__.
0

0
0
•

0
0

o..,_______~---~--~--~--~~__,..

01

0

0

0

~

VJ

0
0
0

0

N
0
0

0

0
0

0

l

0
•

In (1-F)
141

142

Figure 24.

Release of products vs. time for cells incubated in serum-supplemented
medium containing 2 mM Leu. and 40 µg/ml antipain. F is the frac1ion of
total TCA/PTA-soluble (closed circles or TCA/PTA-insoluble (open circles)
radioactivity remaining by each time. The solid Jines were calculated using
the parameters in Table 11. (k1)sol = 1.74±0.36 x 10-Jmin-I,, (kt)ins =
5.79±0.76 x 10-3 min-1, (k2)so] = 10.25±0.31 x 10-5 mjn-1, (k2)ins =
12.08±0.69 x 10-5min-l. See Figure 12 for details.

-·
:J
......_,,,,

3

,,.........

(1)

-·
3

-;

c.o

•

CX>

•

I

0
O>

•
-....J
•

I

0

I

0
•
CJ1

I

0
~

•

I

0

I

0
•
VI
f\J

•

I

0
~

.

l

0

0
0
t

0
0

0-+---~--~-----~----,~--,.....~-r-~

c.n

0
0

0

~

0

0
0

(.,.I

0

0
0

N

0

0

0

0

I

0

In (1-F)

143

144
Table 18.

Effects of proteinase inhibitors on the rate constants fm the slow phases of
release of TCA/PTA-soluble and TCAJPTA-insoluble radioactivity.

I. Model 1. Lysosomal degradation plus leakage.
Additions

kye

kLe

ko'e

kRe

kJJkL

None

6.30±0.71

2.70±0.31

N.D.a

N.A.6

2.45

20 µM Leupeptin

6.69±0.47C

2.87±0.22C

N.D.

N.A.

2.33

200 µM Leupeptin

6.52±0.62C

2.66±0.25C

N.D.

N.A.

2.45

40 µg/ml Antipain

7.65±0.68C

3.13±0.28C

N.D.

N.A.

2.45

kL

kD'

kR

kn'fkR

II. Model 2. Lysosomal degradation plus regurgitation.
Additions

ky

None

8.05±0.59

N.A.

N.D.

N.D.

2.45

20 µM Leupeptin

9.56±0.25

N.A.

N.D.

N.D_

2.33

200 µM Leupeptin

9.18±0.42

N.A.

N.D.

N.D.

2.45

40 µg/ml Antipain

10.78±0.42d

N.A.

N.D.

N.D.

2.45
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Table 18. (Continued)
III. Model 3. Cytosolic degradation plus leakage.
Additions

kT

kL

kn'

kR

kD'fkL

None

N.A.

2.70±0.31

6.30±0.71

N.A.

2.45

20 µM Leupeptin

N.A.

2.87±0.22C

6.69±0.4 7c

N.A.

2.33

200 µM Leupeptin

N.A.

2.66±0.25C

6.52±0.62C

N.A.

2.45

40 µg/ml Antipain

N.A.

3.13±0.28C

7.65±0.68C

N.A.

2.45

aN.D.--Not determinable
bN.A.--Not applicable
CNot significantly different from control
doifference statistically significant at a level of p < 0. OJ 0
ecx 105 min-1)
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produce a small but apparently significani increase in kT for Model 2. Model I predicts
that the rate determining step in the lysosomal degradation of cellular proteins is the
transfer of substrates into the lysosome, kT. The intrinsic degradation rate constant, kn',
is undeterminable.

Consequently, if a steady state is mainia:ined in the presence of

leupeptin and antipain, and if kT is unaffected by these agents, ihen the results in Table
18 are not inconsistent with Model 1. Model 2 is least consistent with the results in Table
18. Although kT is expected to be rate determining for ihe lysosomal degradation of
cellular proteins, the relative contributions of lysosomal degradaiion and regurgitation,
kn'lkR, is related to [(P3)s0 1/(P3)totaJ], the ratio of TCA/PTA-soluhle to total
radioactivity released during the second slow phase of prote:in tumover. From Tables 11
and 18, it can be seen that [(P3)s0 1/(P3)t0 taLl and kD'/kR are illlaffected by boih]eupeptin
and antipain.

This is unexpected since these inhibitors should have decreased both

[(P3)s 0 1/(P3)totall and kn'lkR as was seen with chloroquine and ammonjum chloride.
The lack of an effect of leupeptin and antipain on ihe ratio kD')kR mgues strongly against
Model 2 for intracellular protein catabolism. It cannot be due to faih1re of lenpeptin to
gain entry to lysosomes, since leupeptin can be internalized by Onid phai>e endocytosis.
In addition, leupeptin inhibits the degradaiion of endocytosed pro1eins and causes the
accumulation of cellular protein in autophagic lysosomes in rat liver (:Kominamj et al.,
1991). In contrast, the failure of leupeptin to inhibit ihe slow and fast pha:;ei> of protein
degradation may not argue against the participaiion of cytosolic leupepti11-sensitive
enzymes such as calpain, since evidence suggesi:; that leupeptin J1u1y not peneilaie io the
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cytosol (Mehdi, 1991 ).

Effects of Temperature and Agents which Affect the Cytoskeleton of Cells
A new batch of GM 3440 fibroblasts was received in July,, 1986.

A second

control experiment was performed in the presence of 2 mM Leu in complete growth
medium (Figure 25) in order to compare these cells with ihe ftbroblasts used in earlier
work. The rate constants were similar to the first controls (Table 11 ). k 1(sol) and k1 (ins)
were slower for the new cells, although these differences do noi appear to be significantly
different.

In addition, values for k2(sol) and kz(ins) were higher.

For k2(sol), the

difference was not significant. In contrast, k1(ins) was much higher (14.13 as compared
with 10.01, p < 0.005). In addition, [(PJ)soJl(PJ)total1 was higher for the new batch of
fibroblasts (0.74 as compared with 0.71).

As a result, the weighte() aYerages of the

observed rate constants for the slow phase of protein tumover were not significantly
different for the two batches of cells (10.12 ± 1. 34 x 1o-5 min· L as compared with 8 .49 ±
0.62 x 10-5 min-1). The new control was used for purposes of comparison in subsequent
experiments.
Vinblastine, a microtubule inhibitor,, increased k L(sol)> kt (ins),, and :k:2 (sol)
(Tablell; Figure 26). However, k2(ins) was unaffected. Also,, from T11ble 11, it can be
seen that the substrate pool for the fast secretory phase of release of TCA-inso Jubie label
was greatly decreased (0.044 as compared with 0 .165 in the control). [(P3 ho1r(P3 hotall
was substantially decreased (Table 11) from 0.74 to 0.58. Jn 11ddiiion,

it~an

be seen that

the observed rate constants for the slow turnover of cellular protein Ckobs in Table 15)
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Figure 25. Release of products vs. 1ime for cells incubated in serum-supplemented
medium containing 2 mM Leu (7-86). F is the frac1ion of total TCA!PTAsoluble (closed circles) or TCA!PTA-insoluble (open circles) radioactivity
remaining by each time. The so !:id Jines were calcula1ed usi_ng tbe parameters
in Table 11. (k1)sol = 0.63±0.16 x 10-3min-1, (lq)L0 s = 4.47±0 .72 x 10-3
min-1, (k2)sol = 8.71±1.63 x 10-S m:in-1, (k2)i_ns = 14.13±0.53 x Jo-Smin-1.
See Figure 12 for details.
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Figure 26. Release of products vs. time for cells incubated in :;erum-supplemented
medium containing 2 mM Leu and 55 µM vinblastine. F is the :fraction of
total TCA/PTA-soluble (closed circles) or TCAJPTA-in:;()luble (open circles)
radioactivity remaining by each time. The solid lines were calculated using
the parameters in Table 11. (kt)sol = 2.17±0.05 x J()-3min-1, (kJ)ins =
11.43±0.34 x 10-3 min-1, (k2)so] = 13.58±0.66 x 10-j min-1, (k2)ins =
12.03±0.41x10-Smin-l. See Figure 12 for details.
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was increased from 10.12 x 10-5 min-1to12.93 x 10-5 min·l (p < 0.05).
Table 19 shows the intrinsic rate constants calculated for the slow phase of
metabolism of cellular protein in the presence of vinblastine. According to Models 1 and
3, vinblastine-induced increase in kobs for the slow phase [k2(sol) or k1(jns)] js largely
due to an increase in the rate of leakage of pmtein from the cellular monolayer. Thus, kL
in Table 19 doubles from 2.63

± 0.48

x 10-S min-1 to 5.43

± 0-49

"10-S mjn·l (p <

0.005). In contrast, kT (or kn' for Model 3) is unchanged. IfModel 2 is conect, then the
major effect of vinblastine is to either decrease Jysosomal degradatjon (kD'), increase
lysosomal regurgitation (kR), or both, such thai ko'/kR decreases by more than 50%,
from 2.85 to 1.38.
Cyiochalasin B, an actin inhibitor, had little if any effeci on any of ihe kinetic
parameters: kt (sol), kt (ins), k2(sol), k1(ins), and kobs (Tables J 1 and 15). Pool sizes
and the fraction of the slow turnover pool degraded to TCA-soluble products,
[(P3)s01/(P3)tota1], were also unaffected. The vari_ous intrinsic rate constants calculated
for Models 1 through 3 were substantially similar to those ()f the control (Table 19;
Figure 27).
The effect of temperature on intracellular protein turnover was next examined.
The lowest temperature that could be attained with the incubator was 26° C, though the
original proposal stated 190. At 260, the cells under conirol condiiionii (2 mM Leu in
complete growth medium) began to contraci after 6 h.

Therefore~

overnight, during which time they appeared io recover.

the" -were k:.ept at 37°

After Ute 370 overnight
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Table 19.

I.

Effects of reduced temperature and agents which disrupt microfilaments
and microtubules.

Model 1. Lysosomal degradation plus leakage.
Additions

None

7.49±1.37

2.63±0.48

N.o.a

N.A.b

2.85

55 µM Vinblastine

7.50±0.67C

5.43±0.49f

N.D.

N.A.

l.38

6.6 µg/ml Cyto. B

7.58±0.73C

J.09±0.30C

N.D.

N.A.

2.45

Temperature 260 C

4.70±0.39d

1 .57±0.J3d

N.D.

N.A.

3.00

II.

Model 2. Lysosomal degradation plus regurgitation.

ko'

Additions

None

10.12±1.34

N.A.

N.D.

N.D.

2.85

55 µM Vinblastine

12.93±0.51 d

N.A.

N.D.

N.D.

1.38

6.6 µg/ml Cyto. B

10.68±0.50C

N.A.

N.D.

N.D.

2.45

Temperature 260 C

6.27±0.21 e

N.A.

N.D.

N.D.

3.00
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Table 19. (Continued)
III.

Model 3. Cytosolic degradation plus leakage.
Additions

None

N.A.

2.63±0.48

7.49±1.37

N.A.

2.85

55 µM Vinblastine

N.A.

5.43±0.49f

7.50±0.67e

N.A.

1.38

6.6 µg/ml Cyto. B

N.A.

J.09±0.30C

7.50±0. 73c

N.A.

2.45

Temperature 260 C

N.A.

1.57±0.IJd

4.70±0.39d

N.A.

3.00

aNot determinable
bNot applicable
CNot significantly different from control
dnifference statistically significant at a level of p < 0.05
enifference statistically significant ai a level of p < 0. 01
fDifference statistically significant at a level of p < 0 .()05
g(x 105 min-1)
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Figure 27. Release of products vs. time for cells incubated in serum-supplemented
medium containing 2 mM Leu and 6.6 µgfml cytocbalasin B. F is the
fraction of total TCA/PTA-soluble (clo s.ed circles) or TC AJPT A-insoluble)
radioactivity remaining by each time. The solid lines we1e ~!llc:ulated using
the parameters in Table 11. (k 1)sol = 0.56±0. 05 x: 10-3min· 1, (k1 )ins =
6.73±1.80 x 10-3 min-1, (kz)sol = 9.07±0.53 x 10-S min-I,, (k2)ins =
14.65±0.42 x 10-5min-1. See Figure 12 for det!lils.
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incubation, the initial rapid phases of release of TCA/PTA-soluble and -insoluble radioactivity had ended. The cells were then returned to 260 C and data was collected between
1620 and 1800 min. The cycle of warming and cooling was repe!lted and data was
collected between 3060 and 3240 min.

From the slopes of the 1wo Line segments

obtained for both TCA/PTA-soluble and TCA!PTA-insoluble radioactivify released,
k2(sol) and k2(ins) were calculated (ACPMs0 1/TotaL CPMs()l
~CPMinslTotal

remaining

and

CPMins remaining). [(P3)s0 1/(P3)total1 was calculated from the ratio of

TCA/PTA-soluble to total radioactivity between 3060 and 3240 min. The results are
presented in Tables 11, 15, and Figure 28. [t can be seen that k 1(sol) and k] (:ins) were
unaffected. However, k2(sol), k2(ins) and Kobs were significantly decreased. The size of
Pool 3 and the fraction of Pool 3 degraded t() TCA/PTA-soluble products was also
unaffected.
The intrinsic rate constants calculated for each of the three models are
Table 19.

C() !Jected

in

According to Model 1, decreasing the temperature to 26° C produced a

proportional decrease in the rate of transfer ()f proteins into

l~:;<>somes

and tbe rate of

leakage of proteins from the cells such that kTfkL is essentia!J:r unaffected_ Model 2
predicts that decreasing temperature decreases the rate of
lysosomes.

tran~fer

()f proteins into

Any effects on degradation :in the lysosome and re,gorg:itati_on from the

lysosome are similar so that kn'lkR is not si_gni:ficantly changed. Model ; also predicts
similar effects of decreasing temperature on cytosolic degradati_on !ll1d le!lkage so that
kn'lkL is not affected.

Both Models 1 and ; predict that de<:-reasinJ; temperature J 1° C
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Figure 28. Release of Protein Products from Human Fibroblasts Cultured :in Serum and
Leucine Supplemented Medium at 260 C. Media S!lllp]es were collected at
intervals between 30 min and 6 hr. The fibroblasts were then iransferred to
370 C overnight. The cells were returned to 26 ° C and at intervals between
1520 min and 1800 min media samples were obiained. After recovering at
370 C overnight the cells were again returned 1o 26° C and medfa samples
collected between 2940 min and 3240 min. (k1)sol ~ (kJ)fos, (k2)sol and
(k2)ins were estimated from a least squares regression analysis of ihe initial
data at 26° C. Values of (k2)sot and (k2)ins were also estamated from the
slopes of the lines obtained by plotting CPMs 0 tfTotal CPMsol remaining and
CPMins/Total CPMins remaining during the two inteJYllls at 26° C at late
times. Other details are similar to Figue 12. Each point is the average of
three determinations (N = 3).
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reduces leakage from fibroblasts by 40%.
From the effect of temperature on the rate contants in Table 19, it was possible to
estimate activation energies (Ea) for the putative steps in each of the models. Ea was
calculated from the relationship
Ea

ln k2 - ln kt

R

l/T2 - l/T1

These activation energies were found to be similar, ranging from 1.& kcalJmol for kT
(Model 1) or kn' (Model 3) to 7.8 kcal/mol for kL (Models 1 and 3). Ea for kT (Model
2) was similarly calculated to be 8.0 kcal/mo!. These values a.re much smaller than 27

±

5 kcal/mol reported for the degradation of proteins microinj ected into HeLa cells using
red cell ghosts as a vehicle (Rechsteiner et al., 1984).

Protein Turnover during Amino Acid De_privation and Protein Starvation
I was initially concerned by the failure of the lysosoma.l proteina.se inhibitors
leupeptin and antipain to inhibit intracellular protein turnover jn cultured filHoblasts. I
now believe that this may be due to the fact that proteolysis in the

l~sosome

is not rate-

determining for lysosomal protein catabolic pa.ihways. Rather, the rate-determiJ1ing step
would be the transfer of cellular proteins to the lysosomes.

T<l explore this question

further, I sought to examine the effecis of amino acid deprivation and/01 protein
starvation on the turnover of cellular proieins. These conditions are reported to iJ1c1ease
autophagy in rodent liver.

This is manjfested by an

accumtLl~LtjoJl

of cytoplasmic

constituents in lysosomes and an increase jn p1otein caia.boJism (Mortimore & Ward,
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1981; Mortimore et al., 1993). Starvation has also been reported to iJlcrease the turnover
of a subset of cytosolic proteins by a lysosome-dependent pathway jn fibroblasts (Dice,
1990).
Conditions which were intended to depict protein stanrati on were very difficult to
attain with this cell line. Even at 1% PCS, the rate constants for the slow phase of protein
turnover did not change appreciably (Tables 15, 20; Figure 29). Howeyer, major changes
did occur in Leu-free/Gln-free medium containing no (0%) FCS (Figure 30)- Contrary to
an expected increase in protein breakdown, k1(sol) and k2(ins) were decreased to 2.07E-5
and 5.16E-5, respectively (Table 14). In addition, the ratio of TCNPIA-soh1ble to total
radioactivity, (P3)s0 1/(P3)total' (Table 14) was greatly decreased from about 0_74 for the
control to 0.23. The effects of this amino acid and protein deprivation were similar to
those produced by the protein synthesis inhibitor cycloheximide . .As siru'Yation js also
expected to lead to an inhibition of protein synthesis, these results <1gajn poiJlt to a
coordinated regulation of protein synthetic and degradative pathways in fibroblasts.
However, starvation did increase the rate of degradation of short-Ii ved proteiJls, ko
[(k1)sol in Table 14], from 0.63E-3 min-1 to l.26E-3 min-I witb011t great effect on the
size of the pool of short-lived proteins (PJ /Po). Starvation djd appear to iJlcrease the
extent of the initial rapid phase of protein sec1etfon (Pz!Po), but decre<1Sed its rate by a
comparable amount [(k1)ins in Table 14].
In Table 20 are collected the intrinsic rate constants calculated for each of the 3
models of protein catabolism. If Model 1 is correct, then the princip<1L effect of protein
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Table 20.

I.

Effects of serum and amino acid deprivation on the raie constants for the
slow phases of release of TCA-soluble and TCA-insoluble radioactivity in
the presence of inhibitors.

Model 1
Additions

kTm

kLm

kn'm

kRm

kTlkL

Nonea

1.04±0.IOf

3.43±0.33h

N.D.

N.A.

0.30

2 mM Leu+ 13% Fesh

7.49±1.32

2.63±0.40

N.D.

N.A.

2.85

1% FeS, 1.2 mM Leuc

6.48±0.73h,i

2.64±0.28h,i

N.D.

N.A.

2.45

100 µg/ml Antipaind

o.97±0.1 of,j

4. 73±0. 17f,k

N.D.

N.A.

0.20

Sat. Pepstatind

l.26±0.13fj

4. 72±0. sof,l

N.D.

N.A.

0.27

5 µM ehloroquined

l.86±0.19f,k

7.42±0.21 f,i

N.D.

N.A.

0.25

Temperature, 26oee

l .48±0.07f,k

l.42±0.06g,1

N.D.

N.A.

1.04

kL

kD'

kR

kD'lkR

II. Model2

Additions

kT

Nonea

4.45±0.43e

N.A.

N.D.

N.D.

0.30

2 mM Leu+ 13% Fesh

10.12±1.34

N.A.

N.D.

N.D.

2.85

1% FeS, 1.2 mM Leuc

9.12±0.89h,i

N.A.

N.D.

N.D.

2.45

100 µg/ml Antipaind

s.10±0.2of,I

N.A.

N.D.

N.D.

0.20

Sat. Pepstatind

5.98±0.6og,l

N.A.

N.D.

N .D.

0.27

5 µM ehloroquined

9.28±0.25h,i

N.A.

N.D.

N.D.

0.25

Temperature, 26oee

2.90±0.13f,k

N.A.

N.D.

N.D.

1.04
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Table 20.

Continued.

III. Model3
Additions

kTm

kn'm

kLm

kRm

kn'JkL

Nonea

N.A.

3.43±0.33h

1.04±0.JOf

N.A.

0.30

2 mM Leu+ 13% Fesh

N.A.

2.63±0.40

7.49±1 .32

N.A.

2.85

1% FCS, 1.2 mM Leuc

N.A.

2.64±0. 23hJ

6.48±0.7Jh,i

N.A.

2.45

100 µg/ml Antipaind

N.A.

4.73±0.17f,k

o.97±0 .1 ofJ

N.A.

0.20

Sat. Pepstatind

N.A.

4. 72±0. 5of,l

1.26±0. 1 3fj

N.A.

0.27

5 µM Chloroquined

N.A.

7.42±0. 21 f,i

1.86±0.19f,k

N.A.

0.25

Temperature, 26oce

N.A.

l.42±0.06g,1

l.48±0.01f,k

N.A.

1.04

aserum and amino acid deprived control.
hcontrol performed 7/86 in complete medillm.
CI% FCS and 1.2 mM leucine added to serum-free medium contcdning glu1amine.
d1nhibitors added to serum-free medium from which leucine and g1utamine have
been omitted.
eTemperature reduced to 260 C in serum-free medillm from which leucine and
glutamine have been omitted.
fniffers from control in complete medium at a level ofp <0.005.
gDiffers from control in complete medillm at a level ofµ < 0.01 D.
hNot significantly different from control

jn complete

medixlm.

lDiffers from serum and amino acid deprived control at a level of p < 0.005.
JNot significantly different from serum and amino add deprived c:onir<>L
kniffers from serum and amino acid deprived control at a. leYel <>f p < (). 01 .
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lniffers from serum and amino acid deprived control at a level of p < 0.05.
m105 min-I
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Figure 29. Release of products vs. time for ce11s incubated in medium containing l %
serum and 1.23 mM Leu. F is the fraction of total TCNPTA-soluble (closed
circles) or TCA/PTA-insoluble (open circles) radioactivity remaining by each
time. The solid lines were calculated using the par!ll11eters jn Table 14.
(k1)s0 1=0.86±0.13 x 10-3min-1, (kt)ins = 3.57±0.47 x 10-3 min-J, (k2)sol
= 8.20±1.00 x 10-5 min-I, (k2)jns = 11.37±0.63 x 10-jmin-l_ See Figure 12
for details.
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Figure 30. Release of products vs. time for cells incubated in serum-free, LeuJGln-free
medium. F is the fraction of total TCA/PTA-so]uble (dosed circles) or
TCA/PTA-insoluble (open circles) radioactivity remaining by each time. The
solid lines were calculated using the parameters in Table 14. (lq)sol =
1.26±0.06 x 10-3min-1, (kJ)ins = 1.92±0 .03 x J ()-3 min-], (k2)sol =
2.07±0.06 x 10-5 min-1, (k2)ins = 5.16±0. 38 x 10-Srnjn· l. See Figure 12 for
details.
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and amino acid deprivation is to decrease by about a factor of 6- 7 the rate of transfer of
substrates to the lysosome, from 6.5-7.5 x 10-5 min-1to1.0 x l0-5 min-1. The rate of
leakage is not significantly affected, as kL changes from 2.6 x 10-5 mjn· 1 to 3.4 x 10-5
min-1. If Model 2 is correct, then starvation results in a 2-fold decrease in the rate of
transfer of substrates to lysosomes, while at the same time eithe1 decreasjng lysosomal
proteolysis, increasing lysosomal protein regurgitation, or both, s11ch that ko'lkR
dramatically decreases from 2.4-3.2 to 0.30. If Model 3 is correct, the main effect of
starvation is to decrease the activity of extralysosomal degradatiYe pathways by 6- 7 fold.
I next examined the effects on cellulai proteolysis jn ihe starved siaie of many of
the same agents previously studied in the fed state (Figures 31-34). The results are
collected in Tables 14 and 20. Antipain--at 100 µg!ml under conditions of serum and
amino acid deprivation--caused a large increase in the observecl rate constant for the
initial rapid phases of protein degradation, from l.26E-3 min-1 to L0.2E-3 min-1.
However, the size of the substrate pool subject to rapid degrada.ti«>n was diminished
proportionately from 0.14 to 0.020 (Table 14; Figure 31). The ammmt of cell-associated
radioactivity released as TCA/PTA-insoluble material during the iniiial rapjd phase was
not significantly affected (from 1.92

± 0.30 x

10-J min-1to1.10±D.64x10-3 min-1).

Antipain did not cause further decreases in the observed rate consian.ts f«>r the slow phase
of appearance of TCA/PTA-soluble and -insoluble products (TalJle 15).

When the

intrinsic rate constants for the slow phases were calculated for each of the three models,
these were found to be similar to the corresponcling yafues fm the serum- "11d amino acid-
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Figure 31. Release of products vs. time for cells incubated in serum-free, Leu!Gln-free
medium containing 100 µg/ml antipain. F is the frac1ion of total TCA/PTAsoluble (closed circles) or TCAJPTA-insoluble (open circle1>) radfoactivity
remaining by each time. The solid lines were cakulated u~dng t:he parameters
in Table 14. (k1)sol = 10.lS±L.46 x 10-3min-1, (ki)ins = 2.70±0-64 x 10-3
min-1, (k2)sol = 5.49±0.16 x 10-5 min-1, (k2)ins = 5.74±0.21 x 10-:'imin-l.
See Figure 12 for details.
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deprived controls (Table 20).

The small increase in the rate of leakage appears

statistically significant. For Model 2, the small effect of antipain on the raiio kn'lkR
(decreases from 0.30 to 0.20) is similar to the result obiained with compleie media.
I next examined the effect of chloroquine on intracellular protein turnover under
starvation conditions (Figure 32). The concentration of chloroquine had to be reduced to
5 µM, because cell death occured within 24 hours at higher concentrations 11r1der these
conditions. The effect of 5 µM chloroquine was to increase the rate constants for the
initial phases of protein degradation and secretion by factors of 4.4 and 1. g, respectively,
relative to the serum- and amino acid-deprived control (Table 15).

Cbloroqu:ine also

caused an increase in the observed rate constants for the slow phase of release of
TCA/PTA-soluble and -insoluble products (from 2. 07 and 5.16 x 10-j rnjn· 1 to 10.23 and
9.03 x 10-5 min-I, respectively, Table 14). However, when intrinsic rate constants were
calculated (Table 20), it was found that for Models l and 3 that a

s11b~rtantial

part of this

increase could be explained by a highly significant increased leakage of proteins from the
cell and/or increased cell death, although smaller increases in kt <Model I) and ko'
(Model 3) were also observed. The rate constanis calculated for Model 2 indicate that
chloroquine increased the rate of transfer of proteins into the Jys.osome t<> a value which
approached that of the control in the presence of amino acids. and serum. However, the
ratio ko'lkR resembled that of the serum- and amino acid-deprived co11trol (0.25 as
compared with 0.30, Table 20) and was much less than the contrnl i11 the presence of
complete medium (Table 20). These results for chloroquine -were toiall)'

une~pected,

as
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Figure 32. Release of prooducts vs. time for cells incubated in serum-free, Leu!Gln-free
medium containing 5 µM chloroquine. Fis the fraction of total TCAIPTAsoluble (closed circles) or TCAJPTA-insoluble (open ci1cles) radioactivity
remaining by each time. The solid lines were calculated us:ing the proameters
in Table 14. (k1)sol = 5.56±0.64 x 10-3min-L, (k:J)ins = 3.Jg±0.39 x 10-3
min-1, (k2)sol = 10.23±0.38 x 10-5 min-1, (k2)ins = 9.()3±0.22 x 10-5min-1.
See Figure 12 for details.

'--"

3
-·
:::J

~

en

3

-·

--i

•
CXJ

I

0
•
-...J

en

•

l

0
(J1

•

I

0

I

.pa

•

0

l

0
•
0J

I

0
•
N

I
•_,,.
0

0
0
•

0
0

o.._~--~~---~--T"""'"~--~~_,~--1""

.f:i.

VJ

0
0
0

N
0
0
0

0
0

0

0

I

0

In ( 1-F)

174

175
earlier studies on protein catabolism in rodent liver and cultured fibroblasts had suggested
that serum and amino acid deprivation increases the contribu1ions of lysosomal (and thus
cloroquine-sensitive) degradative pathways in cellular protein turnover.

Instead, in

human fibroblasts, serum and amino acid deprivation abolishes 1he chloroquine
sensitivity of intracellular proteolysis.
Pepstatin A, an aspartyl protease inhibitor, produced opposite effects on the rapid
phase of appearance of TCA/PTA-soluble and -insoluble products, increasing (kt)sol and
decreasing (k1)ins· The soluble fraction in the fast phase (P11Po) was decreased more
than 2-fold, and the insoluble fraction (PiPo) was increased nearly 2-fold (Table 14;
Figure 33). The observed rate constants for the slow phase, k2(sol) and k2(ins), were
actually increased moderately over serum-deprived controls (Table 14), though not to the
extent seen with chloroquine. When intrinsic rate constants were

~<tlculated

(Table 20),

this small increase was principally reflected in kL for Models l and 3 . Jf Model 2 is
correct, then the moderate increases in k1(sol) and k2(ins) ma, be due to the increased
transfer of substrate to the lysosomes. kD'fkR was unaffected. Since pepstatin inhibits
lysosomal protein degradation, this result indicates that either M()del 2 is incorrect or
lysosomes do not participate in protein 1umover under serum- and amino acid-deprived
conditions. It should be noted that pepstatin A was not very soluble,, and its actual
concentration could not be determined.
Vinblastine (12 µM) and cytochalasin B (7.5 µgfml) caused ceJlu]aJ derachrnent
and death within 6 hand 3 h, respectively, under serum-deprived conditfo11s. Therefore,
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Figure 33. Release of products vs. time for cells incubated in serum-free, LeuJGln-free
medium containing saturated peps1a1in A. F is the fracti_on of total
TCA/PTA-soluble (closed circles) or TCAJPTA-:insolub1e (open circles)
radioactivity remaining by each time. The solid lines were calculated using
the parameters in Table 14. (k1hol = 3.77±0.41 x io-3mio-1, (k1)ins =
0.75±0.10 x 10-3 min-1, (k2)sol = 9.67±0.63 x 10-5 rnin·L, (IQ)ins =
5.00±0.59 x 10-5min-l. See Figure L2 for details_
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the kinetic parameters were not determined for these experimental conditions.
At 26°, the cells in serum-deprived media faired betier than under control
conditions. The cells were able to remain a1 260 throughout the en1ire experimen1 (Figure
34). The rate constants for the fast phase, k] (sol) and kt(ins) did not Yaty appreciably
from those of serum-deprived controls (Table 14). However, the pool of subs1ra1es which
were degraded in the rapid phase (P1IP0) or which were sec1etecl (P2JP0) were decreased
9-fold and 3-fold from control values (Table 14). The slow phase rate constants, k2(sol),
k2(ins), and kobs• were somewhat lower than the serum- and amino acid-depriYed control
(Tables 14 and 15).
When intrinsic rate constants (Table 20) we1e calculated for the three models of
intracellular protein catabolism, it was found that the decreases in k2(sol) and k1(ins) at
26° C, relative to the serum- and amino acid-deprived controls, were ]aJgely due to
decreases in kL (Models 1 and 3).

For Model 2, these clec1eases -were d11e to kT.

According to this model, the decrease in the ra1e of release of TCAJJ>TA-insoluble
radioactivity during the slow phase is due to a decrease in the rate of lysosomal substrate
regurgitation, such that kn'lkR is increased 10 1. 04 from 0.30.
An interesting observation from these data is that 1educjng the 1emperature
decreases the intrinsic rate constants for protein catabolism in the fed state but not in the
deprived state. For the fed state, kT (Maciel 1) or kn' (Model 3) declines 40% from a
value of 7.49 x 10-5 min-I at 370 C to 4.70 x 1o-5 min·l at 260 C. F'«>r the deprived
state, the corresponding rate constants at 3 70 C and 26° C, if anything, have <:hanged in
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Figure 34. Release of products vs. time for cells incubated in serum-free, Leu!Gln-free
medium at 260 C. F is the frac1ion of total TCA/J>TA-soluble (closed
circles) or TCA/PTA-insoluble (open circles) radioactiYi1y remaining by each
time. The solid lines were calculated using the parameters in Table 14.
(k1)sol = 0.75±0.33 x 10-3min-1, (k1Xns = 3.52±0.33 x 10-3 mi_n-1, (k2)sol
= 2.99±0.97 x 10-5 min-I, (k2)ins = 3.52±0.33 x lo-5min-1_ See Figure 12
for details.
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the opposite direction from 1.04 x 10-5 min-1 to 1.48 x 10-5 min-1. For Model 2, the
effect of reducing the temperature is a 3 5% decrease in ky under both conditions.
Lowering the temperature also appears to reduce leakage (Models 1 and 3) or
regurgitation (Model 2) under deprived conditions.

Lactate Dehydro~enase Assay
LDH was used as a marker enzyme to determine whether the TCA-insoluble
radioactivity released was due to cell leakage. In preliminary experiments, it was noted
that LDH activity appeared in the cell culture medium within l h of adding media to
cells, and that a plateau activity was attained within 2 h.
Table 21 gives the LDH activity over an incubation period of29 h ming the first
procedure given in the Methods section. LDH activity increased over the first 2 hand
thereafter, reached a plateau value of 1.03 x 10-2 µmol lactatefml medium (average of 2-5
h). These results implied that LDH was released for only the ftr1;t 2 hours. and 1emained
active in the medium, or that LDH was released continually. and the IJlaieau was the point
of steady state between cellular release and inactivation in the medium.
Table 22 gives the LDH activity using the second procedure [the e11ti1e medium
was removed every hour and replaced with fresh medium]. In this assay, the release of
LDH was constant (average= 4.40 x 10-3 µmo] lactate!mlrb) o-ver

:i

5-bollf time period.

This amounted to the release of 0.422% of cellular LOH activity into the medium each
hour (0.00422 h-1) and was of similar magnitude to the intrinsic rate coostani f01 leakage
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Table 21.

LDH assay, procedure 1.

Sample
Oh
lh
2h
3h
4h
5h
25 h
29 h

µmo I lactate/
ml medium
6.53 x
5.93 x
1.62 x
1.74 x
1.60 x
1.79 x
1.02 x
1.45 x

10-J
10-3
10-2
10-2
10-2
10-2
10-2
l 0-2

Correcied
activityl

-6 x 10-4
9.70 x 10-3
1.08 x 10-2
9.47x 10-3
1.14 x 10-2
3.67x 10-J
7.97x 10-J

I obtained by substracting 0 h activity from the activity at each time point.

Table 22.

LDH assay, procedure 2.

Sample
Oh
FCS(full
strength)
lh
2h
3h
4h
5h
Whole cell

µmol lactate(
ml medium

Corrected
actiYiiyl

7.58 x 10-3
7.98 x 1o-2
1.20 x 10-2
1.23 x 10-2
1.22 x 10-2
1.20 x 10-2
1.14 x 10-2
s.29 x 10-1

4.42
4.72
4.62
4.42

xi o-3
10-3

x
x
x
3.82 x

io-3
1o-3
1o-3

1.042

I Obtained by subtracting 0 h aciivify from ihe actiYity at eat:h timeJ>oint_
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calculated for Models 1 and 3 (kL = 0.0015 to 0 .0018 h-1).3

Electrophoresis and Autoradio~raphy
In order to further assess the source and nature of the TCA!PTA-insoluble
radioactivity released into the culture medium, cell lysates and media samples from
metabolically-labeled fibroblasts were subjected to SDS-PAGE.

Photographs of the

stained gels appear in Figures 35a and 35b. The lanes are read from left to right such that
the left-most lane is 2 and the right-most lane 14. Lane identities are given in Table 23.
Molecular weight (Mr) standards and their corresponding Rf values appear ill Table 24;
the standard curve, log10 Mr vs. Rf, appears ill Figure 36. The sian.drud<:.urve is linear up
to Mr= 66,000, then becomes curvilinear at higher Mr's.
Photographs of the developed films from autoradiography appear in Figures 37
and 38. Figure 37 is 1 month exposure; Figure 38 is 1 week exposure. The numbers
indicate the lanes of the gel. [Lanes 7 and 8 are blank, because the Mr standards were
non-radioactive.]
For the whole cell lysate obtained after a 42-hour Jabeling period and a 72-hour
chase period (lane 14), the one month exposure proved too long to permit individual
bands to be identified. For the remaining lanes, a one month exposme -was. necessary for
the visualization of the protein bands.

The unique bands, their cal<:.ulated Rfs and the

lanes in which they appear are presented in Table 25 for some of the lanes.

3

The activity at 0 h in Table 24 was due to an endogenous LDH activity in the fetal
calf serum, as shown by the activity obtained with 100% PCS.
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Figure 35a. Fractionation of cell lysates and media :;amples from cultured human
fibroblasts by SDS-PAGE. Gels were stained with ~aomassie blue and
photographed. The content of each line is identlfied in Table23.
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Figure 35b. Fractionation of cell lysates and media samples from culimed human
fibroblasts by SDS-PAGE. Gels were stained with Coomassie blue and
photographed. The molecular weights x 10-3 of the standards (lanes 7 and 8)
appear in the right margin. The remaining lanes are identified in Tab le 23.
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Table 23.

Lane identities for electrophoresis.
Lane#

Contents

1

Blank

2

30-min labeling medium (S)l

3

Incubation medium 0-60 min (S)

4

Whole cell after 60 min incubation (S)

5

42-h labeling medium (L)2

6

Incubation medium 90-180 min (L)

7

Low Mr standards

8

High Mr standards

9

Incubation medium 0-90 min (L)

10

Incubation medium 180-360 min (L)

11

Incubation medium 360-1620 mjn (L)

12

Incubation medium 1620-3030 min (L)

13

Incubation medium 30 30-4250 min (L)

14

Whole cell after a 42 h pulse and T2 h chase (L)

15

Blank

Is= short-term labeling period (30 min)
2L = long-term labeling period (42 Ji)
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Table 24.

Electrophoresis Mr standards and Rf values.

Mr

Distance
traveled
(cm)

Rf

Mr

Myosin (rabbit muscle, subunit)

205,000

1.2

0.108

5.31

B-galactosidase
(E. coli, subunit)

116,000

2.4

0.216

5.06

Phosphorylase B
(rabbit muscle, subunit)

97,400

3.5

0.315

4.99

Albumin (bovine plasma)

66,0()0

4.25

0.3~}

4.82

Albumin (egg)

44,000

5.9

0.532

4.64

Glyceraldehyde
Dehydrogenase (rabbit
muscle)

36,000

7.0

0.631

4.56

Carbonic Anhydrase
(bovine RBC)

29,000

8.4

0.757

4.46

Trypsinogen (PMSF treated)

24,000

8.9

(), ~02

4.3 8

Trypsin Inhibitor
(soybean)

20,10()

10.55

(), 95()

4.30

Mr Standard

gel length = 11.1 cm

Jog
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Figure 36. Standard curve for the determination of molecular weigh.ts b_y SDS-PAGE.
Graphed are the log 10 of the molecular weights vs. the relative mo bi! ify (Rf)
of the standard.
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Figure 37. Fractionation of all lysates and media samples from culiured human
fibroblasts by SDS-PAGE after incorporaiion of 35 S - methionine.
Radioactive products were identified by au1oradiography after a one month
exposure. [Note: lanes 7 and g are blank, as the,. contain the Mr standards.]
The remaining lanes are identified in Table 23.
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Figure 38. Fractionation of cell lysates and media samples from cultured human
fibroblasts by SDS-PAGE. Same as Figure 37 except after aut01adiography
for one week.
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Table 25.

Rf values of protein bands detected following electrophoresis and
autoradiographs of cell lysates and media samples from pulse-chase
experiments with 35s-methionine.
Cells after
42-h pulse and
72-h chasel
0.07
0.11
0.13
0.15
0.17
0.22
0.26
0.29
0.31
0.34
0.41
0.43
0.45
0.46
0.49
0.51
0.53
__2

__2

0.63
0.65
0.66
0.69
0.71
0.73
0.76
0.78
0.83
0.86
0.89
0.94

Cells after3
60-min pulse

Labeling medium3
after 42hrs

0.07

0.07

0.14
0.17
0.1 g
0.23
0.27
0.29
0.31
0.35

O.B
0.144
0.11
0.23
0.28

0.43
0.45
0.47
0.48
0.51
0.53
0.55
0.5~

0.64
0.67

0.31
0.35

0.45
0.4~

0.5()
0.53
0.5~

0.61
0.65
0.69

0.71
0.73
0.76
0.7~

0.87
0.88
0.93
0.96
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Table 25.

Continued.
Chase medium3
0 - 90 min
0.07
0.135
0.155
0.17

0.515
0.54

0.64
0.67

Chase medi um3
90 -180 min

Chase medium3
360 - 1620 min

Chase medium 3
1620 - 3030 min

0.07

0.07

0.17
0.22
0.26
0.29
0.30

0. 17
0.22
0.26
0.29
0.3 0

0.45

0.45

0.49

0.49

0.54

0.53

0.53

0.64
0.66

0.62
0.65
0.67

0.62
0.65
0.67

0.70

O.?O

0.76

0.76

0.86

0.86

0.96

0.96

0.135
0.155
0.18

o.s2s
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1One week exposure.
2A broad smear appears on this region of the gel.
3one month exposure.
4Detected in the one week exposure; in the one month exposure, this band appears
to be obscured by the intense band at Rf= 0.17.
5These bands are present in the chase medium between 0 and L80 min after the
pulse, but are absent from the chase medium in samples obtained afte1 360 min.
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Approximately 32 distinct bands could be de1ected in the autoradiograms, of which
at least 29 were visible in the cell lysate obtained from ce11s pulsed for 4 2 hours and
chased for 72 hours (lane 14, Figure 3 8). Three additional bands, which appear in the
lysates of cells pulsed for 60 min, at Rf equal to 0.55, 0.58 and 0.96 were probably also
present in lysates of cells pulsed for 42 hours, but were either poorly resolved or were
obscured by an intense neighboring band.
A comparison of the cell lysates ob1ained from cells pulsed for 42 hours and cells
pulsed for 30 min (lanes 14 and 4) reveal that proteins with Rf Yalues greater than 0.55
incorporated less 35s-methionine than did pro1ejns which migra1ed more slow]'. This is
in agreement with earlier claims that large proteins or proteins composed of larger
subunits turnover more rapidly, and therefore incorporate Label more quickly, than do
smaller proteins (Neff et al., 1981 ).
Lanes 9 and 6 (Figures 38 and Table 25) represent the inc11bai:ion medium
collected 90 minutes and 180 minutes after the start of the chase dUJing 1he rllpid phase of
appearance ofTCA/PTA-insoluble radioac1ivjty. [n contrast, lanes 12 and 13 (Figure 38
and Table 25) are media samples collected at late times during 1he slow phase of p1oduct
release. Three protein bands were detec1ed in the cul1ure medium ai em]' times after the
chase, which were not present in the media sllillples ob1ajned llt Late times.
proteins had Rf values of 0.13 (Mr= 182,000), 0.15 CMr =

158~000)

These

and 0. 50-() .5 2 (Mr=

49,500-45,700). These are presumed to be secreted proteins whic:b contril>ute to the rapid
phase of appearance of TCA/PTA-insoluble material during ihe initilll rapid phase of
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product release. In addition, in the media samples (lanes 5-13) Larger proteins (Rf values
less than 0.55) incorporated more radioactivity than smaller proteins, as was observed for
the cell lysates.
The nature of the TCA/PTA-insoluble material released into the culture medium
during the slow phase of appearance of products is of considerable interest.

Such

proteins are expected to be present in the sample corresponding to the 42-bour labeling
medium (lane 5 in Figure 38 and Table 25) and in samples of 1he incubation medium
collected at late times (lanes 12 and 13 in Figure 38 and Table 25).

Three possible

sources of TCA/PTA-insoluble material released during the slow ph<lse haYe been
considered. First, this material could arise from the reiocorporaticm of labeled amino
acids into secretory proteins during the slow phase of celh1l<lr proiein turooYer. If this
was the case, one might expect to see only a limited subset of protein bands jn_ the 42hour labeling medium and the samples of incubation medium collected at late times when
compared with the cell lysates. This was noi tbe case, as virtlJally all prominant proteins
seen in the whole cell lysates (e.g. bands wiih Rf values of().07, 0.17, 0.22, 0.26, 0.29,
0.31, 0.45, 0.49, and 0.53 in Figures 37 and 38, <lnd Table 25) were also released in1o the
culture medium during the labeling period (Figure 37, l<lne 5, and Table 25) and during
the subsequent chase (Figure 37, lanes 6-J 3, and Table 25). Al1em<ltiYely,, TCA/PTAinsoluble material might arise through the seques1ra6oo of celJular proteins into
lysosomes with subsequent regurgitation of ihe lysosomal contents (Bukteoica et al.,
1987). However, were cellular protein to pass through a degradaiive coml'<lrlmen1 prior
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to secretion, then one might expect to see evidence of proteolysis having occured on
analysis of the 42-hour labeling medium and samples of the incubation medium collected
at late times. This might be reflected in a disappearance of high.er mo! ecular weight
bands and the appearance of new bands in th.e lower molecular weight range of the gels.
This, too, was not seen. Finally, a possible third source of TCAJPTA-insoluhle products
is cell leakage and/or cell death. In this case, one should see similar protein patterns for
the cell lysate after 42 hours of labeling and the 42-hour labeling medilllTI. A comparison
of lane 14 (Figure 37 and Table 25) and lane 5 (Figure 38 and Table 25) shows that
virtually every major band seen in the cell lysate is also represented in the 42-hour
labeling medium, with the conspicuous exception of 2 or 3 bands with Rf values between
0.78 and 0.86. Nearly two thirds of the protein bands seen in the cell lysate are also
detectable in the 42-hour labeling medium. In addition, many of ihese hands are also
present in incubation media collected at late times after the beginning ofihe chase period
(lanes 12 and 13, Figure 38 and Table 25).

Distribution of Radioactivity after Centrifogati()n
The media containing radioactivity released from fibroblasts -wa.s ceILtrifuged at
low and high speeds, as described in the Methods section, to determine whetber the TCAinsoluble material was due to dead cells, vesicular structures shed from ~ells, or was free
in solution. The low-speed pellet coILta.ined detached and dead cells, the high-speed
pellet was presumed to contain vesicles, and the high-speed supernatani contained soluble
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proteins and the TCAIPTA-soluble degradation products. The high-speed supernatant as
treated with TCA-PTA to separate TCA-soluble and -insoluble radioactivity.
Table 26 shows the partitioning of the radioactiYiiy in the cu]ture medium after a
three-hour incubation (fast phase) and after a three-day incubation (slow phase) under
control conditions (2 mM Leu in complete growth medium). After 3 hours, 91% of the
radioactivity released into the culture medium was nonsedimenta.ble at 108,000 x g. Of
that material, 71 % was TCA/PTA-soluble. Dead or detached celJs represented only 2.7%
of the radioactivity in the medium, and vesicles represented 6. 3o/ci of the total
radioactivity in the medium.

On day 3, 92. 8% of the

radioa~hvify

could not be

sedimented at 108,000 x g, and 80% of it was TCAIPTA solubJe. Dead cells and vesicles
accounted for 3.3% and 3.9%, respectively, of the total radioactivity released.
Table 27 shows the partitioning of the radioactivity released ll!1der serumdeprived conditions (Leu-free/Gln-free medium, 0% FCS) after c:entrifugatfon. After 3 h,
76.l % could not be sedimented at 108,000 x g, and of that a

]jtt]e

more thrui haJf (58%)

was TCA/PTA soluble. Vesicles accounted for 17 .8%, and de ad ceJls, 6. 0% of the total
radioactivity released. On day 3, only 59.1% of the radioactivity was not

~edimentable,

and of that only 29.8% was in the TC.AJPTA-soluble fraction of the high-speed
supernatant. Significant proportions of the radioactivity rel eased were due io dead or
detached cells (15.1%, low speed pellet), vesic:les (25.8%, bjgh speed pellet), and soluble
but non- or incompletely degraded proteins (41.6% TCAIPTA prec:ipitabLe).
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Table 26.

Release of soluble and particulate radioac1ivjty from cu]tuJed human
fibroblasts after labeling with 3H-leucine and incubating in complete
medium.

Day

g force
(xg)

1

14,116

1

108,920

1

3H

Sample

(cpm)

% Total

208

2.7

SS

4977

64.5

108,920

SP

2045

26.5

1

108,920

pp

483

6.3

3

14,116

p

245

3.J

3

108,920

SS

5513

?4.6

3

108,920

SP

1348

18.2

3

108,920

pp

268

3.9

pl

1P =pellet (14,117 x g)
SS = TCA soluble fraction of high speed supernatant
SP = TCA insoluble fraction of high speed supernatant
PP =pellet (108,920 x g)
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Table 27.

Release of soluble and particulate radioactiviiy from culiured human
fibroblasts after labeling with 3H-leucine and incubating in medium
lacking serum and amino acids.

Day

g force
(xg)

Sample

1

14,116

pl

340

6.0

1

108,920

SS

2480

44.2

1

108,920

SP

1792

31.9

1

108,920

pp

1004

17.&

3

14,116

p

1020

15. 1

3

108,920

SS

1192

17.6

3

108,920

SP

2815

41.6

3

108,920

pp

1744

25.~

1Same footnote as Table 26.

3H
(cpm)

% Total
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To the extent that cells shed vesicles or become detached from the culture dish,
measurements of TCA/PTA-precipitable radioactivity in the incubation

medium will

overestimate the occurance of protein leakage (Models 1 and 3) or protein exocytosis
(Model 2) from the cellular monolayer. However, the intrinsic rate constants which
characterize the rate-determining step in intracellular protein degradation, kT (Model 1)
and kn' (Model 3), will not be affected because their calculation is not dependent on the
manner by which TCA/PTA-insoluble radioactivity is released into the incubation
medium. In contrast, Model 2 is badly impacted by the occurance of ceJl leakage (see
results of lactate dehydrogenase measurements), cell detachment and vesicle shedding,
since it assumes that all the radioactivity re]eased into tlte culture medium (both
TCA/PTA-soluble and -insoluble) arises from a vacuolar degradative compartment. Thus,
this model presumes that substrates must first be sequestered in

lysosome~

or other

vesicular compartments before being released i_nto the culture medium. Consequently,
the existence of non-lysosomal sources of TCA!PTA-prec:ipitable radi<>activity in the
culture medium will result in a serious overestimation of KT for this model. In addition,
the ratio kn'lkR will not describe the partition of substrates -withjn the lysos<>me between
degradation and exocytosis under conditions where leakage or similar processes occur.

Cathepsin B Assay
The results of the cathepsin B assay are given in Table2B. The s]()pe of A-300 vs.
time was 2.6 for the cells incubated under control conditions; this val11e cones ponds to 22
nmol/min/plate of confluent fibroblasts. The serum-dep1ived ce!Js Jiad a slope of 2.2,
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Table 28.

Effects of serum and amino acid deprivation, and aniipain pretreatment, on
cellular levels of Cathepsin B in human fibroblasts.

A3oo

Sample

_ _ ±S.E.
min

Aciivity 1

2mMLeu2

2.6±0.10

22

0 Leu/Gln

2.2 ± 0.06

1g

100 µg/ml Antipain

2.9±0.17

24

I Activity expressed as nmol/minlcell plate
2cells were incubated for 66 hours in the indicated medium prior to measuring
the enzyme activity. See MATERIALS AND METHODS for details.
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which was more than 2 standard deviations below that for the control value. The cells
incubated with antipain had a slope of 2 .9, which was just within 2 standard deviations of
the control value.

CHAPTER IV
DISCUSSION

PART I. LIPOSOMES
Liposomes have been prepared from a variety of phosphoLipid spec:ies employing
a number of techniques.

The addition of calcium chelating agents io the hydrated

calcium salt of PS which produces PS-LUV (PapahadjopouLos, 1970; Papahadjopoulos et
al., 1975) was the method selected to prepare liposome-encapsulatecl proteill substrates.
LUV typically have relatively large aqueous interiors compared io LMV and SUV (Table
3). In addition, liposomes prepared from fluid-charged lipids such as PS were reported to
be incorporated into cultured cells by fusion rather than
Papahadjopoulos, 1976).

b~

enclocytosis (Paste &

Of the two methods for preparing PS-LUV, reverse phase

evaporation and calcium chelation, the former, while producing hlgheryielcls and greater
trapping efficiencies (Szoka & PapahadjopouLos, 1978), was thouglit t<> be Jess suitable
for the preservation of the tertiary structure of the encapsulate cl protein substrates.
In this study, electron microscopy was usecl to monitor the irnlividuitl sieps in the
formation of PS-LUV. Sequentially, these steps are: (1) :hydration ruid sonicaiion of
dried phospholipid films to produce small vesicles; (2) additioll (}f calcium, causing
progressive aggregation and rupture of the small vesicles producing calcium chocleate
cylinders in which the phospholipid bilayer is w<>und around a ce11tri1l axis ill tJte manner
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of a "jelly roll"; (3) addition of the calcium chelator, which results in dissociation of the
chocleate structures and LUV formation (Papahadjopoulos, 1970; Papahadjopoulos et al.,
1975). A number of staining procedures were tried, including 11ranyl actate and osmium
tetroxide (results not shown), in order to visualize these steps by electron microscopy.
Encapsulation of a phosphotungstate negative stain provided the best resolu1ion of vesicular structures, particularly with regard to the SUV formed during the first step of PSLUV formation (Figure 1).

In con1rast, chocleate-type struc1ures, the reported

intermediate in PS-LUV preparation, could no1 be clearly iden1ifted by phosphotungstate
negative staining. Instead, I observed an apparen1 lattice-like s1ruct11re composed of
aggregates of ill-defined individual units (Figure 2). PS-LUV appeared as aggregates of
vesicles with electron-dense centers (Figure 3); resolution of the lipid bilayer was less
distinct than for PS-SUV initially produced by sonication.

The effec1 of the

phosphotungstate negative stain on aggregation is not known. [n addition, the vesiclevesicle interfaces in PS-LUV aggregates were not well-visualized in this study.
Estimates of PS-LUV size gave diameters in the range of 200 to 300 run, in excellent
agreement with values obtained by gel excl11sion chromatography (0 .2 6-0_2&

µm)

(Figure 4) and values calculated from determinations of capt11red Yolume to pb.ospbolipid
ratios (234-276 nm) (Table 3). These latter calculations are significan1 becau1;e sizable
quantities of large multilamellar struc1ures wo11ld haYe resulted in a significant
underestimation ofliposome size based on trapped volume measurements.
While PS-LUV were relatively impermeable to 14c-sucrose, FD,. :1luorescein
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isothiocyanate-labeled BSA, and a number of 1251-labeled proteins, they appeared
permeable to protons. Thus, the fluorescence of PS-LUV-encapsulated FD responded to
changes in the pH of the external buffering medium in a similar fa!lhion as free FD
(Figure 10). In addition, PS-LUV were either unable to efficiently trap 6-CF or were
permeable to this fluorophore. Thus, PS-LUV prepared in ihe presence of high, selfquenching concentrations of 6-CF were nevertheless highly fluorescent and yielded only
a small increment in fluorescence on addition of detergent (Tab]e 7). Jn contrast, PCSUV prepared in the presence of similar high concentrations of 6-CF bad Yery little
intrinsic fluorescence, but became highly fluorescent after lys:is and dilution of the
entrapped fluorophore.
Contrary to implications in the liierature regarding liposome-cel1 fus:ion, the work
from this laboratory showed that whiJe liposomes prepared from PS or PCrLL/SA
adhered tightly to cells, they rarely fused with cellular membranes to deJiver their
contents to the cytosol.

There has been a considerable decrease :in recent literature

involving liposome-cell fusion experiments. One report claims to have slto""MI fusion
between 3T3 cells and liposomes composed of various combinations of phosphatidic acid
(PA), PC and PS (Siegmann, 1987).

Carboxyfluorescein (CF) was used as an

intracellular marker, and cellular fusion was determined by ::fluorescent microscopic
examination. In that study, cells were incubated with either CF -conta:ining Liposomes or
with CF free in solution. The authors reported no uptake offree CF, while the liposomeencapsulated CF was incorporated into the c:ells. This is in contrast to our findings,
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which showed rapid cellular uptake of free CF (Figure 7).

Furthermore, Siegmann's

study did not show any photomicrographs of :fluorescent cells, so it is impossible to
evaluate whether the fluorescence was located diffusely within the cytoplasm (consistant
with fusion or diffusion) or in vesicular structures (more consistent with endocytosis or
adherence of liposomes to the cell membranes).

It is apparent that a careful re-examination of the earlier ]iposome-cell fusion
studies is necessary in view of our results. 11 should be reiterated that fusion was rarely
proven by direct evidence, nor was it ever shown to be quantitatively significant. One
study describing the use of endocytosis inhibitors (Paste & Papahadj opoulos, 1976) was
particularly hampered by dependence on presumptive evidence. Fusjon was determined
by the presence of cell-associated radioactivity after washing to "1emove" fiee liposomes.
However, we found that approximately 2.5% of the PS liposomes adbe1ed tightly to the
cells after numerous washings (Tables 5, 6) so that cell-associated radj<>activity cannot be
used to assess fusion. These authors may have been correet, however, in proposing that
fluid-neutral (PC) and solid-charged (PSfDSPCfDPPC) vesicles were i_nce>rpmaied into
cells primarily through endocytosis. They also implied ihat a significant fraction (3040%) of charged-fluid vesicles (PC/PS) were endocytosed as well. The differences in
behavior of the liposome species presumably jnvo]ved surface chroge and surface tension
properties (Kachar et al., 1986).

PS/PC liposomes were perhaps capabJe of forming

stable bilayer interfaces with the cell membranes, while PC and PSIDSPCrDPPC vesicles
were not.
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A lipid uptake study (Papahadjopoulos, 1974) showed that cholesterol and DPPC
were incorporated into cells in the same molar ratio as was present in Liposomes. In
addition to fusion, another equally plausible explanation of these results is liposome-cell
adhesion.

The electron-micrograph of a RBC ghost incuba1ed wjth MLV was re-

examined. There appeared to be an interface between the cell memlJrane and the vesicles,
which would be more consistent with vesicle adherence than with fusion.

Similar

objections can also be raised about electron micrograph.s of PC, lysolecithin and
stearylamine SUV which are proported to demonstrate li:posome cell fusion (Martin &
MacDonald, 1976b).
The enzyme repletion study of Gregoriadis and Bud:! and (I 97 3) is less
questionable, since endocytosis was shown to be the mechanism of cellular deHvery. An
interesting experiment to confirm this conclusion would have included cytochalasin B in
the incubation medium. A decrease in the release of radioact:ivi1y C()upled with retention
of the phase-lucent vacuoles would be additional evidence for end<>cytosis of the
liposomes.
The results obtained with liposome-encapsulated viral 1>0Lynucleo1ides and whole
viruses (Mayhew et al., 1977; Taber et al., J 97 g; Wilson et al., 1977; Wi]s<>n et al., 1979)
to demonstrate liposome fusion may be more difncult to djscount. The observation that
liposome-encapsulated naked nucleotides remain functional after del iYery to ceJls implies
that they are not significantly degraded upon entry as would be expec1ed for endocytosis
(Mayhew et al., 1977; Wilson et al., 1979).

Similarly~ CHO

cells, wh:ich have no
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membrane receptors for poliovirus, can be infected by encapsulated poliovirus, but not by
the free virus (Taber et al., 1978). However, in both cases the adherence of PS liposomes
to cellular membranes may act to promote nucleotide/viral deliYery. It may be possible
for membrane-associated nucleotides to enter the cell by some presently unknown
mechanism which does not involve endocytosis or fusion. With whole viruses, Jiposomemediated binding to the cell surface may obviated the need for receptms, and viral entry
may be due to the presence of viral proteins.
A more important objection to the above assays of lip()some-cell fusion is their
employment of potent biological agents which exert iheir effects at very low
concentrations through (an) amplification step(s) associated with their actions. Agents
used in such assays include plant and bacierial ioxins which possess eJl2Ymatic (ADPribosylation) activities, viruses which can undergo replica6<>n, and oligcmucleotides
which can function as templates in biasythetic reactions. Consequently, such assays
magnify the effects of rare events and are unsuitable for quantifying the extent to which
cell surface-bound liposomes fuse with the plasma membrane.
In contrast, we have developed an assay which provides quantitittive information
about liposome-cell fusion with PS-LUV. When the pH

sensjtive~

n()n-permeani probe,

FD, was used as an aqueous space marker, about 2.5% of the aqueous spitce entrapped in
PS-LUV becomes associated with the ce1lular monoJayer under our experimental
conditions.

In addition, the majority of the cellular fluorescence remained within a

compartment which was sensitive to manipulations of the pH of the medium. Only very

214
little, if any, of the FD was delivered to a cellular compartment which was insensitive to
changes in the external pH. Similar conclusions were reached independently in our
laboratory from studies of the delivery and degradation of 12j I-labeled proteins to
fibroblasts using PS/PC-LUV prepared by a freeze-thaw method (Thyagarajan, 1985). In
these studies, between 2 and 3% of the entrapped radiolabeled proteins became a5sociated
with the cellular monolayer. However, these proteins were remarkably inert. Very little
degradation could be detected based on the appearance ofTCA/PTA-soluble radioactivity
(t112 > 30 days).

When ca++ was added to cells preincubated with PS/PC-LUV-

encapsulated substrates to effect fusion, degradation of the radiolabeled proteins ensued.
However, the time course of appearance ofTCAIPTA-soluble products was qualitatively
similar to that seen with endocytosed protein substrates (Thyagaraj an, 198 5).

This

suggested that ca++ treatment either induced the uptake of liposomes by enclocytosis or
that the 125I-labeled proteins had leaked from the liposome5 and were ihen intemalized
by endocytosis.

In agreement, when cells were preincubated with PSJPC-LUV-

containing FD, addition of ca++ causecl a progressive quenchin~ of the cellular
fluorescence (Ex495; Em519) consistent with the delivery of FD to an acidic
(lysosomal/endosomal) compartment (Thyagarajan, unpublishecl results).
During the past decade, a number of fusion studies have been pedormed using
complex systems (Arvinte, 1987). Fusogenic proteins ltave been well-described and
characterized from enveloped viruses (Stegmann et al., 198j; White &

Eelemus~

1980;

White et al., 1982), mitochondria (Schneider et al., 1980), cbromatophores (Snozzi &
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Crofts, 1984), and bacterial membranes (Duzgunes et al., 1985).

Fusion of cells or

vesicles may also be induced by high electric field impulses (1-20 kV!cm, 1-20 µs)
(electrofusion) (Sugar et al., 1987).

It is possible that fusogenic prote:ins exist in

eukaryotic intracellular organelle membranes, since intracellular vesicular fusion is a
widely-accepted phenomenon. Whether or not fusogenic proteins exist in the plasma
membrane is currently unknown.
Liposomes, regardless of their ability to fuse with cell membranes, may cause
profound cellular changes. Phosphatidic acid (PA), whether incorporated into l:iposomes
or suspended in solution, was shown to stimulate DNA synth.esis :in quiescent cells
(Siegmann, 1987). SUV prepared from PC!PS caused an increase :in aberrant mitoses in
both diploid and heteroploid cell lines (Nuzzo et al., 198 7). This effect was p1eviously
demonstrated with MLV (Nuzzo et al., 1985). When combined with the fusogenic agent
polyethlylene glycol (PEG), the mixture was highly cytotoxic (Nuzzo ei al, 1987). The
highest level of chromosome abnormalities was seen with liposame-encapsulated
ONAase. The mechanism may be related to the interaction ofihe liIJosonH::s or PEG with
cell membranes with the production of free radicals, or thei1 interaction with Lysosomes
and the intracellular release of endogenous nucleases (Nuzz:o et lll ., L9&7).
The failure of PS-LUV to deliver proteins to the cytosol of cultured cells and
reports of profound cellular changes caused by lipos()smes i)T<>mpied alternative
approaches to the study of cellular protein degradation. Ih.e resulis aie di scu5sed in the
next section.
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PART II. INTRACELLULAR PROTEIN TURNOVER
The unsuitability of liposomes, either PS-LUV prepared from ca++-Ps, PS/PCLUV prepared by freeze-thawing (Thyagarajan, 1985), or

PCJLLJSA-SUV~

as vehicles

for the microinjection of radiolabeled proteins directly into fue cyiosol of cells prompted
a reexamination of cellular protein turnover in cultured fibroblasts using a standard
method. In this procedure, cellular proteins were labeled by pre:incubating fibroblasts
with [4, 5-3H] L-leucine for 40-48 hours.

Protein degradation was ihen studied by

monitoring the release of TCA/PTA-soluble and -insoluble radioactivity into the culture
medium. This study differed from a number of earlier studies of protein turnover in
cultured cells in that I monitored the appearance of products over a longer time period,
encompassing as much of the reaction as feasible. ln addition, in analy2in,g the data I
have attempted to account for the observation that, up to 75% of the racli()acti vity released
by the cellular monolayer appears a:s TCAIPTA-insoJnble material, depending on
conditions. This is presumed to be undigested or :incompJeteJy degmded ce!Jnlar proteins
released by cell leakage, cell death, and/or exocytosis.
Although rate constants were calculated from the amount of substrate remaining
in the cellular monolayer at each time point, what was actually mea.sllfed was the amount
of TCAIPTA-soluble and TCA/PTA-insoluble products released into tbe c11Lt11re medium.
It was therefore necessary to convert products released to sullstrate remaining. This was

done with the aid of the conservation equation: (substrate remaining at time "t")

=

(total

substrate) - (products released at time "t"). T()tal substrate wa:s calc:ulated at ihe end of

217
the experiment with a second conservation equation:

(total substrate)

=

(substrate

remaining in the monolayer) +(total products released by the end of the experiment).
This analysis was complicated by the observation that the labeled proteins in the
cellular monolayer gave rise to two products, TCAIPTA-soluble and TCA/PTA-insoluble
radioactivity. For parallel (competitive) first order reactions which convert substrate to
two different products, it has been shown that rate constants can be calculated by
analyzing the appearance of each product separately (Buktenica et al., L987). For this, it
is necessary to predict the amount of radioactivity remaining in the cellular monolayer at
the end of the experiment which is destined to give rise to the TCAJPTA-solub]e product
and the amount which will appear as TCA/PTA-insoluble material. This is accomplished
by calculating R2, the ratio of the rates of TCAIPTA-soluble to total products released
from the data obtained in the time period immediately preceding the termination of the
experiment. The amount of cellular radioactivity remaining in the monolayer at the end
of the experiment which is destined to give rise to the TCAIPTA-soh1ble prodllct is R2 x
[CPM]monolayer· For the TCA/PTA-insoluble product the corresponding -value is (1 R2) x [CPMlmonolayer· The validity of this method and the "goodness" of the 'alculated
value of R2 is strongly inferred from the observation that identical rate constants were
obtained for the appearance of both products, which is exactly what is expected for
parallel first order reactions (Buktenica et aL, 1987; Frost & Pearson, 1961).
The source of the TCA/PTA-insoluble radioactivity released by rnet.a.bolicallylabeled fibroblasts is of considerable

interest~

as it contribllte s 2j to 7 5%

~f

the total
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products released by these cells depending on the experimental conditions.

This

TCA/PTA-insoluble material could represent extracellular matrix proteins which are
synthesized and secreted by fibroblasts.

(Clark, 1993).

[t is possible that tritiated

leucine, arising from the degradation of cellular proteins, is continual1y reincorporated
into secretory proteins during the chase in unlabeled medium, giving rise to a continued
release of TCA/PTA-insoluble material. Extensive reutilization of tritiated leucine would
also result in a considerable underestimation of the observed rate constants for cellular
protein turnover. However, when the intracellular pool of tritiated leucine was diluted by
the addition of unlabeled leucine to the medium, the relative amount of TCAIPTAinsoluble products released (given by I - RT) was not decreased, and kobs for the
appearance of TCA/PTA-soluble products was not increased (Table 11 and Figures 1214). In addition, concentrations of cycloheximide which inhibited protein synthesis by
90% (Table 12) failed to decrease 1 - RT or increase kobs· Instead, kobs was actually
decreased by 50% (discussed later). Thus, no evidence could be obtained that tritiated
leucine reutilization was significant under the experimental c.ondi tions employed. Thus,
the source of the TCAIPTA-insoluble radioactivity relea!>ed by fibrobJasis dUJing the
slow phase could not be due to labeled secreted proteins whose syntbe:ies reutilized
tritiated leucine generated during the chase in unlabeled medium.
Two additional sources have been considered for the TCNPTA-insoluble
radioactivity released during the slow phase of cellular protein cataboli!>m. The:ie are cell
disruption (e.g. cell detachment, cell leakage andJor celJ death) {Model!> l and 3), and
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exocytosis (regurgitation) of cellular proteins following the:ir transfer to lysosomes
(Buktenica et al., 1987) (Model 2). Models 1 and 3 agree with respec1 to the source of
TCA/PTA-insoluble radioactivity (disruptionlleakage) bu1 disagree with respect to the
site of cellular protein turnover. Model I presumes that cellular proteins are primarily
degraded in lysosomes, whereas Model 3 supposes that the majority of cellular proteins
are degraded by extralysosomal proteases.
degradative systems would include:

Poss:ible candidates for extralysosomal

(I) a high molecular weight oligomeric protein

particle, which is composed of several d:istinct proteolyt:ic activities (Bond & Butler,
1987), calcium-dependent proteinases or calpains which have been found in association
with the soluble cytosolic fraction of cells (Bond & Butler, 198 ?), and a ubiquitindependent proteolytic system which has been documented in rabbit ret:iculocytes and in
yeast (Hersko & Ciechanover, 1982; Bachma:ir et al., 1986), that catalyzes the
polyubiquitinylation of proteins prior to their degradation

(Bond & Butler, 1987).

Proteolytic and peptidylytic activities have also been reported

in ass()ciation with

ribosomes (Archambault de Vencay et al., 1991 ), endoplasmic reticulum <Uiade & Kito,
1992), the Golgi apparatus (Amitay et al., 1992), mitochondria <Desautels, 1992), and the
nucleus (Rivett et al., 1992). Models 1 and 2 agree with respect to the sLte of degradation
of cellular protein--the lysosome--but disagree w:ith respect to tbe source of TCA!PTAinsoluble products (leakage as opposed to regurgitation ()f cellular proteins from
lysosomes). Not unexpectedly, the meaning of the rate constaJltscalculatedfr()m the time
course of release of TCA/PTA-soluble and -insoluble products depe11ds

()D

which model
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is being considered.

Before discussing the predicted consequences of each of these

models, I will describe how the individual rate equations for each of these models were
derived.
For Model 3, which presumes that proteins are degraded within the cellular
compartment in which they initially reside, no additional assumptions are required to
derive the respective rate equations for the appearance of TCA!PTA-soluble and
-insoluble products. For Models 1 and 2, the additional assumption is made that a steady
state exists between the rate of transfer of substrates into the lysosome and the rate of
substrate degradation and egress from the lysosome. Consequenily, after an initial presteady state period following some perturbation, the amount of cellular substrates within
the lysosome (P3'), and thus the lysosomal space (volume), approa<:.hes a new constant
level which remains unchanged over time. Support for this assumption has come from
studies of protein degradation in perfused livers from rats and mice (Morhmore et al.,
1983; Mortimore & Ward, 1981; Schworer et al., 1981). Thus, under condiiions of basal
proteolysis in liver, the lysosomal space and the fraction of cellular protein substrates
residing in the lysosome is about 2% of the toiaL On removing essential amino acids
from the liver perfusate, there is a significani increase in the rate of ce1lular protein
degradation, which is accompanied by expansions of the lysosomal space and the
lysosomal protein substrate pool to new values corresponding to aboui 7% of the total.
On refeeding, the lysosomal space immediatedly shrinks io the initial value of 2%.
Partial hepatectomy, which results in a dramatic: decrease in proiein iurnoYer iJ1 perfused
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liver, results in a decrease in the lysosomal space and lysosomal substrate pool to about
0.2% of the total cellular space and 0.2% of the total cellular substrate pool (Scomik &
Botbol, 1976; Swick & Ip, 1974). Furthermore, a direct linear relationship was observed
between the volume of the lysosomal space and the rate of cellular protein catabolism in
liver, which extrapolated to zero space at zero proteolysis. [n addition, it was observed
that the rate of protein degradation in isolated lysosomes was always mt1.ch greater than
the overall rate of cellular protein degradation in rodent liver under all conditions. From
these observations, it can be concluded that a steady state exists between protein uptake
and degradation in lysosomes, with transfer to lysosomes being the n1te-detennining step
in cellular protein catabolism in the perfused rodent liver (Mortimore & Ward, 1981 ).
A consequence of the steady state assumption in deriving the raie equations for
Models 1 and 2 is that protein transfer to lysosomes, kT, becomes rate-determining; kobs

= kT + kL for Model 1 and kobs = kT for Model 2. Thus, both models for lysosomal
degradation predict that the rate constant, kobs.' corresponds to the disa::ppeanmce of the
extralysosomal substrate pool, P3, rather than the dis.appearance of the lysosomal
substrate pool, P3'.
A variety of evidence support the condusion thai p1oteolytic steps in the
lysosome are not rate determining during the degradation of cellular and extracellular
proteins. Dunn et al. (1980) has reported that the rate-limiting step in the de gradation of
asialoglycoproteins in the perfused rodent Live1 is their tJansfer from a J>re-lysosomal
compartment to lysosomes. Work in our laboratory to charactedz:e endocytosis in human
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fibroblasts has revealed a degradative compartment with the capacity to convert 20 to
50% of an endocytosed protein to TCA/PTA-soluble products wi1h half-lives of 5 to 10
minutes. In contrast, the half-lives of the majority of cellular pro1eins in :fibroblas1s from
my present work is about 5 days. Thus, the rate of lysosomal protein degradation could
be nearly 1000 times faster than the rates of turnover of a large proportion of cellular
proteins in fibroblasts. For the slow phase of cellular protein turnover to involve the
participation of the same vacuolar degrada1ive compartments as in

endo~ytosis

(Models 1

and 2) then the rate-determining step in cellular protein ca1abolism must come prior to
peptide bond hydrolysis in the endosomal/lysosomal system.
Although Models 1 and 2 both predict 1hat the transfer of substrates to lysosomes
makes a major contribution to the observed rate consiant for 1he appearance of
TCA/PTA-soluble and -insoluble radioactivity, kobs = kT + kL (Model I) and kobs

=

kT

(Model 2), they disagree as to the meaning of R2, the ratio of TCAIPTA-soluble
radioactivity to total radioactivity released by the cellular monolayer

dur:in~

the slow

phase of protein catabolism. For Model 1, R2 is the fraction of 1he cellular pro1ein which
is degraded, 1 - R1 is the fraction of the cellular protein which escapes degradation by
leakage or other disruptive processes, and R2J( 1 - R1) = kTlkL. tbe rab() of 1he rate
constants (or rates) for transfer of proteins 1o lysosomes and leakage ()f proteins from
cells.

For Model 2, however, R1 describes the parti1ion of substrates within the

lysosome, P3', between degradation and regurgitation. Thus, R2({ 1 - Ri) gives directly
kn'lkR

Models 1 and 2 can therefore be distinguished by exa:mining 1he effects of
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lysosomal proteinase inhibitors at concentrations known to inhibit the degradation of
endocytosed proteins. From Tables 11, 15, 18 and 20, it can be seell thai ]eupeptin,
antipain and pepstatin have no effect on the values of R2 and R1/(l - R1) either under
basal conditions or conditions of serum and amino add depriYation_

At the

concentrations in which these agents were employed, subsialltial inhibitions of Lysosomal
cysteine or aspartie acid proteinases were expected (Choudhuri et al., 1992; Buktenica et
al., 1987). The failure to observe a decrease in the values of R1/( I - R1) in the presence
of these agents argues strongly against Model 2.
Other evidence for models where cell disruption or leakage is the source of
TCA/PTA-insoluble radioactivity released into the culture medium is ihe :finding of
similar radiolabeled protein profiles in cell lysates and in the culture medill!TI collditioned
by the cells. Thus, nearly identical patterns of proiein bands were observed in cells
prelabeled for 42 hours with 35s-methiolline and in the culture medium collecied after
the 42 hour labeling period (Figures 37 and

38~

Table 25). This is exactly what one

would expect for cell leakage. Were cellular proteins sequestered into a degradative
compartment prior to their exocytosis (Model 2), then one might baye expecied to see
released into the medium decreased amounts and numbers of high molecular weight
proteins and increased amounts and numbers of Lower molecular weight protein
degradation products. Second, measuremenis of ihe fractional rate of re]eai;e of LDH, a
presumptive marker for cell leakage (Bukienica et al., I 9i7), gaye lealcltge rates which
were similar to those observed for the release of TCA!PTA-insol uble radi oaciivity into
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the culture medium. Finally, the large increase in the amonnt of TCAIPTA-insoluble
material released into the medium under conditions of serum and amino acid deprivation
was accompanied by the recovery of significant amounts of radioactivity in the pellets
obtained after low and high speed centrifugation of the medium. This was consistent
with disruptive processes leading to cell detachment and release of particulate/vesicular
structures under conditions of nutritional stress. Thus, of the three models which we have
described, only Models 1 and 3--which identify cell leakage and/01 other disruptive
processes as the cause of the release of TCA/PTA-insoluble radfoactivity into the culture
medium during the slow phase of protein catabolism--seem to best explain the data.
Consequently, further discussions will be largely confined to these iwo modeJs.
A remarkable finding in this work is the complete insensitiYity of cellular protein
turnover to inhibitors of lysosomal proteinases. Although the in1Iacel111lar concentrations
of leupeptin, pepstatin and antipain cannot be easily determined, their concentrations in
the medium were sufficient to have produced substantial

inhibition of their target

enzymes. Thus, leupeptin concentrations of 20 µMand 2()0 pM were 4000 and 40,000
times higher than the reported Ki for leupeptin inhibition of cathepsin B (S chnJtz et al.,

1989). Similarly, the Ki for pepstain inhibition of cathepsin Dis reported to l>e 0.5 nM,
and saturated concentrations of pepstatin were previously shown to iohibi1 the ly sosomal
degradation of endocytosed BSA by 50% in mouse peritoneal macrophages (Buktenica et
al., 1987).
One explanation which can be proposed for the fai]me to see inhil>iiion of
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intracellular protein turnover by inhibitors of lysosomal proteinases is that lysosomes are
not participants.

Instead, protein degradation occurs in an nnidenti:fied degradative

compartment by proteinases which are insensitive to the inhibitors which J employed, or
degradation occurs within the same compartment (Model 3) in which ihe proteins initially
reside by enzymes insensitive to these same agents (e.g. cytosolic proteins are degraded
by inhibitor-insensitive cytosolic proteinases). By this reasoning, ihe calcium-dependent
extralysosomal proteinases, calpains, may not be involved in cellular p1otein catabolism
as they are leupeptin inhibitable. However, even for Model 3 where Kobs= kD' + kL and

kn' can be obtained explicitly, peptide bond hydrolysis may not occur in the rate
determining step. Instead, kn' could represent a step in which the subsiraie undergoes a
physical or chemical modification prior to degradation (Bachmair et al., J 986; Bond &
Butler, 1987; Hershko & Ciechanover, 1982). In such a case, ihe rate deiermining step
might be associated with a regulatory function of the proteolytic sysiem, or a step
associated with the assembly of a multiproiein degradative complex (Rechsteine1 et al.,
1984). Then, proteinase inhibitors could have little effect on kobs· Alguing against

Model 3 as an exclusive explanation is the observation of a mmlced sensitivity of the slow
phase of protein catabolism to the lysosomotropic amines, NH4CI llnd c:h.Loroquioe.
A second explanation for the lack of inhibition by pre>teiJ1ase inhibitors is that
protein degradation occurs within the lysosome (Model 1), hat that IJeptide bond
hydrolysis is not rate limiting. It has previously been proposed that the raie controlling
step in lysosomal proteolysis is the ill-defined "sequestration of celhilt1r p1oteins into
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lysosomes or autophagic vacuoles" (Mortimore & Ward, 1981; Katunuma & Kominami,
1983; Bond & Aronson, 1983). In addition, lysosomal proteinase activity is notoriously
difficult to abolish, even when using a combination of inhibitors (Ahlberg et al., 1985).
This may be due to the fact that lysosomal proteinases are present in excess (Katunuma &
Kominami, 1983), or else the lysosome contains a wide diversity of proteinase and
peptidase activities with differing inhibitor specificities so as to make their complete
inhibition difficult to accomplish. Thus, even were the individual inhibitors capable of
producing a significant reduction in the activity of its target proieinases, ko' could still be
one or more orders of magnitude greater than kT A sample calclliation may suffice to
illustrate this point.

Frankfater (1988) has observed that a major componeni of the

endosomal/lysosomal system in fibroblasts is capable of degrading BSA to TCA/PTAsoluble products with a half-life of about 10 minutes. Mortimore and Ward (1981) have
reported that lysosomes from rat liver labeled with [14c] valine release TCAlPTAsoluble products in vitro with a half-life of about 30 minutes. Esiimates of lysosomal
proteolysis in rat liver in vivo from the rates of regression of the Yolume of autophagic
vacuoles on refeeding yielded half-lives of about 8 minutes (Mortimore & Ward, 1981).
Using the half-life for the slow phase of cellular protein turnover t() calcu1aie the rate of
transfer of substrate to lysosomes yields a half-life of 7780 minutes (S.4 days) in this
present work. P3'/P3 can then be calculated (kTfko) to be 0.1 to 0.3%, which is similar
to the fractional lysosomal space in rodent liver following partial hepatectomy.
addition, Steinman et al. (1983) have reported a value of aboui

0.5~/() inm11rine

In

fibroblasts

227
(L-cells) by stereologic analysis. A 50% inhibition oflysosomal proteolysis, as seen with
saturating concentrations of pepstatin in mouse macrophages (Buktenica et al., 1987),
would result in an expansion of the initial substrate pool to 0.2 to 0.6% (or 1% based on
the initial value reported for L-cells) without any discemable decrease in the overall rate
of cellular protein turnover.

If fibroblasts were able to tolerate an expansion of the

lysosomal space to 7-10% of the cellular volume without impairjng kJ, then agents
which produce a 93 to 99% inhibition of lysosomal proteolysis might still not produce a
detectable inhibition of intracellular protein turnover.
Based on the preceding discussions, it should be clear that the failure of the
lysosomal proteinase inhibitors--leupeptin, pepstatin and antipain--to decrease kobs for
the appearance of TCA/PTA-soluble products in metabolically-labeled fibroblasts may be
in agreement with Model 3, which identifJ.es inhibitor-insensitive extralysosomal
degradative systems as primarily responsible for cellular protein tlll1JoYer. This lack of
inhibition is also not inconsistent with Model 1 under conditjons where the rate
determining step in cellular protein turnover is the transfer of substrates to lysosomes. In
contrast, the failure of these inhibitors to alter the ratio

Rz

is inconsistent with Model 2

which explicitly indentifies R2 as being equal to kn'fkR. [ohibition of the slow phase of
protein degradation by the lysosomotropic amines, Nrf4CI and chloroquine, provides
further support for Model 1.
A putative lysosomal pathway of cellular protein turnove1 mjght be expected to
include one or more of the following steps:

(l) sequestration of cellulllr proteins in
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vacuoles derived from existing membrane elements such as the endoplasmic reticulum,
the Golgi apparatus, or components of the endosome/lysosome system; (2) transport of
the newly formed vesicles from their site(s) of formation to the lysosome-rjch perinuclear
region of the cell; and (3) fusion of these vacuoles with newly formed or preexisting
lysosomes.

Similar kinds of steps have been observed during the degradation and

endocytosis of extracellular proteins. Endosomes formed by invagination of the plasma
membrane at the cell periphery migrate toward the perinuclear or irans-Golgi region and
fuse with lysosomes (Gruenberg & Howell, 1989). Direcied movement of membranebound vesicles and membrane-vesicle fusion have also been observed during exocytosis
(Burgess & Kelly, 1987), during the biosyntheiic transport of membrane pro1ejns and
lysosomal enzymes (ibid), and during fibroblast migration as plasma membrane is
retrieved from the retreating edge of the cell and is inserted in1o ihe leading edge (Singer
& Kupfer, 1986). Thus, agents which inhibit endocytosis, exocytosis, or cell migration

might also be expected to inhibit cellular protejn turnover.
Endocytosis is temperature dependent with a Q10 of 2.7 (corresponding to an
activation energy, Ea, of 17.6 kcal/mol) (Steinman ei al., 1974)~ and fusion of endosomes
with lysosomes is almost completely abolished at iemperatures Jess 1han 1go C (Dunn et
al., 1980; Wall & Hubbard, 1981). Low temperatures (10-ljO C) also blockihe vesicular
transport of proteins between the rough endoplasmic reticuh1m and the Golgi complex
(Saraste & Kuisman, 1984; Saraste et al., 1986).
The cytoskeleton of cells has also been implicated in membrane associated
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processes. Cytochalasin B, which binds to the "forked end" of ac1in :filaments, prevents
microfilament elongation (Sampath & Pollard, 1991).

In cell cultures it inhibits

endocytosis (Gottlieb et al., 1993), exocytosis, plasma membrane blebbjng, and cell
migration (Singer & Kupfer, 1986).

In addition, cytochalasin B jnhibits plasma

membrane glucose and glucosamine transport and lysosoma] membrane N-acetyl-Dglucosamine and N-acetyl-D-galactosamine transport (Jones et al., 1989). Micro1ubules
radiate from a microtubule organizing center (MTOC) whjcJ1 is adjacent to the nucleus
and Golgi complex outward toward the periphery of the cell.

Most membraneous

organelles are found in association wi1h 1his microtubu]ar ne1work.

These include

lysosomes, mitochondria, the Golgi apparatus, secretory gran11les and the endoplasmic
reticulum. Attachments of microtubules 10 cell organelles appear to be of two 1ypes.
Static attachments of the endoplasmic reticulum and Golgi apparatus Jiave a structural
role in organizing and positioning these elements.

VinbJastin and o1her microtubule

depolymerizing agents cause connections between adjacent Golgi stacks to be broken and
induce the ER to retract from the cell periphery and to coalesce in the central region of
the cell (Singer & Kupfer, 1986; Terasaki et aL, 1986). In contra.st, mobile mganelles
such as mitochondria and small cytoplasmic vacuoles have dynamic aitacJiments which
permit movements in both directions along microtubule filaments. Colchicine, which
also causes depolymerization of microtubules, inhibits such saltatory movements of
vesicles in cultured cells (Freed & Lebowitz, 1970; Wang &

Goldman~

197 g).

In my study, cytochalasin B had virtually no effect on any of ihe kinetic
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parameters for the slow phase of protein turnover in cultured cells (Table 11 , part B and
Table 15). In addition, cytochalasin B did not inhibit the release of TCA!PTA-insoluble
radioactivity during the initial rapid phase (Table 11, part A). This is consisten1 with the
recent consensus that actin microfilaments are not directly involved in vesicle transport in
most animal cells (Burgess & Kelley, 1987).
Vinblastine had an unusual effect. It appeared to increase the rates of the fast
phase of products released (Table 11). Both (k1)so] and (kt)ins increased by more 1han a
factor of 2. In addition, the pool which gave rise 1o the fas1 phase of appearance of TCAsoluble products, P1, was also decreased under these conditions..

P2, however, was

largely unaffected. The failure ofvinblastine to decrease P2, 1he labeled pool which gave
rise to the rapid phase ofrelease ofTCA-insoluble radioactiYi1y, may be inconsistent with
our identification of P2 as newly synthesized secretory proteins, as inhibi1ion of
microtubule assembly would be expected to affect the transport of new1y synthesized
proteins from trans-Golgi elements to the plasma membrane (Burgess & Kel1ey, 1987).
Therefore, vinblastine should have reduced either P2 or (k] )in~·
The release of products in the slow phase was no1 inhibited by YiJ1blas1ine. In
fact, there was a small increase in (k2)sol and kobs (Tab1e LI, part B and Table 15),
which can be attributed to an increased release of TCAJPTA-in~oluble produc1s. This is
also reflected in moderate decreases in (P3)s 0 1l(P3)tota] from coJ1troL va1ues (Table 11,
part B). According to Models 1 and 3, the increase in kobs was entirely due to a 2-fold
increase in kL(Table 19). Increased cell leakage andlor death is certain1y plausible, since
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vinblastine is cytotoxic. kT (Model 1) and kn' (Model 3) appeared to be unaffected.
Model 2 is again implausible since it attributes the vinblastine effects to an increase in
regurgitation from the lysosome or a decrease in degradation in the lysosome. If either
Models 1 or 3 are correct, it would appear that vinblastine-sensitive steps are either
nonexistent or are not rate-determining for the slow phase of protein tu.mayer in cultured
fibroblasts.
The role of microtubules in vesicle transport is not entirely clear. Vinblastine
inhibits locomotion in fibroblasts by preventing the directed transport of plasma
membrane-derived vesicles from the trailing edge to the leading edge of the migrating
cell. However, vinblastine does not block vesicle formation or vesicle-membrane fusion.
Instead, vesicle membranes are inserted into the plasma membrane in a random fashion
(Singer & Kupfer, 1986).

Similarly, microtubule disruption in liver does not block

albumin secretion but causes albumin to appear in the bile (Mullock et al., 1980). Thus,
an intact microtubule network may not be required for vesicular transport per se, but is
required for directional transport. In addition, cell free studies suggest mi crotubules are
not involved in vesicular transport between the ER and the Golgi

comple~

nor between

the various cistemal elements of the Golgi stack (Pfeffer and R()t:hman, J 987). Thus, the
failure of vinblastine to inhibit the slow phase of protein turnover does not preclude the
participation of lysosomes.
The results in Tables 11, part B, Table 15, part A, an(j FigUJe

2~

show that

intracellular protein turnover is markedly temperature dependent in the fed state. Because
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fibroblasts did not tolerate the 260 C incubation, it was necessary 10 limit the time of
exposure to this temperature to periods of 3 hours between 1629 minutes and 1800
minutes and between 3060 minutes and 3240 minutes after the chase in unlabeled
medium. From the slope of the lines obtained, kobs was found to be reduced to about 2/3
of the control value of 37°. kT (Model 1) and kn' (Model 3) were similarly decreased
(Table 19). This was similar to the magnitude of the reductions in kobs' kT and kn'
caused by the lysosomotropic amines, NH4Cl and chloroquine. In view of the sensitivity
of endosome-lysosome fusion and biosynthetic protein transport to decreasing
temperature, my results are consistent with the participation of a lysosomal pathway in
cellular protein turnover. A further observation is that the decrease in k0 bs at 260 C is
due equally to a decrease in kT (or kn' for Model 3) and kL for cellular protein leakage.
Consequently, the ratio R2 is essentially unaffected by 1emperature. As celh1lar protein
leakage and intracellular vesicle formation (substrate sequestration step in Model 1) and
vesicle fusion may all involve similar kinds of transient discontinuities jn membrane
structure, it may not be surprising that they show similar temperature dependencies.
Among the most convincing evidence for the participation of lysosomes in
intracellular protein turnover is the inhibition caused by lipophilic weak bases such as
chloroquine, methylamine, and ammonium chloride. These l)'sosomotropjc agents are in
fact acidotrophes, accumulating in acidic cellular compartments s11ch as lysosomes and
endosomes in which they act to raise the intravacuolar pH (Ohk:uma & Poole, 1978).
Buktenica et al.(1987) observed chloroquine at a concentration of 150 µM cans.ed an 88%
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inhibition of degradation and a stimulation of regurgitation of endocytosed bovine serum
albumin in stimulated mouse peritoneal macrophages.

Chloroquine also affects

molecular sorting and recycling in endosomes (Tietze et al., 1980). Acidotropic agents
and proton ionophores also exert effects at the trans-most cistema of the Golgi stack,
causing dilation of the Golgi cistema and Golgi-associated vesicles (Millman et al.,
1986). As a consequence of these effects, proteolytic processing oflysosomal enzymes is
inhibited and their delivery to lysosomes blocked (Nishimura et aL, 198g). In mouse 3T3
fibroblasts, latent precursor forms of cathepsins B and L accumulate in1racellularly, and
are secreted in large quantities into the culture medium (Achkar et al., 1990). Prolonged
incubation of fibroblasts with chloroquine produces an increased Yacuolization of the cell
(possibly through vacuolar dilation) and profound deficiencies in the leYels of Lysosomal
hydrolases. Removal of chloroquine results in cellular recovery of lysosome function
(Wiesmann et al., 1975).
Despite the profound lysosomal dysfunction likely to be induced by chloroquine
and other weak bases, these agents were incapable of completely abolishing intracellular
protein turnover. Inhibitions of cellular protein degradation of 40 io 70% have also been
reported by others, depending on the tissue or cell and its metabolic state (Knowles &
Ballard, 1976; Dean, 1979; Hapgood et al., 1977; Seglin et al., 1979; Ame11ta et al., 1979;
Poole & Wibo, 1973).

The incomplete inhibition of i11tracellular protejn tumvover

afforded by weak bases has often been cited as evidence for t:h.e participation of
extralysosomal proteolytic enzyme systems in intracellular protei11 turnover (Seglen et
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al., 1979).
In this present study, chloroquine and ammonium chloride produced, respectively, a
20% and a 24% decrease in kobs for the appearance of TCAJPTA-solub]e and -insoluble
radioactivity. However, the decrease in kobs was partially masked by a modes1 increase
in the rate of leakage of proteins from the cells, as reflected :in a substantial decrease in
RT from the control value of about 0.7 to 0.45 and 0.57 in 1he presence of chloroquine
and ammonium chloride. Recalling that kobs

=

kT (or kD' for Model 3) + kL, it is

possible to calculate from the experimental value of (P3)s 0 1/(P3}toial 1hat chloroquine
and ammonium chloride produced a 50% and 36% inhibition of kT (Model 1) or kn'
(Model 3) and a 48 and 8% increase in leakage (kL), respectively. From ihis result, it
seems reasonable to conclude that a lysosomal degradati ve pathway contribu1es 3 5 to
50% to the turnover of cellular proteins in fibroblasts in the fed state, as it seems less
likely that chloroquine and ammonium chloride would affeci extralysosomal protein
degradation occuring in a pH-neutral compartment.
The lack of effect on cellular protein turnover of lysosomal pro1einase inhibitors
and the incomplete inhibition caused by chloroquine prompted an examinati_on of cellular
protein degradation in the absence of serum and an essential amino acid. It Ji.as been well
established that protein/amino acid deprivation causes a marked increase in cellular
protein turnover and in the size of the lysosomal substrate pool in perfused rodent liver
(Schworer et al., 1980; Mortimore & Ward, 1981). Serum and amino acid deprivation
has also been reported to result in an increase in intracelJular pr()tein degradation in
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cultured rat fibroblasts (Poole et al., 1978; Poole, 1975; Poole & Wibo, 1973) and in
cultured hepatoma cells (Epstein et al., 1975; Mcrlhinney & Hogan, 1974). Furthermore,
it has been suggested that lysosomes are responsible for the enhanced rate of cellular
protein turnover under conditions of nutritional deprivation (Mortimore & Ward, 1981;
Dean, 1975). Consequently, I had expected to see an increased sens:itivity of protein
degradation to lysosomal proteinase inhibitors and chloroquine in the absence of serum
and amino acids.
In contrast to expectations, the combined effects of am:ino add depriYation and
protein starvation caused a 55-60% decrease in kobs and large decreases in
(P3)s 0 1/(P3)total (Table 14, part B amd Table 15, part B). kT (Model I) or ko' (Model
3) was inhibited 85-90% (Table 20). The reason for the djfferences between my results
and those of Poole et al. (1978), who reported that degradation of long-lived
endogenously-labeled proteins in rat lung fibroblasts more than doubled in the absence of
serum, is presently unclear. The results may reflect differences in short-term (Poole et
al., 1978) and long-term (my results) responses to nutritional depriv-lltion. Differences
between my results and those of Mortimore and Ward (1981), who obseJYed increased
protein catabolism in rat liver, could be explained in terms of the role of liYer in amino
acid homeostasis.

Thus, amino acid and protein deprivat:ion could f)e expected to

increase liver protein degradation to mobilize amino acids fm release iILto the blood.
Fibroblasts, which are not known to function in the same mllnller as Liver in this regard,
might be expected to respond to long-term amino acid and serum depri_vatioIL "by reducing
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protein turnover in order to conserve cellular proteins. Interestingly, my results show that
the addition of 1% serum to the media is not sufficient to restore

kc bs

to the control

values in the fed state. However, when the medium was supplemenied with 1 mM
leucine in addition to 1% serum, kobs for the slow phase of proiein tumoYer was restored
to the value seen in the fed state. Of significant interest is the :finding that both nutritional
deprivation and cycloheximide cause a significant inhibition of cellular protein turnover
in fibroblasts. As amino acid and serum deprivation, like cycloheximide, is expected to
inhibit protein synthesis, these results imply that protein synthesis and protein
degradation in fibroblasts are reciprocally and coordinately regulated.
Inhibition of protein degradation by inhibitors of protein synthesis has been
reported previously in perfused liver (Pastan et al., 1975), liver s]ices (Simpson, 1953),
and hepatoma cells (Epstein et al., 1975) maintained in vitro in medium lacking :insulin or
serum. Under such conditions, protein degradation is acceleraied above basal levels, and
inhibitors of protein synthesis act to reduce protein degradation raie.s to basal levels.
Thus, it appears that the behavior of human fibroblasts is fundamentally different from
that of liver. In liver, nutritional deprivation produces enhanced proieolysis which is
inhibitable by inhibitors of protein synthesis, while under basa] conditions liYer protein
degradation is insensitive to cycloheximide and puromycin.

[n fibrobJasis, however,

basal proteolysis is sensitive to inhibition by cyclohex:im:ide (49-69-0/11>, and nutritional
deprivation brings about a decrease in intracellular protein turnover (84-g6%).

The

decrease in the rate of cellular protein turnover caused by serum aJJ.d amino acid
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deprivation was probably not due to a decrease in lysosomal proteases, as cathepsin B
levels were only slightly (18%) decreased (Table 28).
From Table 20 it is also apparent that amino acid and serum depriYation produced
a 30% increase in the rate of leakage or cellular disruption. This was accompanied by an
increase in the amount of radioactivity in the 14,000 x g and 109,000 x g pellet following
centrifugation of media samples. The proportion of radioactivity in these pellets was
much greater during day 3 than during day 1, indicating that leakage andfor disruption
became more severe the longer the fibroblasts were exposed to serum and amino acid
deprived conditions. As noted earlier, these results could not be explainecl by Model 2.
Antipain and pepstatin A in the fasted state produced increases in lobs for the
slow phase (Table 15, Part B). These increases were principally due to increases in cell
leakage or death (Table 20). However, kT (Model 1) or kn' (Model 3 > were largely
unaffected (Table 20).
Chloroquine caused a more substantial increase (100%) in Kobs for the slow phase
release of products in the absence of leucine and serum (Table 15, Part B). This was
principally due to an increase in the release of TCA-insoluble radioactiYit,. According to
Models 1 and 3, this was principally due to a 2-fold increase in the leakage rate constants
kL, which is easily explained by the cytotoxic nature of this amine. HoweYer, k1 (Model
1) or kn' (Model 3) was, if anything, slightly increased. Thus, protein tumoYer in the
absence of serum and amino acids is completely insensitive i«> inhibition by acidotropic
agents, suggesting that lysosomes are not the site of cellular protein de ~radation under
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such conditions.
The serum and amino acid deprived cells tolerated the 260 C incubation better
than the serum-supplemented cells. It is proposed that the deprived state may induce
changes in cellular physiology which render the cells more resistant to lower
temperatures. For Models 1 and 3, the 27% decrease in kobs seen at 26° C in the fasted
state was due almost entirely to a decrease in leakage, k1 (Table 20). Decreased leakage
was also noted in serum-supplemented conditions at 26° C (Table 19). What differs
between the results obtained in the presence and absence of serum is that serumsupplemented cells show marked decreases in cellular protein turnoYer

O'T or ko') at 26°

C, whereas in the absence of serum and amino acids kT (Model I) or kD' (Model 3) are,
if anything, increased at 26° C from serum and amino acid deprived controls. Thus, the
slow phase of cellular protein degradation was not inhibited when :fibroblasts were
transferred from 37° C to 260 C under starvation condititions, in contrast to results
obtained in the fed state.
It is proposed that there are 2 proteolytic systems which participate in the turnover

of long-lived proteins (slow phase) within fibroblasts; one sys.tern is inhibitable by
decreasing temperatures between 37 and 26° C, while the other is large]" 11naffected by
this transition.

In the deprived state, only the system unaffected by decreasing

temperature is operable. The observation that chloroquine did not inllibit degradation in
deprived conditions indicates that the temperature-insensitive system is non-lysosomal.
In contrast, the chloroquine sensitivity of degradation in the fed state suggests that the
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temperature dependent pathway is lysosomal.
The results obtained with serum-supplemented cells suggest that Model 1 may
account for 30 to 50% of the degradation of long-lived proteins.

Model 3 is less

consistent because it does not account for the decrease in degradation effected by the
lysosomotropic amines. When examining the results collecied from serum and amino
acid deprived cells, however, Model 3 is more consistent. Chloroquine did no1 decrease
degradation during the slow phase; in fact, there was a small increase in kr (Model 1) or

kn' (Model 3). Also, at 26° C, there was no concomiiant decrease in kr or kn' as
compared with serum-supplemented conditions (Table 20).

Therefore, ii appears that

there are at least two degradative pathways responsible for ihe slow phase of protein
turnover in fibroblasts:
(1) A system which functions in a pH neutral compartmeni (non-Jysosomal), is
temperature-insensitive between 26-370 C, and predominates in serum and amino
acid deprived conditions.
(2) A lysosomal system which increases in rate between 26-370 C and which
contributes 50% or more to the slow phase of protein degradation in t:h.e fed s1ate.
Thus, the proposed model for protein turnover under normal culture conditions is a
combination of Models 1 and 3 (Figure 39). In t:h.e fed state, both models are probably
operative, with the lysosomal pathway making a significant contributfon io proiein
degradation (53% based on chloroquine sensitivity, 3 ?% based on temperature
dependency, and 82% based on sensitivity to serum and amino acid depriYation) such 1hat
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Figure 39. Illustration for the proposed model of the metabolism of celh1Lar proteins in
fibroblasts. Pi, P2, kn and ks are explained in Figure 18. In the fed state,
proteins in P3 may be transferred (kT) to the Lysosomes (P3'), where they are
degraded (kn"), degraded by a non-lysosomal degradative system Ckn'), or
leaked from the cell (kL). Under conditions of serum and amino acid
deprivation, kT approaches 0.
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kobs for the slow phase is equal to kT + kn' + kL.

Under deprived condtions, the

lysosomal pathway is non-operative, such that kr approaches 0 and k0 bs

=

ku' + kL

(Model 3).
It is probable that the compartmentalization of cellular proteolysis is tissue-

specific.

In rat liver, the lysosomal substrate pool is largest during starvation and

smallest during the fed state (Mortimore & Ward, 19&1).

Onr results in human

fibroblasts indicate that lysosomal degradation is minimal during prolonged starvation.
However, fibroblasts and hepatocytes have different functions wjtb:in the jntac:t organism;
therefore, it should not be surprising that they respond differently to a partic:ular stimulus
(starvation). In addition, when working with tissue culture, it must be remembered that
results cannot be interpreted too generally. For example, results obtained with an intact
organ (e.g. liver) may differ somewhat from those obtained witb cultured cells
(hepatocytes), because organs are generally composed of several cell types which
interact, and because the culture medium may not replicate the extrace!Jlllar :fluids which
bathe the intact organ.

CHAPTERV
SUMMARY

Large unilamellar liposomes (LUV) were successfully prepared from the calcium
salt of phosphatidylserine (PS) as putative vehicles for the injection of labeled proteins
into the cytosolic compartment of fibroblasts.

Methods were developed to quantify

liposome-cell fusion which did not rely on cellular biological responses.

My studies

concluded that PS-LUV do not fuse with cellular membranes, but im;tead adhere tightly
to the cell surface.
Since our PS-LUV preparations were unsuitable for microinjection, intracellular
protein degradation was investigated using proteins metabolically-labeled -with [4, 5-3H]L-leucine. Both TCA-soluble and -insoluble products were recovered from the culture
medium, and their appearance was monitored over time. The release of both products
occured in 2 phases. Approximately 10% of the Labeled protein products -were rel eased in
the fast phase, which was largely completed within 5 hours.

The remaining labeled

proteins were released in a slow phase with a half-life of approximately 5.4 days.
TCA-insoluble radiolabeled products released into the celJ c11lmre medium were
similar in composition to whole cell extracts, as revealed by electrophoretic analysis. This
suggested that these products resulted from celJular leakage or cellular dissolution.
Addition of inhibitors of protein synthesis did not affect the releCtse of ICA-insoluble
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products, thereby precluding the possibility that TCA-inso1nble radioactivity resulted
from the reincorporation of labeled amino acids into secretory proteins. In addition,
centrifugation of the culture medium revealed that dead or detached cells accounted for
only a small fraction of the TCA-insoluble products released.
Our results show that at least 2 pathways exist for cellular protein turnover in
fibroblasts, one inhibited at 26° C and the second, a temperature-im;ensitive system. The
temperature-sensitive pathway presumably involves

lysosomes~

is

inhibited by

lysosomotropic amines, is more prominant under control ("fed") conditions, and Is
responsive to changes in protein synthesis.

The

temperatnre-insen~iiive

pathway IS

dominant under deprived conditions, and is presumably nonlysosomal because it IS
largely unaffected by acidotropic amines known to inhibit lysosomal protein degradation.
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APPENDIX
DERIVATIONS OF THE RATE EQUATIONS FOR THREE MODELS OF
CELLULAR PROTEIN METABOLISM
Definition of Rate Constants
kn = degradation rate constant for proteins in pool I
ks = exocytosis rate constant for prate ins in :poo I 2
kT =rate constant for transfer of protein in pool 3 to lysosomes
kn• = degradation rate constant for protein~ in pool 3
kL =rate constant for cellular leakage of proteins in pool 3
kR =rate constant for regurgitation of proteins in pool 3

Model 1
In this model a fraction of newly synthesized proteins may undergo ia:pid degradation
(pool 1) or secretion (pool 2). A third pool of cytosolic proteins (pool 3) may slowly leak
from the cell or may be slowly transferred to lysosomes (pool 3') where they are
degraded.

P3 = (P3)oe-(kT + kL)t
1

dP3
Assuming _ _ = 0 = kTP3 - kn'P3'
dt
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kTP3
then P3'

= __

kn'
d (TCA)ins
=

ksP2 + kLP3

=

knP1 + kn'P3'

=

ks(P2) 0 e-kst + kL(P3) 0 e-(kL + kT)t

dt
d (TCA)sol
=

knP1 + kTP3

dt
d (TCA)ins
dt
Integrating yields:
kL
(TCA)ins = -(P2) 0 e-kst - - - - (P3)0 e-(k1 + kT)t + C
kL +kT
The constant can be evaluated at the limit of t=O, where e-k()bst = l.
kL(P3)0
then C = (P2) 0 + - - kL +kT
Hence:
kL(P3)0
x [1 - e·(kL + kT)t]

[(TCA)insh = (P2) 0 [1 - e-kst] +
kL +kT
kL(P3)0
In this equation, (P2) 0 +
kL +kT

(the constani C) is equa] to the total

TCA-insoluble radioactivity released by the end of the reaction, [(ICA)io:sJc;akL(P3)0
(P2)o and

can be determined directly from a no0Jioectrregress]a11
(kL + kT)

analysis of progress curves for the release of TCA-insoluble radioal:tiYi ty ~btaioed by
plotting
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[(TCA)ins1oo - [(TCA)insh vs. time
This procedure also yields two observed rate constants, ks and (kL + kr).
In a similar fashion, it is possible to demonstrate that
kT(P3)0
[(TCA)solh = (P1)0 [1 - e-knt] +

x [1 - e-(kL + kT)t]
kL +kT

again
(P 1)0 and

can be determined directly by a nonlinear regre s 1>i on anitl ysis of a
(kL + kT)

plot of [(TCA)sol1oo - [(TCA)solh vs. time
This procedure also yields the two rate constants kn and (kL + kT). Noie ihitt the rate
constant for the degradation of proteins in the lysosome, kn', is not obtainable from this
analysis.
Model2
In this model, cellular leakage is thought to be insigni:ficcn1t, and <TCA)ins
radioactivity arises solely by exocytosis from secreiory vacuoles in step 1> ks (JJ oo] 2) and
regurgitation from the lysosomes in step kR (pool 3 ').

P3 = (P3)oe-kTt
kT(P3)0
P3'=--kn'+kR
d (TCA)ins
kRkTP3
- - - = ksP2 + kRP3' = ksP2 + - - dt
kn'+ kR
d (TCA)sol
knkTPJ
_ _ _ _ =knP1 +kn'P3'=knP1 + _ __
dt

kn' +kR
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d (TCA)ins
kRkT
_ _ _ =ks(P2)oe-kst+ - - dt
Integrating yields
kR
[(TCA)ins1t = -(P2)0 e-kst -

(P3) 0 e-kr1 + C
kn'+kR

Solving for the constant of integration at t = 0, where e-k0 bst = I gives
kR
[(TCA)ins1t = (P2) 0 [1 - e-kst] +

(P3) 0 [I - e-krt]
kn'+kR

Similarly
kn'
[(TCA)solh = (P1) 0 [1 - e-knt] +
(P3)0 (1 - e-krt]
kn'+kR
kn'(P3) 0

kR(P3) 0

Again, (P1) 0 , (P2)0 ,
, kD, ks, and kT
(kn'+ kR) (kn'+ kR)
can be obtained from the nonlinear regression analysis of plots of
[(TCA)sol]oo - [(TCA)solh vs. time
[(TCA)insJoo - [(TCA)insh vs. time
Again, as for Model 1, the intrinsic degradation and exocytosis rate co11stan1s kD' and kR
cannot be determined. However, in this case the ratio kn' /kR can be calculated.
Model3
According to this model, there is no significant protein degradaiio11 in the
lysosomes. Instead, protein degradation occurs within the c~iosol and i11vQ]ves two
substrate pools (and possibly two degradative systems). 011e protein pool (P1) is
degraded rapidly, while the other (P3) is degraded slowly. The differences i11 clegradation
rates for these two populations may depend on the presence or abse11ce of J>rntein signals
which are recognized by particular cytosolic degradatiYe systems~ or may be due to
differences in the rates with which proteins in each pool undergo a modi:ficaiio11 which
precedes degradation.
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P 3 = (P 3)0e-(kn+ kn')t
d (TCA)ins
dt
d (TCA)ins
____ =

ks(P2) 0e-kst + kL(P3) 0e-(kL + kn')t

dt
Similarly:
d (TCA)sol
____ =

knP 1 + kn'P 3

dt
d (TCA)sol
- - - = kn(P1) 0 e-kn + kn'(P3) 0 e-(kL

+ kD')t

dt
Integrating these equations yields
kL
(P3) 0 x [I - e-(kL + ko')t]

[(TCA)inslt = (P2) 0 [1 - e-kst] +
kL +kn'

kn'
[(TCA)sollt = (P1) 0 [1 - e-knt] +
(P3) 0 x [I - e-(kL+ kn'h]
kL +kn'
Again, nonlinear regression analysis of plots of [(TCA)insloo- [(TCA)j 11s1t vs. tlme and
[(TCA)sollcX)- [(TCA)sollt vs. time yields values for
kL(P3)0

kn'(P3)0

(kn' + kL)

(kn' + kL)

, kn, ks and (kD' + kL)·

(P1) 0 , (P2) 0 ,

The kinetic consequences of Model 3 differ from Models I .and 2 in ihat the :intrinsic
degradation rate constant, kn', for the slow phase ofrelease of(TCA)sol radio.activity can
now be calculated. However, kn' may not correspond io a tme d~gradatiYe step, but to a
step in which a cytosolic protein is first recognized or modified.
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